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Introduction	  and	  aim	  of	  this	  thesis	  
	   11	  
	  Worldwide,	  an	  increasing	  number	  of	  biomaterial	   implantations	  are	  performed	  for	  
the	  restoration	  of	  human	  function	  to	  ensure	  a	  high	  quality	  of	   life	  during	  aging.	  Of	  
these	   operations,	   hip	   arthroplasty	   is	   considered	   one	   of	   the	  most	   successful.	   The	  
success	   of	   this	   frequent	   procedure	   has	   led	   to	   large	   patient	   cohorts.	  
Notwithstanding	   a	   vast	   improvement	   in	   surgical	   protocols,	   the	   complication	   of	   a	  
biomaterial-­‐associated	  infection	  still	  occurs	  in	  around	  1%	  of	  the	  patients	  receiving	  a	  
hip	  or	  knee	  replacement	  (1).	  Although	  1%	  may	  seem	  like	  an	  acceptable	  risk,	  deep	  
infections	   and	   the	   accompanying	   high	  morbidity	   remain	   a	   significant	   problem	   in	  
modern	  medicine	  due	  to	  the	  large	  numbers	  of	  implant	  operations	  (9).	  	  
Two	  decades	  ago,	  metal-­‐on-­‐metal	  (MOM)	  bearings	  were	  reintroduced	  on	  
the	  market.	  These	  “new”	  implants	  were	  initially	  praised	  because	  of	  their	  low	  wear	  
rates	  compared	  to	  the	  metal-­‐on-­‐polyethylene	  (MOP)	  bearings.	  MOM	  implants	  have	  
since	   been	   used	   frequently,	   primarily	   in	   the	   United	   Kingdom,	   Australia	   and	   the	  
United	   States	   (2;3;7).	   However,	   MOM	   bearing	   surfaces	   are	   currently	   becoming	  
under	   scrutiny	   of	   the	   scientific	   community	   (4),	   partly	   because	   of	   potential	   side-­‐
effects	   of	   their	   wear	   particles.	   Research	   institutions	   have	   been	   focusing	   on	   the	  
influences	   of	   metal	   particle	   debris	   in	   the	   human	   body,	   but	   due	   to	   its	   recent	  
introduction	  and	  the	  shortage	  of	  long	  term	  studies	  (6;8),	  the	  clinical	  outcome	  is	  still	  
unclear.	   Moreover,	   if	   and	   how	   MOM	   implants	   would	   influence	   infection	   rates	  
compared	  to	  conventional	  MOP	  bearings	  remains	  uncertain	  (5;8).	  The	  host	  defense	  
mechanism	   is	   compromised	   in	   the	   presence	   of	   a	   foreign	   material:	   the	   mere	  
presence	   of	   a	   foreign	   body	   itself	   reduces	   the	   minimum	   number	   of	   bacteria	  
required	   to	   cause	   infection	   (10).	   However,	   the	   influence	   of	   wear	   products	   from	  
modern	  orthopaedic	  bearing	  materials	  on	  infection	  is	  not	  yet	  established.	  
The	  aim	  of	   the	  work	  described	   in	   this	   thesis	   is	   to	  assess	   the	   influence	  of	  
MOM	  bearing	  wear	  on	  infection	  risk.	  Specifically,	  this	  involves	  the	  effects	  of	  Co-­‐Cr	  
ions	  and	  particulate	  Co-­‐Cr	  debris	  on	  bacterial	  growth.	  The	  majority	  of	   the	  studies	  
included	   in	   this	   thesis	   are	   in	   vitro	   studies,	   while	   two	   final	   chapters	   deal	   with	   an	  
animal	  study	  on	  the	  effects	  of	  different	  particulate	  debris	  on	  infection	  and,	  lastly,	  a	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Joint	  reconstructions	  with	  metal-­‐on-­‐metal	  (MOM)	  bearings	  have	  gained	  popularity	  
in	  the	  last	  decades	  in	  young	  and	  active	  patients.	  However,	  possible	  effects	  of	  MOM	  
wear	   debris	   and	   its	   corrosion	   products	   are	   controversial.	   Alongside	   potential	  
disadvantages	   such	   as	   toxicity,	   influences	   of	   metal	   particles	   and	   metal	   ions	   on	  
infection	  risk	  are	  unclear.	  	  
Methods	  	  
We	  reviewed	  available	  literature	  on	  the	  influence	  of	  degradation	  products	  of	  MOM	  
bearings	  in	  hip	  arthroplasties	  on	  infection	  risk.	  	  
Results	  	  
Wear	   products	   were	   found	   to	   influence	   the	   risk	   of	   infection	   by	   hampering	   the	  
immune	   system,	   inhibiting	   or	   accelerating	   bacterial	   growth	   and	   by	   a	   possible	  
antibiotic	  resistance	  and	  heavy	  metal	  co-­‐selection	  mechanism.	  	  
Conclusion	  	  
Whether	  the	  combined	  effects	  of	  MOM	  wear	  products	  predispose	  MOM	  bearings	  
as	   being	   less	   or	   more	   prone	   to	   infection,	   needs	   to	   be	   investigated	   in	   the	   near	  
future.	  
MOM	  wear	  effects	  on	  the	  host’s	  immune	  system	  and	  infection	  in	  hip	  arthroplasty	  
	   17	  
Introduction	  
Many	   young	   patients	   with	   painful	   coxarthrosis	   want	   to	   return	   to	   a	   high	   level	   of	  
activity	  and	  seek	  an	  implant	  that	  provides	  durability.	  Low	  wear	  rates	  of	  metal-­‐on-­‐
metal	   (MOM)	   bearings	   have	   led	   to	   a	   resurgence	   in	   the	   use	   of	   MOM	   bearings	  
(27;79;95;106;110).	   Thirty-­‐five	   percent	   of	   all	   prostheses	   in	   the	   United	   States	   in	  
2006	   (7)	   and	   16%	   of	   all	   prostheses	   implanted	   in	   Australia	   from	   1999	   to	   2007	  
contained	  MOM	  bearings	  (40).	  	  
Metal	   alloys	  used	   in	  MOM	  bearings	  degrade	  by	  wear,	   corrosion,	  or	  by	   a	  
combination	  of	   them	   (49;118).	  Consequently,	  MOM	  bearings	  produce	  nanometer	  
to	   submicrometer-­‐sized	   metal	   particles	   (19;30).	   The	   high	   number	   of	   these	   very	  
small	   particles	   presents	   a	   large	   cumulative	   surface	   area	   for	   corrosion.	   The	  
biological	   influences	   of	   these	   particles	   and	   its	   corrosion	   products	   in	   the	   human	  
body	  are	  for	  the	  most	  part	  unclear.	  Since	  the	  renewed	  interest	   in	  MOM	  bearings,	  
extensive	   research	   has	   been	   done	   to	   determine	   the	   consequences	   of	   local	   and	  
systemic	  exposure	  to	  wear	  particles	  and	  accompanying	  biologically	  active	  corrosion	  
products	   (2).	   It	   is	  well	   known	   that	  metal	   debris	   can	   induce	   pathological	   changes	  
such	   as	   the	   release	   of	   inflammatory	   cytokines	   from	   macrophages,	   histiocytosis,	  
fibrosis,	  or	  necrosis	  (5;15;16;39).	  Metal	  debris	  is	  also	  thought	  to	  be	  associated	  with	  
hypersensitivity	   and	   osteolysis	   (20;38;41;42;47).	   However,	   literature	   is	   scarce	   on	  
the	   bacteriological	   effects	   of	   these	   degradation	   products	   (3;45).	   It	   is	   therefore	  
unclear	  if	  the	  risk	  of	  infection	  is	  influenced.	  	  
The	   Australian	   and	   the	   New	   Zealand	   Joint	   Registry	   have	   demonstrated	  
that	   between	   9-­‐15%	   of	   all	   total	   hip	   arthroplasty	   (THA)	   revisions	   are	   carried	   out	  
because	  of	  infections	  related	  to	  the	  primary	  prosthesis	  (40;85).	  In	  case	  of	  infection,	  
bacteria	   adapt	   a	   biofilm	   mode	   of	   growth	   on	   the	   surface	   of	   the	   prosthesis,	  
increasing	   antibiotic	   resistance	   of	   biofilms	   which	   result	   in	   major	   treatment	  
difficulties	   (102).	   Removal	   and	   replacement	   of	   an	   infected	   implant	   is	   usually	  
required	  to	  eliminate	  the	  infection	  (8;107).	  Recent	  research	  efforts	  suggested	  that	  
particulate	   debris,	   of	   any	   composition,	   promotes	   bacterial	   growth	  by	   providing	   a	  
scaffold	   for	   bacterial	   adhesion	   and	   biofilm	   growth	   (3).	   On	   the	   other	   hand,	   high	  




Considering	   the	   paucity	   in	   publications	   on	   MOM	   particle	   influences	   on	  
infection,	  we	  here	  review	  the	   literature	  on	   influences	  of	  MOM	  wear	  particles	  and	  




First-­‐generation	  MOM	  hip	  bearings	  encompass	  prostheses	  developed	  in	  the	  1960s,	  
such	   as	   the	   McKee-­‐Farrar-­‐,	   the	   Ring-­‐,	   the	   Stanmore-­‐	   and	   the	   Sivash-­‐prostheses	  
(66;84;89;98).	   Implants	   from	  this	  era	   survived	   for	  more	   than	  25	  years	  because	  of	  
low	   wear	   rates	   and	   minimal	   osteolysis	   (2).	   An	   analysis	   of	   253	   Ring	   MOM	   hip	  
arthroplasties	   revealed	  a	   cumulative	   survival	   rate	  of	  60%	  after	  21	  years	   (12).	  The	  
McKee-­‐Farrar	  prosthesis	  performed	  equally	  well	  compared	  to	  the	  Ring	  arthroplasty	  
up	  to	  26	  years	  after	  initial	  implantation	  (91).	  However,	  alongside	  these	  encouraging	  
durability	   results,	   first-­‐generation	   MOM	   studies	   also	   demonstrated	   metal	   wear	  
debris	   in	   tissues	   adjacent	   to	   the	   implants,	   particularly	   in	   prostheses	   with	   loose	  
components	  or	  impingement	  (46).	  Furthermore,	  early	  MOM	  designs	  turned	  out	  to	  
cause	  frequent	  early	  cup	  loosening	  (91).	  	  
First-­‐generation	   MOM	   articulations	   were	   commonly	   used	   until	   the	   mid	  
1970s.	  Most	  were	  abandoned	  in	  favor	  of	  metal-­‐on-­‐polyethylene	  (MOP)	  articulation.	  
The	  main	  reason	  for	  this	  change	  was	  the	  introduction	  of	  the	  Charnley	  low-­‐friction	  
arthroplasty	   (23),	   which	   is	   still	   one	   of	   the	   most	   extensively	   documented	   hip	  
prosthesis	  in	  the	  literature	  (17;18;117).	  Long-­‐term	  results	  of	  first-­‐generation	  MOM	  
implants	   had	   boosted	   their	   popularity	   and	   lead	   to	   development	   of	   second-­‐
generation	  MOM	  implants	  in	  the	  early	  1980s.	  In	  addition,	  polyethylene	  wear	  from	  
MOP	  implants	  had	  then	  been	  hypothesized	  to	  cause	  osteolysis	  around	  the	  implant	  
(77;116),	  which	  stimulated	  renewed	  interest	  in	  alternative	  bearings	  lacking	  a	  MOP	  
interface,	  like	  the	  second-­‐generation	  MOM	  bearings	  (11).	  	  
Second-­‐generation	  MOM	  implants	  possess	  an	  improved	  bearing	  interface	  
and	   are	   comprised	   of	   alloys	  with	   an	   increased	  metal	   hardness.	   Therefore,	   newly	  
produced	   bearings	   have	   substantially	   lower	   wear	   rates	   than	   highly	   cross-­‐linked	  
polyethylene	   (36).	   On	   the	   whole,	   volumetric	   wear	   is	   decreased	   20	   to	   100-­‐fold	  
compared	   to	  MOP	   implants	   (95),	   suggesting	   second-­‐generation	  MOM	  prostheses	  
may	   considerably	   reduce	   osteolysis	   (94).	   Although	   mid-­‐	   and	   long-­‐term	   clinical	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results	   of	   MOM	   bearings	   appeared	   to	   have	   demonstrated	   excellent	   durability,	  




For	   implant	   alloys	   worldwide,	   two	   nomenclatures	   are	   practiced	   parallel	   to	   each	  
other	   (Table	   I).	   First	  of	  all,	  ASTM-­‐standards	  with	   the	  capital	   “F”	   (medical	  devices)	  
are	  practiced	  mainly	   in	  the	  USA	  (44).	  Secondly,	   ISO-­‐standards	  are	  accepted	   in	  the	  
rest	  of	  the	  world.	  The	  two	  approved	  cobalt-­‐chromium	  (Co-­‐Cr)	  alloys	  contain	  almost	  
similar	  amounts	  of	  alloying	  elements.	  However,	   information	  on	  the	  exact	  content	  
of	  certain	  elements	  such	  as	  nickel	  (Ni)	  and	  iron	  (Fe)	  is	  unknown	  as	  these	  standards	  
only	  report	  maximum	  dosages.	  
	  
Table	   I.	   Required	   chemical	   composition	   and	  mechanical	   properties	   of	   CoCr	   alloy	  
concerning	  ASTM	  F75	  and	  ISO	  5832-­‐4	  
	  
aTensile	  strength	  is	  the	  stress	  at	  which	  a	  material	  breaks	  or	  permanently	  deforms.	  	  




Wear	   of	   bearings	   can	   result	   from	   scratching	   and	   pounding	   of	   the	   surfaces	   and,	  
eventually,	   in	  erosion	  of	  the	  material.	  Wear	  and	  corrosion	  are	  probably	  the	  major	  
cause	  of	  metal	  release	  into	  tissues	  of	  MOM	  patients	  and	  this	  poses	  a	  major	  concern	  
regarding	  the	  use	  of	  MOM	  articulating	  devices.	  Linear	  wear	  rates	  range	  from	  5	  to	  
	   ASTM	  F75	  	   ISO	  5832-­‐4	  	  
Rma	  (MPa)	   	   655	   665	  
Rp	  0.2%b	  (MPa)	   450	   450	  
	   	   	  
Cobalt,	  Co	   balance	  to	  100%	   balance	  to	  100%	  
Chromium,	  Cr	   27-­‐30%	   27–30%	  
Molybdenum,	  
Mo	  
5.0-­‐7.0%	   4.5-­‐7.0%	  
Nickel,	  Ni	   <0.5%	   <1%	  
Iron,	  Fe	   <0.75%	   <1%	  
Silicon,	  Si	   <1%	   <1%	  
Manganese,	  Mn	   <1%	   <1%	  
Carbon,	  C	   	   <0.35%	   <0.35%	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25	   µm/year	   and	   are	   dependent	   on	   a	   multitude	   of	   factors	   such	   as	   the	   type	   of	  
implant	  and	  positioning	  (76;93;114)	  (Table	  II).	  	  
	  
Table	  II.	  Wear	  rates	  of	  MOM	  bearing	  couples	  defined	  in	  different	  units	  
Type	  of	  wear	   Wear	  rate	   Method	  	   Ref.	  
Linear	  wear	  rate	  of	  femoral	  
heads	  per	  year	  
	  
First	  year	  
>	  3	  year	  
7.6	  μm	  (range	  2.9-­‐13)	  to	  














Volumetric	  wear	  rate	  of	  femoral	  
heads	  per	  year	  
2.0	  mm3	  (range	  0.55-­‐3.7)	  





Mass	  wear	  rate	  per	  year	   17	  mg	  (range	  4.6-­‐31)	   Explanted	  implant(s)	   (83)	  
Number	  of	  particles	  per	  unit	  
volume	  of	  wear	  (mm3)	  
2.7	  x	  1012	  	  to	  1.5	  x	  1013	   Pin-­‐on-­‐plate	   (101)	  
Number	  of	  particles	  per	  106	  
cycles	  
4	  x	  1012	  –	  6	  x	  1013	   Pin-­‐on-­‐plate	   (101)	  
Number	  of	  particles	  per	  year	   6.7	  x	  1012	  –	  2.5	  x	  1014	  	   Explanted	  implant(s)	   (30)	  
Note:	  Retrieval	  study	  data	  was	  obtained	  from	  patients	  undergoing	  revision	  of	  THAs	  with	  MOM	  bearing	  
couples.	  Radiograph	  wear	  analysis	  was	  performed	  with	  digitized	  anteroposterior	  (AP)	  radiographs	  with	  a	  
computerized	  method.	  	  
	  
Metal	  particles	  
Currently,	   tribological	   research	   is	   being	   conducted	   towards	   the	   exact	   process	   of	  
particle	   generation.	   Recent	   tribological	   investigations	   revealed	   that	   a	   nano-­‐
crystalline	   layer	  of	  250	   to	  400	  nm	  thick	   is	   formed	  on	   the	  MOM	   implant	   surfaces,	  
containing	  amongst	  others	  proteins	   from	  the	   interfacial	  medium	  (81).	  Cracking	  of	  
this	  nano-­‐crystalline	  layer	  due	  to	  surface	  fatigue	  has	  been	  suggested	  to	  be	  the	  main	  
mechanism	  of	  wear	  particle	  generation	  (13).	  Abrasive	  particles	  of	  MOM	  prostheses	  
can	  cause	   local	  damage,	  resulting	   in	  an	  accelerated	  release	  of	  metal	  particles	  and	  
ions	  (119).	  	  
Germain	   et	   al.	   (2003)	   emphasized	   that	   nature,	   size,	   and	   amount	   of	  
particles	  are	  important	  determinants	  in	  biological	  effects	  of	  wear	  debris	  on	  cells	  in	  
vitro.	  The	  reaction	  of	   the	  body	   is	  dependent	  on	  the	  particle	  characteristics	   (Table	  
III).	   Size	   analysis	   of	   particles	   isolated	   from	   failed	   arthroplasties	   revealed	   a	  mean	  
size	   of	   660	   nm	   for	   polyethylene	   particles	   in	  MOP	   patients	   (68)	   and	   a	   size	   range	  
from	  51	  to	  116	  nm	  for	  MOM	  debris	  (29).	  	  
	  
Metal	  ions	  
The	  first	  report	  on	  visible	  corrosion	  of	  an	  orthopedic	  Vitallium	  implant	  (60%	  Co	  and	  
20%	  Cr)	  was	  published	  by	  Weightman	  et	  al.	   in	  1969.	  Before	  this	  clinical	   finding,	   it	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was	   generally	   accepted	   that	   Vitallium	   alloys	   provided	   adequate	   corrosion	  
resistance	  (90).	  However,	  generation	  of	  metal	  ions	  is	  also	  evident	  in	  modern,	  more	  
corrosion	  resistant,	  MOM	  alloys.	  	  
Various	  mechanisms	  of	  corrosion	  can	  cause	  the	  release	  of	  metal	  ions.	  One	  
is	  fretting	  corrosion	  due	  to	  the	  movement	  of	  articulating	  surfaces	  causing	  damage	  
to	  one	  or	  both	  surfaces.	  Disruption	  of	  the	  passive	  oxide	  layer	  causes	  direct	  contact	  
with	   the	   metal	   surface	   promoting	   fretting	   corrosion	   (Figure	   1),	   which	   can	   be	  
further	  enhanced	  by	  the	  presence	  of	  adhering	  microorganisms	  (70).	  	  
	  
	  
Figure	  1.	  Schematic	  drawing	  illustrating:	  
a. Generation	  of	  wear	  particles	  
b. A	   metal	   alloy	   (grey	   scaffold)	   with	   an	   oxidated	   surface	   film	   (red	   molecules)	   on	   the	   upper	  
surface.	  	  
c. Damaging	  of	  the	  passive	  surface	  film	  (e.g.	  by	  scratching	  or	  pounding).	  
d. Corrosion	  occuring	  due	  to	  the	  lack	  of	  a	  protective	  layer.	  	  
e. Soluble	  compounds	  and	  wear	  particle	  liberation.	  	  
f. Repassivation	  of	  the	  surfaces	  including	  wear	  particles	  (arrows). 
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Metal	   ions	  of	  different	  valencies	  are	  released	  from	  Co-­‐Cr	  alloys	  and	  their	  
effects	  vary	  with	  the	  type	  of	  oxide	  compound	  they	  form	  (108)	  (Table	  IV).	  Co+2	  and	  
Cr+3	  ions	  dominate	  under	  physiological	  conditions	  because	  these	  ions	  are	  the	  most	  
stable	   at	   neutral	   pH.	   However,	   no	   stable	   Co-­‐oxide	   exists	   and	   thus	   formation	   of	  
soluble	  Co-­‐ions	  instead	  of	  solid	  Co-­‐oxides	  is	  favored.	  On	  the	  other	  hand,	  Cr+3	  oxides	  
are	  stable	  in	  physiological	  conditions.	  In	  vitro	  models	  show	  that	  toxic	  effects	  of	  Co-­‐
Cr	  are	  probably	  due	  to	  Co+2	  ions	  (37;82).	  	  
	  
Table	   III.	   Size	   and	  morphology	   of	  wear	   particles	   generated	  by	   a	   hip	   simulator	   or	  
derived	  from	  tissue	  samples	  
Size	  and	  morphology	   Particles	  generation	  and	  type	  of	  prosthesis	  	   Method	   Ref.	  
80	  ±	  40	  nm,	  round	   Hip	  simulator	  with	  bearing	  ASTM	  F	  799	  and	  
F1357	  Co-­‐28Cr-­‐6Mo	  
TEM	   (21)	  
50-­‐90	  nm,	  oval	  or	  needle	   Hip	  simulator	  with	  bearing	  ASTM	  F	  799	  and	  
F1357	  Co-­‐28Cr-­‐6Mo	  
SEM	   (101)	  
25-­‐36	  nm,	  round	   Hip	  simulator	  with	  bearing	  ASTM	  F	  799	  and	  
F1357	  Co-­‐28Cr-­‐6Mo	  
TEM	   (35)	  
<	  50	  nm	  	  (range	  6-­‐834	  nm),	  
oval	  or	  round	  
Periprosthetic	  tissue	  samples	  of	  2	  McKeeFarrar	  
and	  one	  McMinn	  prosthesis	  
TEM	   (30)	  
<	  50	  nm,	  irregular	   Periprosthetic	  tissue	  samples	  of	  640	  Sikomet	  
SM21	  	  	  
SEM	   (10)	  
40-­‐120	  nm,	  needle	  
<90	  nm,	  round	  
Periprosthetic	  tissue	  samples	  of	  one	  Bicon	  plus	  
Ti	  shell	  with	  polyethylene	  liner,	  Sikomet	  SM21	  






TEM:	  Transmission	  electron	  microscopy	  
SEM:	  Scanning	  electron	  microscopy	  
XPS:	  X-­‐ray	  photoelectron	  spectroscopy	  
	  
	  
Table	  IV.	  Oxidation	  states	  found	  in	  compounds	  of	  the	  Co-­‐Cr	  alloy	  elements	  
Cobalt	   Chromium	   Manganese	   Iron	   Nickel	  	   Silicon	   Molybdenum	  
-­‐1	   -­‐2	   -­‐3	   -­‐2	   -­‐1	   -­‐4a	   -­‐2	  
+1	   -­‐1	   -­‐2	   -­‐1	   +1	   -­‐3	   -­‐1	  
+2a	   +1	   -­‐1	   +1	   +2a	   -­‐2	   +1	  
+3a	   +2	   +1	   +2a	   +3	   -­‐1	   +2	  
+4	   +3a	   +2a	   +3a	   +4	   +1	   +3	  
+5	   +4	   +3	   +4	   	   +2	   +4a	  
	   +5	   +4a	   +5	   	   +3	   +5	  
	   +6a	   +5	   +6	   	   +4a	   +6a	  
	   	   +6	   	   	   	   	  
	   	   +7a	   	   	   	   	  
a	  represents	  more	  common	  oxidation	  states. 
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Local	  concentrations 
Metal	   ions	   may	   spread	   throughout	   the	   body.	   Ion	   levels	   have	   been	  measured	   in	  
whole	   blood,	   serum,	   erythrocytes	   and	   various	   solid	   tissues	   (24;58;87).	   Serum	   Co	  
levels	  are	  the	  most	  frequently	  reported	  metal	   ion	  concentrations	  and	  were	  found	  
to	  be	  5	  to	  6-­‐fold	  greater	  in	  patients	  after	  MOM-­‐implantation	  than	  pre-­‐operatively	  
(58).	  	  
Two	  well-­‐received	  consensus	  papers	  describe	  the	  need	  to	  measure	  metal	  
ion	  concentrations	  in	  joint	  fluids	  of	  MOM	  patients	  (1;65),	  in	  addition	  to	  measuring	  
metal	   concentrations	   in	   serum	   (87;106).	   However,	   most	   research	   into	  metal	   ion	  
concentrations	   does	   not	   report	   the	   regional	   or	   local	   dissemination,	   as	   synovial	  
biopsies	  are	  undesirable	  in	  otherwise	  healthy	  MOM	  patients	  (87).	  
Reliable	  information	  about	  the	  exact	  local	  concentrations	  of	  Co–Cr	  around	  
prostheses	  is	  thus	  scarce	  (Table	  V).	  Concentrations	  of	  metal	   ions	  are	  found	  with	  a	  
range	  of	  6	  to	  6,000,000	  µg/L	  Co.	  This	  difference	  is	  related	  to	  alignment	  and	  type	  of	  
the	  prostheses	  (76;93;114),	  but	  also	  to	  improving	  detection	  methods	  (31).	  	  
	  
Table	  V.	  Maximum	  local	  tissue	  Co-­‐Cr	  ion	  levels	  in	  patients	  with	  a	  MOM	  implant.	  
Sample	   Prosthesis	   Cobalt	  (µg/L)	   Chromium	  (µg/L)	   Method	   Ref.	  
Capsule	   Cemented	  and	  loose	   26,000	   88,000	   NAA	   (33)	  
Synovial	  fluid	  	  
Capsule	  
Cemented	  and	  loose	   250	  
22,000	  
	   NAA	   (51)	  
Femoral	  neck	  	  
Acetabulum	  	  
Lining	  from	  femoral	  
stem	  	  
Adjacent	  to	  articular	  
surfaces	  
Acetabular	  pelvic	  lining	  












SES	   (99)	  






Tissue	  (mid	  femur)	  










GSGSD	   (28)	  








(well	  fixed	  and	  loose)	  
	  
Cementless	  













GFAAS	  	   (31)	  
Synovial	  fluid	  
Synovial	  fluid	  
Cemented	  and	  well	  fixed	  





GFAAS	   (9)	  
NAA:	  Neutron	  activation	  analysis	  
SES:	  Spark	  emission	  spectroscopy	  
AAS:	  Atomic	  absorption	  spectroscopy	  
GFAAS:	  Graphite	  furnace	  atomic	  absorption	  spectrophotometry	  




Table	   VI.	  Maximum	   levels	   of	   Co-­‐Cr	   ions	   as	   measured	   in	   hip	   simulator	   lubricant,	  
categorized	  by	  MOM	  implant	  head	  size	  and	  amount	  of	  cycles.	  
Head	  
size	  
Cobalt	  (µg/l)	   Chromium	  (µg/L)	   Method	   Cycles	   Ref.	  
55	  mm	  	  





ICP-­‐MS	   0.13	  Mc	   (59)	  






ICP-­‐MS	   0.13	  Mc	   (60)	  






ICP-­‐MS	  	   4	  Mc	  	   (113)	  
ICP-­‐MS:	  Inductively	  coupled	  plasma	  mass	  spectroscopy	  
Mc:	  Million	  cycles	  
	  
Wear	  rates	  reported	  in	  recent	  hip	  simulator	  studies	  turn	  out	  to	  be	  closely	  
correlated	   to	  Co	   ion	   levels	   (113),	   but	  measuring	   ion	   levels	   in	   the	   lubricant	  of	   hip	  
simulators	  resembles	  only	  certain	  aspects	  of	  the	  clinical	  situation.	  There	  is	  no	  free	  
exchange	  between	  blood	  and	  synovial	  fluid	  (31)	  and,	  therefore,	  wear	  products	  can	  
accumulate	  in	  simulator	  systems	  resulting	  in	  higher	  Co-­‐Cr	  levels	  than	  would	  occur	  
clinically	  (Table	  VI).	  	  
	  
Influence	  of	  MOM	  wear	  particles	  and	  corrosion	  products	  on	  the	  immune	  system	  
Orthopaedic	   metals	   and	   their	   corrosion	   products	   modulate	   the	   activities	   of	   the	  
immune	  system	  by	  influencing	  immunocompetent	  organs	  and	  cells	  by	  a	  variety	  of	  
immuno-­‐stimulatory	  or	  immuno-­‐suppressive	  mechanisms.	  Metal	  particles	  and	  ions	  
spread	   throughout	   the	  whole	  body	  via	   lymph	  and	  blood	  have,	   for	   instance,	  been	  
identified	   within	   macrophages	   in	   the	   liver	   and	   spleen	   (104;105).	   The	   long-­‐term	  
effects	   of	   the	   distant	   spread	   and	   accumulation	   of	  wear	   particles	   in	   the	   liver	   and	  
spleen	  are	  unknown,	  but	   indicate	   that	   the	   immune	   system	  may	  be	  hampered.	   In	  
this	   context,	   it	   should	   be	   emphasized	   that	   the	  mere	   presence	   of	   a	   foreign	   body	  
itself	  already	  reduces	  the	  minimum	  number	  of	  bacteria	  required	  to	  cause	  infection	  
(122).	  	  
Another	   important	   issue	   is	   the	  hypothetical	   carcinogenesis	   due	   to	  MOM	  
implants	  and	   its	  accompanying	  occupation	  of	   the	   immune	  system	   in	  combination	  
with	   the	  use	  of	   immuno-­‐suppressiva.	   Ion	   release	  has	  been	   suspected	   to	   increase	  
the	  risk	  of	  DNA	  damage	  (57;88)	  and	  it	  was	  recently	  found	  that	  Co-­‐Cr	  nanoparticles	  
cause	   DNA	   damage	   across	   a	   cellular	   barrier	   (6).	   In	   addition,	   a	   reduction	   of	  
circulating	  cytotoxic	  CD8+	  T-­‐cells,	  responsible	  for	  destroying	  tumor	  cells,	  was	  found	  
in	  patients	  with	  a	  MOM	  implant	  (64;75).	  However,	  epidemiological	  studies	  do	  not	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allow	  conclusions	   regarding	   the	   incidence	  of	   cancer	   in	  MOM	  patients	   (32;74;109)	  
and	   will	   not	   become	   available	   anytime	   soon,	   as	   such	   studies	   would	   require	  
thousands	  of	  patients	  to	  be	  followed	  for	  several	  decades	  (65).	  
 
Spleen	  
The	   spleen	   is	   an	   important	   meeting	   point	   between	   antigenic	   information	  
transported	  by	  the	  blood	  and	  the	  immune	  system.	  Because	  of	  the	  central	  position	  
in	   the	   bloodstream	   and	   the	   large	   blood	   supply	   of	   about	   5%	   of	   the	   total	   blood	  
volume	  per	  minute,	  the	  spleen	  will	  inevitably	  be	  exposed	  to	  corrosion	  products	  of	  
MOM	   bearings.	   High	   concentrations	   of	   metal	   ions	   (375,000/200,000	   µg/L	   Co-­‐Cr)	  
have	  been	   shown	   to	   cause	  alterations	   in	   spleen	  architecture	  and	  depletion	  of	   T4	  
and	   B	   cells.	   Therefore,	   the	   immune	   system	   and	   its	   defence	   against	   bacteria	  may	  
become	  hampered	  by	  metal	  ions	  (34).	  	  
	  
Liver	  
The	   liver	   is	   part	   of	   the	   human	   immune	   system	   and	   not	   only	   contains	   many	  
immunologically	   active	   cells,	   but	   also	   detoxifies	   the	   body	   from	   environmental	  
toxins.	  Metals	   can	   not	   be	   eliminated	   from	   tissues	   by	  metabolic	   degradation,	   but	  
only	   by	   renal	   or	   gastrointestinal	   excretion	   (24).	   There	   is	   evidence	   from	   a	   recent	  
animal	  study	  to	  suggest	  that	  Cr	  ions	  can	  accumulate	  in	  the	  liver	  (50).	  High	  levels	  of	  
metal	   in	   the	   body	   may	   cause	   hepatocellular	   necrosis,	   as	   observed	   after	   acute	  
ingestion	  of	  Cr4+	   in	  humans.	  Clinically	   relevant	   concentrations	  of	  Cr4+	   (10–25	  µM)	  
were	  found	  to	  inhibit	  macromolecular	  syntheses	  in	  the	  liver	  (53).	  	  
	  
Immuno-­‐competent	  cells	  
Phagocyting	   cells	   like	   neutrophils	   are	   vital	   in	   the	   host	   defence	   against	   infection.	  
These	   ‘first	   responders	   in	   microbial	   infection’	   are	   usually	   found	   in	   infected	  
periprosthetic	  tissues.	  However,	  corrosion	  products	  of	  Co-­‐Cr	  implant	  materials	  are	  
reported	  to	  inhibit	  the	  rapid	  release	  of	  reactive	  oxygen	  species	  needed	  for	  bacterial	  
killing	  by	  neutrophils	  (92).	   In	  vitro	  studies	  also	  showed	  that	  Co-­‐Cr	  particles	   induce	  
toxic	   effects	   after	   they	   are	   phagocytosed	   because	   of	   the	   drop	   in	   pH	   within	   the	  
phagosome	   (48).	  Due	   to	  wear	  debris	   induced	  granulocyte	  defects,	  MOM	  patients	  
may	  be	  predisposed	  to	  infection	  at	  the	  implant	  site	  (120-­‐122).	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Degradation	  products,	  either	   in	   the	   form	  of	  metal	   ions	  or	  wear	  particles,	  
can	  complex	  with	  local	  proteins	  and	  induce	  an	  allergic	  response	  comparable	  with	  a	  
delayed-­‐type	   hypersensitivity	   response	   (type	   IV),	   through	   activation	   of	   T	  
lymphocytes	   (26;38).	   The	   histological	   response	   in	   patients	  with	  MOM	  bearings	   is	  
unique	   in	   its	   kind	   and	   is	   referred	   to	   as	   aseptic	   lymphocyte	   dominated	   vasculitis-­‐
associated	   lesion	   (ALVAL)	   (111).	   In	   addition,	   a	   statistical	   reduction	   in	   circulating	  
lymphocytes,	   in	  particular	  of	  CD8	  and	  T-­‐cells,	  has	  been	  observed	   in	  patients	  with	  
MOM	   bearings	   (64;75).	   However,	   beneath	   concentrations	   of	   5	   µg/L	   Co-­‐Cr,	   no	  
reduction	   was	   detected.	   No	   adverse	   clinical	   symptoms	   are	   observed	   in	   patients	  
with	  increased	  metal	  ion	  concentrations	  in	  serum	  (43).	  	  
	  
Influence	  of	  MOM	  degradation	  products	  on	  bacteria	  	  
Heavy	  metal	  toxicity	  
Metal	  ions	  have	  been	  used	  for	  centuries	  to	  cure	  infections	  and	  it	  is	  conceivable	  that	  
wear	  products	  of	  MOM	  prostheses	  may	  be	  toxic	  to	  bacteria.	  There	  is	  in	  vitro	  and	  in	  
vivo	   evidence	   that	  wear	  particles	  have	   toxic	  effects	  on	  human	  cells	   (15;51;78).	   In	  
vitro	   research	   towards	   influences	  of	  Co-­‐Cr	   ions	  on	  bacteria	  provides	  evidence	   for	  
bacteriostatic	  effects	  (3),	  hypothetically	  involving	  competition	  with	  Fe	  for	  uptake	  in	  
the	  bacterial	  cell.	  Fe	  is	  an	  important	  nutrient	  element	  required	  by	  specific	  microbial	  
species	   which	   use	   oxidation	   of	   elemental	   Fe	   or	   conversion	   of	   Fe+2	   to	   Fe+3	   as	   an	  
energy	  source	  for	  their	  metabolism.	  Inhibition	  of	  Fe-­‐dependent	  metabolic	  activities	  
by	  Co	  ions	  has	  been	  demonstrated	  to	  lead	  to	  growth	  retardation	  and	  cell	  death	  in	  
Pseudomonas	  aeruginosa	  (56).	  	  
Within	   tissue	   cells,	   nanoparticles	   are	   exposed	   to	   a	   series	   of	   oxidative	  
mechanisms	  designed	  to	  destroy	  the	  foreign	  body,	  which	  leads	  to	  the	  generation	  of	  
metal	   ions	  (63).	  Reactions	  with	  metal	   ions	  can	   lead	  to	  generation	  of	  free	  radicals:	  
reactive	   oxygen	   species	   (ROS)	   and	   reactive	   nitrogen	   species	   (RNS),	  which	   can,	   in	  
turn,	  cause	  cellular	  dysfunction.	  ROS	  and	  RNS	  are	  known	  to	  be	  involved	  in	  protein	  
oxidation,	   leading	   to	   their	   degradation,	   lipid	   peroxidation,	   and	   DNA	   damage.	  
Generation	  of	  ROS	  and	  RNS	  may,	  hypothetically,	  cause	  toxicity	  in	  bacteria	  as	  well.	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Bacterial	  growth	  and	  biofilm	  formation	  	  
Recent	  publications	  have	  evaluated	  the	  influence	  of	  Co-­‐Cr	  ions	  and	  Co-­‐Cr	  particles	  
on	  bacterial	  growth.	  Co-­‐Cr	  concentrations	  up	  to	  20/9	  µg/L,	  as	  reported	  to	  occur	  in	  
serum,	   revealed	   no	   consistent	   influence	   on	   biofilm	   formation,	   but	   higher	  
concentrations	  of	  200,000/93,000	  µg/L	  statistically	  reduced	  Staphylococcus	  aureus	  
and	  CNS	  planktonic	  growth	  and	  biofilm	  formation	   (45),	  suggesting	  MOM	  bearings	  
may	   be	   less	   prone	   to	   biofilm	   formation	   and	   subsequent	   infection.	   On	   the	   other	  
hand,	   Anwar	   et	   al.	   (2007)	   showed	   that	   wear	   debris	   from	   MOM	   bearings	  
accelerated	   the	   growth	  of	   planktonic	   bacteria.	  Aggregated	  particulate	  debris	  was	  
discussed	  to	  promote	  growth	  by	  providing	  a	  scaffold	  on	  which	  biofilm	  can	  grow.	  In	  
addition,	   it	   can	  be	  hypothesized	   that	  nano-­‐sized	  particles	   scattered	   throughout	   a	  
biofilm	   would	   enhance	   the	   strength	   of	   its	   structure	   by	   working	   as	   a	   composite	  
scaffold	   on	   a	   macroscopic	   level.	   Moreover,	   it	   is	   also	   possible	   that	   detached	  
particles	   embedded	   in	   a	   biofilm,	  might	   act	   as	   carriers	   of	   biofilm	   throughout	   the	  
joint	  and	  body.	  	  	  
	  
Heavy	  metal	  resistance	  	  
Bacteria	  have	  co-­‐existed	  with	  abundant	  toxic	  heavy	  metals	  since	  the	  beginning	  of	  
life.	   Therefore,	   it	   was	   essential	   for	   bacteria	   to	   develop	   mechanisms	   for	   metal-­‐
resistance.	   Bacterial	   resistance	   to	   metal	   toxicity	   is	   not	   only	   an	   environmentally	  
important	   phenomenon,	   but	   also	   has	   clinical	   implications	   for	   metal-­‐bacterium	  
interactions	   in	  MOM	  patients.	   Bacterial	   resistance	  mechanisms	   differ	  widely	   (96)	  
and	   are	   currently	   subject	   to	   extensive	   studies.	   There	   are	   enzyme	   oxidases	   and	  
reductases	   to	   convert	   metal	   ions	   from	   more	   toxic	   into	   less	   toxic	   (14;22;52;62).	  
There	   is	  also	  the	  possibility	  of	  binding	  heavy	  metals	   in	  the	  bacterial	  cell	  wall	   (54).	  
Blocking	  of	  cellular	  uptake	  is	  also	  an	  option	  by	  altering	  the	  uptake	  pathway.	  Once	  
the	   toxic	   heavy	  metal	   has	   reached	   the	   intracellular	   cytoplasm,	   it	   can	  be	  pumped	  
out	   again	   by	   a	   high	   efflux	   system	   (71;73).	   Efflux	   pumps	   are	   the	  major	   currently	  
known	  group	  of	  resistance	  systems.	  	  	  	  
	  
Co-­‐selection	  of	  antibiotic	  and	  metal	  resistance	  	  
There	   is	   growing	   concern	   that	   metal	   contamination	   may	   function	   as	   a	   selective	  
agent	   in	   the	   proliferation	   of	   antibiotic	   resistance	   (4).	   It	   is	   hypothesized	   that	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antibiotic-­‐resistant	  bacteria	  can	  be	  maintained	  in	  the	  environment	  owing	  to	  the	  co-­‐
regulation	  of	  resistance	  pathways	  (4;115).	  These	  co-­‐selection	  mechanisms	   include	  
co-­‐resistance	   (different	   resistance	   determinants	   present	   on	   the	   same	   genetic	  
element)	   and	   cross-­‐resistance	   (the	   same	   genetic	   determinant	   responsible	   for	   a	  
conjoint	   resistance	   to	   antibiotics	   and	  metals).	   Co-­‐resistance	   in	   clinical	   isolates	   of	  
Staphylococcus	  species	  has	  been	  described	  against	  multiple	  metals	  and	  antibiotics	  
(103),	   but	   the	   most	   common	   co-­‐resistance	   involved	   Cr,	   Pb	   and	   penicillin.	   Co-­‐Cr	  
increased	   the	   sensitivity	   of	   staphylococci	   to	   penicillin,	   while	   sensitivity	   to	  
tetracycline	  decreased	  (69).	  The	  mechanisms	  behind	  this	  co-­‐selection	  are	  currently	  
investigated.	   However,	   it	   has	   been	   found	   that	   the	   reduction	   in	   permeability	   of	  
bacteria	  causes	  Co,	  and	  Ag	  resistance,	  via	  a	  similar	  mechanism	  which	  is	  responsible	  
for	   inhibiting	   ß-­‐lactam,	   ciprofloxacin,	   tetracycline	   and	   chloramphenicol	   from	  
entering	  the	  bacterium	  (86;97).	  On	  top	  of	  this,	  reduced	  permeability,	  a	  rapid	  efflux	  
mechanism,	  is	  also	  used	  to	  prevent	  Co,	  Cu,	  Zn,	  Cd	  and	  Ni	  from	  entering	  the	  micro-­‐
organism,	   similar	   to	   the	   resistance	   mechanism	   of	   ß-­‐lactam,	   tetracycline	   and	  
chloramphenicol	   (61;72).	   The	   clinical	   incidence	   of	   co-­‐selection	   mechanisms	   of	  
resistance	  factors	  in	  pathogenic	  bacteria	  for	  antibiotics	  and	  heavy	  metals	  and	  their	  
clinical	  implications	  remain	  unknown.	  
	  
Conclusions	  
Unfortunately,	  long-­‐term	  clinical	  data	  on	  infection	  rates	  for	  MOM	  bearings	  are	  not	  
yet	   available	   and	   therefore	   actual	   clinical	   influences	   on	   infection	   could	   not	   be	  
evaluated.	  To	  assess	  the	  clinical	  influence	  of	  bearing	  type	  on	  infection	  risk,	  studies	  
will	   require	   thousands	   of	   patients	   to	   be	   followed	   for	   several	   decades.	   Such	   data	  
may	  soon	  become	  available	  from	  national	   joint	  registries	  and	  their	  evaluation	  will	  
shed	   light	   on	   the	   net	   influence	   of	   bearing	   type	   on	   infection	   risk.	   However,	   this	  
review	   suggests	   that	  wear	   particles	   and	   its	   corrosion	  products	  may	   influence	   the	  
risk	   of	   infection	   by	   hampering	   the	   immune	   system,	   inhibiting	   or	   accelerating	  
bacterial	   growth	   and	   by	   a	   possible	   antibiotic	   resistance	   and	   heavy	   metal	   co-­‐
selection	  mechanism.	  Whether	  this	   influence	  results	   in	  an	  increase	  or	  decrease	  of	  
clinical	  infection	  rates	  has	  not	  yet	  been	  investigated.	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Metal-­‐on-­‐metal	   (MOM)	  bearings	   involving	   cobalt-­‐chromium	   (Co-­‐Cr)	   alloys	   in	   total	  
hip	   arthroplasties	   are	   becoming	   increasingly	   popular	   due	   to	   their	   low	   wear.	  
Consequences	  of	  corrosion	  products	  of	  Co-­‐Cr	  alloys	  are	  for	  the	  most	  part	  unclear,	  
and	   the	   influence	   of	   cobalt	   and	   chromium	   ions	   on	   biofilm	   formation	   has	   never	  
been	  studied.	  Therefore	  the	  aim	  of	  this	  study	  was	  to	  evaluate	  how	  Co-­‐Cr	  ions	  affect	  
bacterial	  growth,	  biofilm	  formation	  and	  architecture.	  	  
Methods	  
A	  collection	  of	  clinically	   isolated	  and	  commercially	  available	  bacterial	  strains	  were	  
exposed	  to	  Co-­‐Cr	  concentrations	  as	  found	  in	  serum	  and	  higher	  as	  found	  in	  adjacent	  
tissue.	  	  
Results	  
Planktonic	   growth	  of	   bacteria	  was	   inhibited	  by	   concentrations	  of	   200,000/93,000	  
μg/L	  Co-­‐Cr.	  Co-­‐Cr	  concentrations	  up	  to	  20/9.3	  μg/L	  as	  reported	  to	  occur	   in	  serum	  
revealed	  no	  consistent	  influence	  on	  biofilm	  formation,	  but	  higher	  concentrations	  of	  
200,000/93,000	  μg/L	  significantly	   reduced	  Staphylococcus	  aureus	  and	  CNS	  biofilm	  
formation.	   As	   indicated	   by	   confocal	   laser	   scanning	  microscopy,	   no	   dead	   bacteria	  
were	  encountered	  in	  the	  biofilms,	  and	  the	  metal	  ion	  concentrations	  used	  must	  be	  
classified	  as	  growth-­‐inhibiting	  and	  not	  bactericidal.	  	  
Conclusion	  
Long-­‐term	   clinical	   data	   on	   infection	   rates	   for	   Co-­‐Cr	   MOM-­‐bearings	   are	   not	   yet	  
available,	   but	   the	   current	   results	   suggest	   that	   Co-­‐Cr	   ions	   may	   yield	   these	  
prostheses	  less	  prone	  to	  biofilm	  formation	  and	  subsequent	  infection.	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Introduction	  
Total	  hip	  replacement	  is	  a	  highly	  successful	  procedure	  with	  a	  regain	  of	  a	  relatively	  
high	   quality	   of	   life	   and	   an	   almost	   instant	   pain	   relief.	   Success	   of	   the	   procedure	  
resulted	   in	   younger	   cohorts	  of	  patients.	  Many	  of	   these	   younger	  patients	  want	   to	  
return	  to	  a	  high	  level	  of	  activity	  and	  seek	  an	  implant	  that	  provides	  durability.	  Larger	  
femoral	   heads	   were	   indicated	   (10)],	   but	   this	   tended	   to	   cause	   excessive	   wear	   in	  
conventional	   prostheses	   (metal	   ball	   connected	   to	   large	   stem	   and	   a	   cup	   with	  
polyethylene	   interface).	   Polyethylene	   wear	   and	   debris	   is	   a	   suspected	   cause	   of	  
osteolysis	  around	  the	  implant	  (27;44),	  which	  led	  to	  the	  development	  of	  alternative	  
bearings	   lacking	   a	   polyethylene/metal	   interface,	   like	   the	   recently	   reintroduced	  
metal-­‐on-­‐metal	   (MOM)	   bearings.	   In	   contrast	   to	   metal-­‐on-­‐polyethylene	   bearings,	  
wear	   rates	   of	   MOM-­‐bearings	   turned	   out	   to	   be	   impacted	   in	   a	   positive	   way	   by	  
increasing	  the	  head	  size	  (1;22),	  yielding	  20-­‐100	  times	  less	  debris	  than	  in	  traditional	  
metal-­‐on-­‐polyethylene	  bearings	   (34).	   The	   remarkably	   low	  wear	  of	  MOM-­‐bearings	  
has	   led	  to	  a	  rapidly	   increasing	  popularity	  of	  MOM-­‐articulation	  in	  the	  treatment	  of	  
young	  and	  active	  patients	  (40).	  	  
Although	  mid-­‐	  and	  long-­‐term	  clinical	  results	  of	  MOM-­‐bearings	  appeared	  to	  
have	  demonstrated	  excellent	  durability,	   recent	  studies	  show	  that	   there	   is	  at	   least	  
one	   MOM-­‐bearing	   system	   with	   periprosthetic	   osteolysis	   and	   aseptic	   loosening,	  
which	   is	   possibly	   associated	   with	   hypersensitivity	   to	   metal	   debris	   (19;24).	  
Additionally,	   MOM-­‐articulations	   are	   not	   completely	   biologically	   inert,	   since	   they	  
produce	  metal	  particles	  that	  can	  be	  found	  in	  e.g.	  blood	  and	  urine.	  These	  particles	  
tend	   to	   corrode	   and	   serum	   levels	   of	   metal	   ions,	   mainly	   cobalt	   and	   chromium,	  
become	  elevated	   (5;11;30;31;35;43).	  Cobalt	  and	  chromium	  are	  usually	  eliminated	  
only	  slowly	  from	  the	  body	  by	  urine,	  and	  chromium	  is	  even	  retained	  in	  the	  body's	  	  
tissues	   (9;31).	   These	   high	   cobalt	   and	   chromium	   serum	   concentrations	   may	   have	  
toxic	  effects	  which	  include	  the	  increase	  of	  bone	  resorption,	  and	  theoretical	  risks	  of	  
delayed-­‐type	   hypersensitivity,	   organ	   toxicity	   and	   altering	   of	   cell	   homeostasis	  
(15;16;21;23;36;37).	   Furthermore,	   cobalt	   and	   chromium	   have	   been	   shown	   to	   be	  
carcinogenic	   and	   mutagenic	   in	   human	   and	   animal	   models	   (3;28;39;42),	   which	  




Alongside	  these	  possible	  disadvantages,	  it	  is	  also	  conceivable	  that	  the	  risk	  
of	   infection	   is	   influenced	   by	   metal	   ions.	   Infection	   still	   remains	   a	   significant	  
complication	   following	   total	   hip	   replacement	   and	   as	   a	   conservative	   estimate,	  
affects	  about	  1-­‐2%	  of	  all	  patients	  during	   the	   lifetime	  of	  an	   implant	   (7).	   In	  case	  of	  
infection,	  bacteria	  adapt	  a	  biofilm	  mode	  of	  growth	  on	  the	  surface	  of	  the	  prosthesis,	  
which	  represents	  a	  basic	  survival	  mechanism	  of	  the	  organisms	  (14)	  to	  external	  (500	  
to	   5000	   times	   increased	   antibiotic	   resistance	   (13;26))	   and	   internal	   environmental	  
factors	  (the	  host	  immune	  system).	  The	  associated	  increased	  antibiotic	  resistance	  of	  
biofilms	  causes	  major	  difficulties	  in	  patient	  treatment.	  Removal	  and	  replacement	  of	  
an	   infected	   implant	   is	   usually	   required	   to	   eliminate	   the	   infection	   with	  
accompanying	   trauma	   and	   increased	   costs	   to	   the	   health	   service	   (6;8;38).	   Copper	  
and	   zinc	   are	   known	   for	   their	   bactericidal	   properties	   and	   impact	   on	   biofilm	  
formation	  (17),	  but	  no	  research	  efforts	  have	  been	  undertaken	  towards	  the	  specific	  
influence	   of	   the	   cobalt-­‐chromium	   ion	   combination	   on	   biofilm	   formation,	   despite	  
extensive	  other	  studies	  into	  MOM-­‐bearings	  (12;32;33).	  	  
The	   aim	   of	   this	   in	   vitro	   study	   is	   to	   evaluate	   the	   influence	   of	   cobalt	   and	  
chromium	   ions	   on	   bacterial	   growth,	   biofilm	   formation	   and	   architecture	   for	   a	  
collection	  of	  clinically	  isolated	  and	  commercially	  available	  bacterial	  strains.	  	  
	  
	  
Materials	  and	  methods	  
Bacterial	  strains	  	  
Gram-­‐positive	   organisms	   account	   for	   most	   bacteria	   found	   in	   infected	   hip	  
arthroplasties.	   Coagulase	   negative	   staphylococcus	   (67%)	   was	   found	   to	   be	   the	  
predominant	   organism,	   although	   Staphylococcus	   aureus	   (13%)	   is	   gaining	  
importance	   (29).	   Therefore,	   a	   total	  of	  13	   staphylococcal	   strains	  were	  used	   in	   this	  
study	   (Table	   1),	   chosen	   to	   represent	   their	   frequency	   of	   occurrence	   in	   clinical	  
infection.	  Eight	  strains	  were	  isolated	  with	  extensive	  biomaterial	  culturing	  (25)	  from	  
explanted	   metal-­‐on-­‐polyethylene	   joint	   prostheses	   from	   individual	   patients	   with	  
septic	  loosening	  and	  retrieved	  during	  revision	  surgery	  (Department	  of	  Orthopaedic	  
Surgery	   at	   the	   University	   Medical	   Center	   Groningen,	   The	   Netherlands)	   and	   five	  
additional	  strains	  were	  of	  ATCC	  origin.	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Cobalt	  and	  chromium	  ions	  	  
Metal	  ion	  concentrations	  of	  2/0.93;	  20/9.3;	  20,000/9300;	  200,000/93,000	  μg/L	  Co-­‐
Cr	  were	  applied	  throughout	  this	  study.	  The	  lowest	  Co	  concentration	  of	  2	  μg/L	  was	  
inline	  with	  previously	   found	  Co	   serum	  concentrations	   (11;12)	   and	   the	  proportion	  
Co-­‐Cr	   in	   this	   study	   was	   chosen	   similar	   to	   most	  MOM-­‐bearings	   currently	   used	   in	  
Europe	  (±	  61%	  Co	  and	  29%	  Cr).	  The	  second-­‐lowest	   level	  of	  20/9.3	  μg/L	  Co-­‐Cr	  was	  
chosen	   to	   represent	   higher	   serum	   levels,	   described	   in	   the	   literature.	   Higher	  
concentrations	  of	  metal	  ions	  were	  used,	  since	  the	  local	  concentration	  of	  metal	  ions	  
in	  the	  synovial	  fluids	  is	  expected	  to	  be	  much	  higher	  than	  the	  serum	  concentrations.	  	  
Based	   on	   a	   previously	   described	   method	   (4),	   0.847	   mg	   cobalt	   salt	  
(CoCl2.6H2O,	   Sigma)	   and	   0.475	   mg	   chromium	   salt	   (CrCl3.6H2O,	   Merck)	   were	  
dissolved	  in	  10	  mL	  tryptone	  soya	  broth	  (TSB)	  (Oxoid,	  Basingstoke,	  United	  Kingdom).	  
These	  samples	  contained	  200,000/93,000	  μg/L	  Co-­‐Cr	  and	  were	  diluted	  with	  broth	  
to	  reach	  the	  concentrations	  and	  Co-­‐Cr	  proportions	  needed	  for	  the	  experiments.	  	  
	  
Planktonic	  growth	  evaluation	  	  	  	  
Three	   S.	   aureus	   strains	   and	   two	   CNS	   strains	   were	   randomly	   chosen	   for	   growth	  
curve	  evaluation.	  These	  isolates	  were	  routinely	  cultured	  from	  frozen	  stock	  on	  blood	  
agar	  plates	  at	  37°C	  for	  24	  h.	  Precultures	  were	  inoculated	  with	  a	  single	  plate	  colony,	  
grown	  in	  10	  mL	  TSB	  and	  incubated	  aerobically	  overnight	  at	  37°C.	  From	  the	  resulting	  
suspension,	   1	   mL	   was	   inoculated	   overnight	   with	   45	   mL	   TSB,	   45	   mL	   TSB	   with	  
20,000/9300	   μg/L	   Co-­‐Cr	   or	   45	   mL	   TSB	   with	   200,000/93,000	   μg/L	   Co-­‐Cr.	   The	  
absorbance	   at	   600	   nm	   (A600)	   was	   determined	   using	   a	   spectrophotometer.	   All	  
growth	  curve	  experiments	  were	  performed	  twice	  with	  separately	  cultured	  bacteria.	  
	  
Biofilm	  formation	  in	  microtiter	  plates	  	  
All	  strains	  mentioned	  in	  Table	  1	  were	  routinely	  cultured	  from	  frozen	  stock	  on	  blood	  
agar	  plates	  at	  37°C	  for	  24	  h.	  Precultures	  were	  inoculated	  with	  a	  single	  colony	  from	  
plate	  grown	  in	  10	  mL	  TSB	  and	  incubated	  overnight	  aerobically	  at	  37°C.	  A	  bacterial	  
suspension	  of	   200	  μL	   (2	  μL	   preculture	   and	   198	  μL	   fresh	   TSB)	   supplemented	  with	  
different	   concentrations	   of	  metal	   ions,	  was	   used	   to	   inoculate	   a	  well	   of	   a	   96-­‐well	  
polystyrene	   flat-­‐bottomed	   tissue	   culture	  plate	   (Falcon,	  Becton	  Dickinson,	  Oxnard,	  
CA)	  for	  biofilm	  formation.	  After	  24	  h	  at	  37°C,	  the	  growth	  media	  and	  planktonic	  cells	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in	   the	   96-­‐wells	   plates	  were	   removed	   from	   the	   biofilms	   by	   carefully	   replacing	   the	  
volume	   of	   the	   wells	   twice	   with	   200	   μL	   10	  mM	   potassium	   phosphate,	   pH	   7.0	   by	  
pipetting,	  while	  taking	  care	  that	  air-­‐liquid	  interface	  passages	  over	  the	  biofilms	  were	  
avoided.	  The	  wells	  were	  subsequently	  stained	  with	  200	  μL	  1%	  crystal	  violet.	  After	  
30	  min,	   excess	   stain	  was	   replaced	  with	   200	  μL	   demineralised	  water	   as	   described	  
above,	   and	   the	   crystal	   violet	   was	   dissolved	   in	   200	   μL	   of	   ethanol-­‐aceton	   (80:20	  
vol/vol).	  The	  absorbance	  at	  575	  nm	  (A575)	  was	  determined	  using	  a	  microtiter	  plate	  
reader	  (Fluostar	  Optima)	  to	  determine	  the	  amount	  of	  crystal	  violet,	  as	  a	  measure	  of	  
biofilm	  growth.	  The	  influence	  of	  Co-­‐Cr	  ions	  on	  biofilm	  formation	  was	  evaluated	  by	  
measuring	  the	  percentage	  of	  growth	  stimulation/reduction	  according	  to	  
	  
	   	   	   (A575	  presence	  Co-­‐Cr	  –	  A575	  absence	  Co-­‐Cr)	  
growth	  stimulation	  /	  reduction	  =	  	   	   	   	   	   X	  100%	  
	   	   	   	   	   A575	  absence	  Co-­‐Cr	  
	  
Thus	  inhibitory	  effects	  of	  the	  presence	  of	  Co-­‐Cr	  ions	  appear	  as	  negative	  numbers	  in	  
the	   outcome	   parameter.	   All	   experiments	   included	   six	   replicate	   wells	   and	   were	  
performed	  three	  times	  with	  separately	  cultured	  bacteria.	  
	  
Biofilm	  architecture	  determination	  by	  confocal	  laser	  scanning	  microscopy	  (CLSM)	  
Two	  of	  the	  five	  strains	  used	  for	  growth	  curve	  evaluation,	  S.	  aureus	  7388	  and	  a	  CNS	  
5147,	  were	  used	  for	  visualizing	  biofilm	  architecture.	  These	   isolates	  were	  routinely	  
cultured	  from	  frozen	  stock	  on	  blood	  agar	  plates	  at	  37°C	  for	  24	  h.	  Precultures	  were	  
inoculated	   with	   a	   single	   colony	   from	   plate	   grown	   in	   10	   mL	   TSB	   and	   incubated	  
overnight	  aerobically	  at	  37°C.	  From	  the	  above-­‐mentioned	  bacterial	  suspension,	  25	  
μL	  was	  inoculated	  with	  respectively	  3	  mL	  TSB,	  3	  mL	  TSB	  with	  2/0.93	  μg/L	  Co-­‐Cr	  or	  3	  
mL	  TSB	  with	  200,000/93,000	  μg/L	  Co-­‐Cr	  in	  a	  6-­‐wells	  polystyrene	  tissue	  culture	  plate	  
(Costar).	   After	   24	   h	   of	   incubation	   at	   37°C,	   biofilms	   were	   stained	   with	   calcofluor	  
white	  (Bayer)	  to	  visualize	  extracellular	  polymeric	  substance	  (fluorescent	  blue),	  and	  
with	   LIVE/DEAD	   Baclight	   viability	   kit	   (Molecular	   Probes	   Inc.,	   Eugene,	   Oreg.),	   to	  
visualize	  live	  (fluorescent	  green)	  and	  dead	  (fluorescent	  red)	  bacteria.	  After	  15	  min	  
incubation	   in	   the	   dark,	   confocal	   images	   were	   collected	   using	   a	   Leica	   TCS-­‐SP2	  
microscope	  with	  a	  40x	  water	  objective.	  Images	  were	  obtained	  at	  1	  to	  2	  µm	  intervals	  
down	  through	  the	  biofilm	  and	  the	  number	  of	  images,	  therefore,	  corresponded	  with	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the	   thickness	   of	   the	   biofilm.	   The	   CLSM	   experiments	   were	   performed	   twice	   with	  
separately	  cultured	  bacteria.	  
	  
Statistical	  analysis	  
Differences	   in	  optical	  densities	  of	  biofilms	  grown	   in	   the	  absence	  and	  presence	  of	  
metal	  ions	  were	  analyzed	  for	  significance	  by	  the	  Student	  t-­‐test	  for	  paired	  samples.	  
A	  95%	  (p	  <	  0.05)	  confidence	  interval	  was	  applied	  for	  statistical	  significance.	  
	  
	  
Results	  	   	   	   	  
Planktonic	  growth	  
Figure	  1	  summarizes	  the	  planktonic	  growth	  of	  S.	  aureus	  7388	  and	  a	  CNS	  5147	  in	  the	  
absence	  and	  presence	  of	  different	   concentrations	  of	  Co-­‐Cr	   ions.	  Clearly	   for	   these	  
two	   strains	   as	   well	   as	   for	   the	   other	   three	   strains	   involved	   in	   planktonic	   growth	  
experiments	   (data	  not	  shown),	  planktonic	  growth	  was	  not	  significantly	   influenced	  
by	  Co-­‐Cr	  as	  compared	  with	  the	  control	  when	  the	  ion	  concentrations	  were	  less	  than	  
20,000/9300	  μg/L	  Co-­‐Cr,	  but	  at	  the	  highest	  concentration	  of	  200,000/93,000	  μg/L	  
Co-­‐Cr	  all	  S.	  aureus	  and	  CNS	  strains	  showed	  significant	  growth	  reduction.	  	  
	  
Biofilm	  formation	  	  
Table	  1	  summarizes	  the	  effects	  of	  different	  concentrations	  of	  Co-­‐Cr	  ions	  on	  biofilm	  
formation	  of	   the	  S.	  aureus	  and	  CNS	  strains	   involved.	  Whereas	  most	   isolates	  show	  
growth	  reductions	  that	  increase	  with	  increasing	  Co-­‐Cr	  concentrations,	  some	  strains	  
are	  clearly	   stimulated	   in	   their	  growth	  at	   low	  metal	   ions	  concentrations	   (S.	  aureus	  
ATCC	   12600	   and	   S.	   epidermidis	   ATCC	   35984).	   At	   the	   highest	   metal	   ion	  
concentrations,	   however,	   all	   strains	   are	   reduced	   in	   their	   growth.	  When	   averaged	  
over	   all	   isolates	   of	   a	   given	   species,	   it	   becomes	   clear	   that	   S.	   aureus	   and	   CNS	   are	  
inhibited	   in	   their	   growth	   when	   Co-­‐Cr	   concentrations	   are	   above	   200,000/93,000	  
μg/L.	  At	  that	  concentration,	  CNS	  is	  slightly	  more	  affected	  than	  S.	  aureus.	  	  
	  
Biofilm	  architecture	  	  
CLSM	   images	  of	   the	  S.	  aureus	  7388	  and	  CNS	  5147	  biofilms	  grown	   in	   the	  absence	  
and	  presence	  of	  Co-­‐Cr	  ions	  revealed	  a	  decrease	  in	  the	  number	  of	  live	  bacteria	  due	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to	   the	   presence	   of	   Co-­‐Cr	   ions	   (Figure	   2).	   Sectional	   analysis	   of	   each	   biofilm	   layer	  
(about	  1	  µm	  in	  thickness)	  made	   it	  possible	  to	  demonstrate	  the	  three-­‐dimensional	  
structure	  of	  biofilms,	  and	  revealed	  that	  the	  biofilms	  formed	  in	  the	  absence	  of	  Co-­‐Cr	  
ions	  had	  a	   thickness	  of	   respectively	  42	  μm	  (S.	  aureus)	  and	  35	  μm	  (CNS).	  While	   in	  
the	  presence	  of	  the	  highest	  concentration	  Co-­‐Cr	  ions	  (200,000/93,000	  μg/L)	  biofilm	  
thickness	  and	  density	  is	  remarkably	  reduced	  to	  15	  μm	  and	  8	  μm,	  for	  S.	  aureus	  and	  
CNS,	   respectively,	   confirming	   that	   CNS	   is	   slightly	   more	   affected.	   Neither	   dead	  
bacteria	  nor	  slime	  were	  observed,	  regardless	  of	  the	  absence	  or	  presence	  of	  Co-­‐Cr	  
ions	  or	  the	  strain	  involved.	  
	  
Table	  1.	  The	  percentage	  of	  growth	  stimulation/reduction	  after	  24	  h	  metal	  ion	  
exposure.	  
	   Co/Cr	  ion	  concentration	  (μg/L)	  
	  	   2/0.93	   20/9.3	   20,000/9300	   200,000/93,000	  
Staphylococcus	  aureus	   	   	   	   	  
	  	  	  Staphylococcus	  aureus	  5296	   4%	   -­‐4%	   -­‐8%	   -­‐12%	  
	  	  	  Staphylococcus	  aureus	  7388	   -­‐3%	   -­‐7%	   -­‐10%*	   -­‐17%*	  
	  	  	  Staphylococcus	  aureus	  ATCC	  12600	   15%	   9%	   -­‐15%	   -­‐35%*	  
	  	  	  Staphylococcus	  aureus	  ATCC	  25923	  	   -­‐4%	   0%	   0%	   -­‐11%*	  
	  	  	  Staphylococcus	  aureus	  ATCC	  51153	  	   4%	   4%	   0%	   0%	  
	  	  	  Mean	  (SD	  =	  8%)	   3%	   0.4%	   -­‐7%	   -­‐15%*	  
	   	   	   	   	  
CNS	   	   	   	   	  
	  	  	  CNS	  7391	   4%	   -­‐6%	   -­‐20%	   -­‐45%*	  
	  	  	  CNS	  5115	   -­‐9%	   -­‐7%	   -­‐11%	   -­‐20%	  
	  	  	  CNS	  5295	   7%	   11%	   0%	   -­‐4%	  
	  	  	  CNS	  7319	   -­‐4%	   0%	   -­‐8%	   -­‐8%	  
	  	  	  CNS	  7349	   -­‐4%	   4%	   -­‐32%*	   -­‐47%*	  
	  	  	  CNS	  5147	   -­‐9%	   -­‐2%	   -­‐9%	   -­‐38%*	  
	  	  	  S.	  epidermidis	  ATCC	  35984	   10%	   21%*	   5%	   -­‐28%*	  
	  	  	  S.	  epidermidis	  ATCC	  14990	   -­‐3%	   0%	   3%	   -­‐21%*	  
	  	  	  	  Mean	  (SD	  =	  13%)	   -­‐1%	   3%	   -­‐9%	   -­‐26%	  *	  
*	   indicates	   a	   significant	   difference	   versus	   growth	   in	   the	   absence	   of	   	  metal	   exposure,	   i.e.	   0%	   growth	  
stimulation/reduction	   (p	   <	   0.05).	   Values	   are	   averages	   including	   standard	   deviations	   from	   three	  
experiments	  with	   separately	   cultured	   bacteria,	   yielding	   an	   average	  mean	   standard	   deviation	   of	   11%.	  
Note	  that	  mean	  values	  in	  bold	  represent	  the	  mean	  including	  standard	  deviations	  over	  the	  collection	  of	  
isolates	  involved.	  Growth	  reductions	  appear	  as	  negative	  numbers.	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Figure	  1.	  Growth	  curves	  of	  two	  clinically	   isolated	  strains:	  S.	  aureus	  7388	  and	  CNS	  5147	  in	  the	  absence	  
and	  presence	  of	  metal	  ions.	  Error	  bars	  indicate	  the	  standard	  deviation	  of	  the	  mean	  calculated	  from	  two	  








Figure	  2.	  CLSM	  images	  (375	  x	  375	  µm)	  of	  S.	  aureus	  7388	  (top)	  and	  CNS	  5147	  (bottom)	  biofilms,	  grown	  in	  





MOM-­‐bearings	  for	   joint	  arthroplasty	  have	  regained	  popularity	   in	  the	  treatment	  of	  
young	  patients	  because	   they	  offer	  wear	   rates	   low	  enough	   to	  prevent	   the	  bearing	  
from	   wearing	   out	   in	   a	   lifetime,	   but	   little	   is	   known	   about	   the	   way	   infectious	  
microorganisms	   behave	   toward	   the	   Co-­‐Cr	   surfaces	   involved	   in	   MOM-­‐bearings.	  
Recently,	  Anwar	  et	  al.	  showed	  that	  wear	  debris	  from	  MOM-­‐bearings	  accelerate	  the	  
growth	   rate	   of	   planktonic	   bacteria	   [41].	   To	   our	   knowledge,	   this	   is	   the	   first	   study	  
that	  focuses	  on	  the	  influence	  of	  cobalt	  and	  chromium	  ions	  on	  biofilm	  formation.	  	  
An	  intriguing	  novel	  finding	  from	  this	  study	  was	  that	  biofilm	  formation	  and	  
planktonic	  growth	  were	  inhibited	  by	  a	  high	  dose	  of	  chromium	  and	  cobalt	  ions.	  The	  
highest	   concentration	   of	   metal	   ions	   (200,000/93,000	   μg/L	   Co-­‐Cr)	   used,	   reduced	  
biofilm	  formation	  by	  15%	  and	  26%	  with	  respect	  to	  a	  control	  for	  two	  collections	  of	  S.	  
aureus	  and	  CNS	  strains,	   respectively.	  The	   lower	  metal	  concentrations	  revealed	  no	  
consistent	   influence	   on	   biofilm	   nor	   on	   planktonic	   growth.	   CLSM	   images	   of	   the	  
biofilm	   confirmed	   the	   results	   retrieved	   by	   light	   absorbance	   and	   showed	   that	  
biofilm	   thickness	   and	   density	   were	   only	   affected	   by	   exposure	   to	   the	   highest	  
concentration	   Co-­‐Cr.	   The	   highest	   metal	   ion	   concentration	   caused	   a	   reduction	   in	  
biofilm	  thickness	  of	  more	  than	  50%.	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The	   exact	   role	   of	   either	   cobalt	   or	   chromium	   in	   staphylococcal	   biofilm	  
formation	  is	  still	  unclear	  and	  hypothetically	  involves	  competition	  with	  Fe	  for	  uptake	  
in	   the	   cell.	   Iron	   is	   an	   important	   nutrient	   element	   required	   by	   the	   bacterial	  
metabolism,	   and	   interference	   with	   its	   uptake	   could	   provide	   an	   effective	  
mechanism	   to	   contain	   infection.	   This	   suggestion	   is	   confirmed	   by	   a	   study	   on	   the	  
effect	  of	  cobalt	  on	  Pseudomonas	  aeruginosa	  (20),	  demonstrating	  inhibition	  of	  iron-­‐
dependent	  metabolic	  activities	  of	  the	  bacterium	  leading	  to	  growth	  retardation	  and	  
cell	  death.	  	  
Cobalt	  chromium	  alloys	  had	  not	  been	  available	  before	  the	  nineteen	  fifties	  
and	   it	   was	   at	   that	   moment	   when	   the	   first	   designs	   of	   MOM-­‐bearings	   were	  
described.	   Initially,	   infection	   rates	   of	   early	   MOM-­‐bearings	   developed	   in	   the	  
nineteen	  sixties,	  such	  as	  the	  McKee-­‐Farrar	  arthroplasty	  were	  high	  and	  ranged	  from	  
0%	   to	   6%	  with	   antibiotic	   prophylaxis	   and	   from	  0.5%	   to	   11%	  without,	   but	   at	   that	  
time	  in	  many	  centres	  no	  clean	  air	  enclosures	  were	  used	  (2).	  However,	  the	  durability	  
of	   these	   designs	   was	   quite	   poor	   and	   at	   present	   the	   durability	   of	   the	   bearing	  
surfaces	  has	  been	  improved	  by	  appropriate	  surface	  finishes	  and	  forging	  processes.	  
Preliminary	   data	   over	   short	   follow-­‐up	   times	   of	   these	   newly	   developed	   MOM-­‐
bearings	   show	   lower	   infection	   rates	   than	   of	   the	   early	   designs.	   Milosev	   et	   al.	  
reported	  six	  revisions	  because	  of	  infection	  in	  a	  cohort	  of	  640	  total	  hip	  replacements	  
after	  a	  7.1	  year	  follow	  up	  (24).	  In	  addition,	  Korovessis	  et	  al.	  reported	  3	  infections	  in	  
a	  consecutive	  series	  of	  217	  total	  hip	  replacements	  after	  6.4	  years	  (19).	  However,	  no	  
large,	  long-­‐term	  outcome	  studies	  are	  presently	  available.	  	  
Although	   the	   reductions	   in	   biofilm	   formation	   observed	   in	   the	   present	  
study	   seem	   to	   be	   in	   line	   with	   the	   few	   clinical	   data	   on	   infection	   rates	   of	   MOM-­‐
bearings,	   it	  must	  be	  acknowledged	  that	  reliable	   information	  about	  the	  exact	   local	  
concentrations	   of	   Co-­‐Cr	   around	   prostheses	   is	   not	   available.	   However,	   in	   local	  
antibiotic	   treatment	   it	   is	   recognized	   that	   local	   antibiotic	   concentrations	   can	  
become	  up	  to	  5000	  times	  higher	  than	  serum	  levels	  (41),	  which	  suggest	  that	  Co-­‐Cr	  
concentrations	  around	  a	  MOM-­‐bearing	  may	  be	  as	  high	  as	  100,000/46500	  µg/mL.	  In	  
addition,	   serum	   levels	   of	   metal	   ions	   have	   demonstrated	   great	   variability	   from	  
patient	   to	   patient	   (18).	  Moreover,	   local	   concentrations	   of	   Co	   and	   Cr	   ions	   in	   the	  
synovial	   fluids	  will	  probably	  exceed	  these	  serum	  levels	  significantly,	  particularly	   in	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poorly	   engineered	   implants	   or	   in	   case	   of	   increased	   wear	   rate	   because	   of	  
malpositioning	  of	  the	  components,	  impingement,	  or	  loosening.	  	  
In	   conclusion,	   planktonic	   bacterial	   growth,	   biofilm	   growth	   and	   thickness	  
were	  significantly	  reduced	  by	  Co-­‐Cr	  concentrations	  of	  200,000/93,000	  μg/L,	  which	  
are	   higher	   than	   observed	   in	   serum,	   but	   not	   unlikely	   around	   a	   prosthesis	   or	   in	  
synovial	   fluid.	   This	   suggests	   that	   MOM-­‐bearings	   may	   be	   less	   prone	   to	   biofilm	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Background	  	  
In	   the	   last	   decades,	   hip	   prostheses	   with	   a	   metal-­‐on-­‐metal	   (MOM)	   bearing	   have	  
been	   implanted	   by	   orthopedic	   surgeons	   worldwide.	   However,	   concerns	   are	   now	  
raised	   towards	   the	  metal	   particles	   and	   degradation	   products	   released	   by	  MOM-­‐
bearings	   into	   surrounding	   tissue,	   although	  effects	   of	   Co-­‐Cr	  wear	   on	   infection	   are	  
also	  unknown.	  Therefore,	  we	  here	  determine	  the	  viable	  volumes	  of	  staphylococcal	  
biofilms	  formed	  on	  polystyrene	  in	  the	  absence	  and	  presence	  of	  Co-­‐Cr	  particles	  and	  
Co-­‐Cr	  ions.	  	  
Methods	  	  
Three	  clinically	  derived	  and	  two	  commercially	  available	  staphylococcal	  strains	  were	  
grown	   in	   the	   presence	   of	   2	   mg/mL	   Co-­‐Cr	   particles	   or	   1000/500	   µg/L	   Co-­‐Cr	   ions	  
derived	   from	   Co-­‐Cr	   salts	   or	   from	   particle	   supernatant,	   under	   static	   and	   dynamic	  
growth	  conditions.	  A	  dynamic	  model	  simulates	  the	  conditions	  that	  apply	  for	  biofilm	  
formation	   in	   the	   human	   body,	   as	   synovial	   fluid	   in	   mobile	   patients	   with	   hip	  
prostheses	  is	  in	  constant	  motion	  with	  accompanying	  shear	  rates.	  Images	  of	  24	  h	  old	  
biofilms	  were	  made	  with	  confocal	  laser	  scanning	  microscopy	  and	  analyzed	  with	  the	  
mathematical	  computer	  program	  COMSTAT,	  yielding	  the	  biovolume	  of	  a	  biofilm.	  X-­‐
ray	   photoelectron	   spectroscopy	   was	   performed	   on	   the	   particles	   to	   study	   their	  
elemental	  surface	  composition.	  
Results	  	  	  
Most	  isolates	  showed	  a	  tendency	  of	  reduced	  biofilm	  growth	  in	  the	  presence	  of	  Co-­‐
Cr	  particles	  compared	  to	  growth	  during	  exposure	  to	  metal	   ions,	  but	  this	  was	  only	  
significant	   in	   one	   strain	   under	   the	   dynamic	   growth	   condition	   (Staphylococcus	  
aureus	  7388).	  Characterization	  of	  the	  outer	  surface	  of	  the	  particles	  revealed	  a	  Co-­‐
Cr	  oxide	  layer	  enriched	  by	  Molybdenum	  relative	  to	  the	  bulk	  concentration.	  	  
Conclusion	  	  
MOM	  bearings	  produce	  metal	  particles	  which	  were	  found	  to	  possess	  antibacterial	  
characteristics	   under	   dynamic	   growth	   conditions.	   Further	   research	   is	   needed	  
towards	  the	  clinical	  relevance	  of	  this	  finding.	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Introduction	  
Large	   metal-­‐on-­‐metal	   (MOM)	   articulations	   have	   been	   implanted	   frequently	   in	  
active	   and	   young	   patients,	   mainly	   due	   to	   their	   reduced	   dislocation	   rates	   (18;26)	  
and	   low	   wear	   characteristics	   (1;27).	   However,	   active	   MOM	   patients	   accumulate	  
nearly	   1	  mg	  of	  nano-­‐sized	  wear	  particles	  per	   year	   (2;25).	   Concerns	   regarding	   the	  
production	  of	  wear	  particles	  and	  its	  corrosion	  products	  have	  led	  to	  questioning	  of	  
the	   indications	   for	   Co-­‐Cr	   alloy	   bearing	   use	   (5).	   Recently,	   the	  Healthcare	   products	  
Regulatory	   Agency	   in	   the	  United	   Kingdom	  has	   sent	   out	   an	   alert	   to	   hospitals	   and	  
doctors	   regarding	   adverse	   soft	   tissue	   reactions	   to	   wear	   of	   MOM	   implants.	   In	  
addition,	   it	   is	   conceivable	   that	   the	   vast	   amount	   of	   particles	   influence	   infection	  
severity.	  	  
High	  concentrations	  of	  Co-­‐Cr	  ions	  have	  been	  found	  to	  yield	  bacteriostatic	  
effects	  on	  planktonic	  grown	  bacteria	  and	  biofilm	  formation	  (15).	  On	  the	  other	  hand,	  
particulate	   Co-­‐Cr	   debris	   was	   shown	   to	   promote	   planktonic	   bacterial	   growth	   (4).	  
However,	   these	   studies	   were	   performed	   under	   static	   conditions.	   A	   static	   set-­‐up	  
does	  not	  account	  for	  shear	  during	  biofilm	  formation,	  as	  occurring	  between	  implant	  
surfaces	  and	  synovial	  fluid	  of	  mobile	  patients.	  Therefore,	  the	  aim	  of	  this	  study	  was	  
to	  compare	  the	  effect	  of	  Co-­‐Cr	  particles	  and	  Co-­‐Cr	  ions	  on	  viable	  biofilm	  volume	  in	  




Materials	  and	  methods	  
Co-­‐Cr	  particles	  and	  characterization	  
Particles	  were	  derived	   from	  cast	  Co-­‐Cr	  alloy	  Micro-­‐Melt®	  dust	   (Carpenter	  Powder	  
Products,	  Wyomissing,	  PA),	  obtained	  by	  courtesy	  of	  Biomet	  (Warsaw,	  IN).	  The	  Co-­‐
Cr	  alloy	  according	   to	   ISO	  5832-­‐4	  standards,	  contains	  Co-­‐Cr,	  but	  also	  molybdenum	  
(Mo),	  nickel,	  iron,	  silicon	  and	  manganese	  alloying	  elements	  (see	  Table	  I).	  	  
X-­‐ray	   photoelectron	   spectroscopy	   (XPS)	   was	   performed	   with	   a	   S-­‐probe	  
spectrometer	  (Surface	  Science	  	  Instruments,	  Mountain	  View,	  CA)	  equipped	  with	  an	  
aluminium	  anode	  (10	  kV,	  22	  mA)	  and	  a	  quartz	  monochromator.	  The	  binding	  energy	  
scale	   was	   calibrated	   to	   the	   C1s	   peak	   at	   284.8	   eV.	   The	   experimental	   peaks	   were	  
integrated	   after	   linear	   background	   subtraction.	   Elemental	   surface	   compositions	  
Chapter	  4	  
	  60	  
were	  calculated	  from	  the	  integrated	  peak	  areas	  employing	  instrumental	  sensitivity	  
factors	  as	  supplied	  by	  the	  manufacturer	  and	  expressed	  in	  atom%.	  Elemental	  depth	  
profiling	  of	  the	  particles	  was	  done	  by	  Ar+-­‐ion	  sputtering	  using	  a	  VG	  ion	  gun	  AG	  2.1.	  	  
Particle	  size	  distributions	  were	  measured	  with	  a	  Sympatec	  HELOS	  compact	  
KA	   laser	   diffraction	   apparatus	   (Sympatec	   GmbH,	   Clausthal-­‐Zellerfeld,	   Germany),	  
using	  a	  RODOS	  dry	  powder	  disperser	  (at	  3.0	  bar).	  A	  lens	  of	  200	  mm	  was	  used	  and	  
calculations	  were	  based	  on	  the	  Fraunhofer	  diffraction	  theory.	  	  
Wear	   rates	   of	   removed	  MOM	   implants	   for	   early	   aseptic	   loosening	   have	  
been	  reported	  	  as	  low	  as	  4.6	  mg/year	  (23)	  with	  an	  average	  amount	  of	  synovial	  fluid	  
in	   a	   hip	   of	   2.5	   mL	   (range,	   0.1-­‐5.6)	   (16;20).	   Based	   on	   these	   data,	   a	   particle	  
concentration	   of	   2	   mg/mL	   was	   used	   throughout	   our	   experiments,	   assumed	   to	  
reflect	  a	  concentration	  within	  the	  range	  of	  clinically	  expected	  values.	  
	  
Metal	  ion	  concentration	  derived	  from	  salts	  and	  supernatant	  
To	  establish	  diluted	  metal	   ion	  concentrations	  of	  Co-­‐Cr	  particles,	   three	   samples	  of	  
autoclaved	  tryptone	  soya	  broth	  (TSB)	  (Oxoid,	  Basingstoke,	  United	  Kingdom)	  with	  2	  
mg/mL	  particles	  were	  filtrated	  to	  measure	  Co-­‐Cr	  concentrations	  in	  the	  supernatant	  
with	   atomic	   absorption	   spectroscopy,	   by	   courtesy	   of	   Thermo	   Fischer	   (Waltham,	  
MA).	  Supernatant	  samples	  revealed	  concentrations	  of	  1100	  µg/L	  cobalt	  (range	  943-­‐
1440	  µg/L)	  and	  409	  µg/L	  chromium	  (range	  357-­‐501	  µg/L).	  Metal	  salt	  solutions	  were	  
subsequently	   prepared	  accordingly	  with	   a	   concentration	  of	   1000	  µg/L	   cobalt	   and	  
500	  µg/L	  chromium.	  Based	  on	  a	  previously	  described	  method	  (3),	  4.037	  mg	  cobalt	  
salt	  (CoCl2.6H2O,	  Sigma-­‐Aldrich,	  Zwijndrecht,	  Netherlands)	  and	  2.564	  mg	  chromium	  
salt	  (CrCl3.6H2O,	  Merck,	  Darmstadt,	  Germany)	  were	  dissolved	  in	  10	  mL	  TSB.	  These	  
samples	   contained	   100,000/50,000	   µg/L	   Co–Cr	   and	   were	   diluted	   with	   broth	   to	  
reach	  the	  concentrations	  described	  above.	  
	  
Bacterial	  strains	  
A	  total	  of	  three	  Staphylococcus	  aureus	  strains,	  one	  Staphylococcus	  epidermidis	  and	  
one	   coagulase-­‐negative	   staphylococcal	   (CNS)	   strain	   were	   involved	   in	   this	   study,	  
representing	   predominant	   organisms	   in	   infected	   bone	   and	   joint	   samples	   (8;22).	  
Three	   strains	   were	   isolated	   using	   extensive	   culturing	   from	   explanted	   metal-­‐on-­‐
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polyethylene	   joint	   prostheses	   from	   individual	   patients	  with	   septic	   loosening	   (21).	  
The	  remaining	  two	  additional	  strains	  were	  of	  ATCC	  origin.	  
	  
Biofilm	  formation	  
Isolates	  were	  routinely	  cultured	  from	  frozen	  stock	  on	  blood	  agar	  plates	  aerobically	  
incubated	  at	  37°C	  for	  24	  h.	  Precultures	  were	  inoculated	  with	  a	  single	  colony	  from	  	  
an	  agar	  plate	  in	  10	  mL	  TSB	  and	  incubated	  overnight	  aerobically	  at	  37°C.	  From	  this	  
preculture,	  30	  µL	  was	  inoculated	  in	  respectively	  3	  mL	  TSB	  (control),	  3	  mL	  TSB	  with	  2	  
mg/mL	  Co-­‐Cr	  particles,	  3	  mL	  TSB	  with	  1000/500	  µg/L	  Co-­‐Cr	  ions	  derived	  from	  metal	  
salts	  and	  3	  mL	  TSB	  with	  supernatant	  of	  2	  mg/mL	  Co-­‐Cr	  particles	  in	  a	  6-­‐wells	  tissue	  
culture	   polystyrene	   plate	   (Greiner,	   Frickenhausen,	   Germany).	   Each	   set	   of	  
experiments	   was	   performed	   in	   triplicate	   with	   separately	   cultured	   bacteria,	   and	  
grown	  under	  static	  and	  dynamic	  (150	  rpm)	  growth	  conditions.	  	  
	  
Biofilm	  imaging	  with	  confocal	  laser	  scanning	  microscopy	  (CLSM)	  
After	   24	   h	   of	   incubation	   at	   37°C,	   biofilms	   were	   washed	   gently,	   with	   phosphate	  
buffer	   saline	   (PBS;	  pH	  7.0),	  ensuring	   the	  biofilm	   remained	   intact.	   To	  visualize	   live	  
bacteria	   (fluorescent	   green),	   all	   wells	   were	   stained	   with	   LIVE/DEAD	   BacLight	  
viability	   kit	   (Molecular	   Probes	   Inc.,	   Eugene,	  OR).	  Due	   to	   reflecting	   particles	   at	   an	  
excitation	  wavelength	  of	  488	  nm	  and	  emission	  filter	  settings	  of	  600	  nm	  and	  higher,	  
it	  was	  not	  possible	  to	  determine	  the	  amount	  of	  dead	  bacteria	  (fluorescent	  red)	  on	  
particles.	  After	  15	  min	  of	  incubation	  in	  the	  dark,	  representative	  CLSM	  images	  were	  
collected	  using	  a	  Leica	  TCS-­‐SP2	  microscope	  with	  a	  water	  objective.	  	  
	  
Quantification	  of	  biofim	  formation	  with	  COMSTAT	  
CLSM	  images	  were	  analyzed	  with	  the	  mathematical	  computer	  program	  COMSTAT,	  
yielding	  the	  biovolume	  of	  a	  biofilm,	  as	  described	  earlier	  (14).	  Biovolume	  (µm3/µm2),	  
defined	  by	  biomass	  pixels	   in	  all	   images	  of	  a	  stack	  multiplied	  by	  the	  voxel	  size	  and	  
divided	   by	   substratum	   area,	   represents	   the	   overall	   volume	   of	   a	   biofilm.	   In	   this	  




Scanning	  electron	  microscope	  (SEM)	  samples	  
To	  visualize	  the	  biofilm	  on	  the	  Co-­‐Cr	  particles	  with	  SEM,	  biofilm	  of	  S.	  aureus	  ATCC	  
12600	  was	  grown	  under	  static	  and	  dynamic	  growth	  conditions,	  as	  described	  above.	  
Samples	  were	  fixed	  in	  2%	  glutaraldehyde/0.1	  M	  cacodylatebuffer	  for	  at	   least	  24	  h	  
at	   4°C.	   A	   post-­‐fixation	   was	   performed	   using	   1%	   osmiumtetroxide	   in	   0.1	   M	  
cacodylatebuffer	  for	  1	  h	  at	  room	  temperature.	  After	  several	  washings	  with	  water,	  
samples	  were	  dehydrated	  through	  an	  ethanol	  series.	  After	  the	  final	  100%	  ethanol	  
step,	   samples	   were	   treated	   with	   ethanol/tetramethylsilane	   followed	   by	   pure	  
tetramethylsilane	   (both	   15	  min	   at	   0°C)	   and	   subsequently	   air	   dried.	   After	   sputter	  
coating	  the	  samples	  with	  approximately	  5	  nm	  Pd/Au,	  imaging	  was	  performed	  at	  2	  
kV	  using	  a	  JEOL	  JSM6301	  scanning	  microscope.	  
	  
Statistics	  
Differences	  in	  biovolumes	  of	  biofilms	  grown	  in	  the	  absence	  and	  presence	  of	  metal	  
particles	  or	  metal	  ions	  were	  analyzed	  for	  significance	  by	  ANOVA	  and	  followed	  by	  a	  
Mann-­‐Whitney	  U-­‐test.	  A	  95%	  (p	  <	  0.05,	  two-­‐tailed)	  confidence	  interval	  was	  applied	  





The	   Co-­‐Cr	   and	   oxygen	   depth	   profile	   (Table	   I)	   of	   the	   particles	   was	   typical	   for	   a	  
surface	  oxide	   layer;	   the	  oxygen	   signal	   decreased	   towards	   the	  bulk	  metal.	   The	  Co	  
signal	  was	   similar	   to	   the	  Cr	   one	   at	   the	  outermost	   surface	   and	   increased	   strongly	  
after	   Ar+-­‐ion	   sputtering,	   whereas	   the	   Cr	   signal	   only	   increased	   slightly.	   Particle	  
surfaces	   appeared	   enriched	   by	   Mo	   relative	   to	   the	   bulk	   concentration	   prior	   to	  
sputtering.	   After	   sputtering,	   Mo	   was	   present	   in	   lower	   concentrations.	   Carbon	  
contamination,	  as	  present	   in	  all	  XPS	  measurements,	  remained	  to	  be	  present	  after	  
sputtering.	  Co-­‐Cr	  particle	  size	  distributions	  are	  presented	  in	  Table	  II.	  Particles	  were	  
found	  to	  have	  an	  average	  size	  of	  40	  µm.	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Table	  I.	  Chemical	  composition	  and	  surface	  characterization	  of	  Micro-­‐Melt®	  CCM+.	  	   
Elements	   Micro-­‐Melt®	  CCM+	  
bulk	  composition	  
XPS	  surface	  composition	  (Atom%)	  
	   Weight	  %	   Atom%	   Before	  sputtering	   After	  sputtering	  
Cobalt,	  Co	   balance	  to	  100	   60.0	   7.3	   49.0	  
Chromium,	  Cr	   29.5	   32.4	   7.6	   9.4	  
Molybdenum,	  
Mo	  
6.6	   3.9	   4.5	   2.8	  
Nickel,	  Ni	   0.1	   0.1	   	   	  
Iron,	  Fe	   0.3	   0.3	   	   	  
Silicon,	  Si	   0.7	   1.4	   	   	  
Manganese,	  Mn	   0.7	   0.7	   	   	  
Carbon,	  C	   	   0.2	   1.1	   38.7	   24.1	  
Oxygen,	  O	   -­‐	   	   42.0	   14.7	  
	  
Table	  II.	  	  Volume	  size	  distribution	  of	  Co-­‐Cr	  particles	  derived	  from	  Micro-­‐Melt	  ®	  dust.	  
Cumulative	  distribution	  
(%)	  
Particle	  size	  beneath	  (µm)	  
10	   18	  
25	   32	  
50	   40	  
75	   49	  
90	   58	  
99	   71	  
	  
Table	   III.	   Viable	   biovolume	   (µm3/µm2)	   of	   a	   collection	   of	   three	   clinically	   derived	  
staphylococcal	   strains	   and	   two	   ATCC	   strains,	   grown	   under	   static	   and	   dynamic	  
conditions	  and	  in	  the	  absence	  and	  presence	  of	  metal	  ions	  and	  particles.	  	  






Static	   S.	  aureus	  ATCC	  12600	   11	   12.8	   18.8	   7.6	  
	   S.	  aureus	  7388	   13.8	   6.8	   8.9	   4.1	  
	   S.	  aureus	  5296	   13.5	   8.9	   12.5	   18.3	  
	   S.	  epidermidis	  ATCC	  35984	   20.9	   14	   15.7	   15.7	  
	   CNS	  7391	   11.3	   10.7	   4.9	   8.2	  
	   	   	   	   	   	  
Dynamic	   S.	  aureus	  ATCC	  12600	   4.1	   7.1	   2.4	   1.7	  
	   S.	  aureus	  7388	   4.1	   3.8	   0.9*,**	   0.2*,**	  
	   S.	  aureus	  5296	   7.6	   1.5	   13.3	   3.7	  
	   S.	  epidermidis	  ATCC	  35984	   6.3	   4.2	   2.2	   2.7	  
	   CNS	  7391	   2.2	   4.2	   2.8	   0.7**	  
*Indicates	  a	  significant	  difference	  in	  viable	  biovolume	  compared	  to	  the	  control,	  **	  compared	  to	  metal	  
ions	  (salt)	  (p	  <	  0.05).	  Values	  are	  averages	  from	  three	  experiments	  with	  separately	  cultured	  bacteria,	  
yielding	  an	  average	  mean	  standard	  deviation	  of	  22%.	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Biofilm	  formation	  	  
Table	   III	   summarizes	   the	   effects	   of	   Co-­‐Cr	   ions	   derived	   from	   particles	   and	   from	  
metal	  salts	  and	  Co-­‐Cr	  particles	  on	  staphylococcal	  biofilm	  formation.	  Most	   isolates	  
show	  a	  tendency	  of	  biofilm	  growth	  reduction	  when	  grown	  in	  the	  presence	  of	  Co-­‐Cr	  
particles	  compared	  to	  the	  control	  (no	  metal	  ions),	  but	  this	  is	  only	  significant	  for	  S.	  
aureus	   7388	   under	   dynamic	   growth	   conditions.	   CNS	   7391	   and	   S.	   aureus	   7388	  
growth	   was	   inhibited	   significantly	   more	   by	   metal	   particles	   than	   by	   metal	   ions	  
derived	   from	   Co-­‐Cr	   salts.	   Moreover,	   metal	   ions	   derived	   from	   particles	   were	  
inhibiting	   growth	   of	   S.	   aureus	   7388	   significantly	   more	   compared	   to	   metal	   ions	  
derived	  form	  Co-­‐Cr	  salts.	  	  
	  















Figure	   1.	   	   CLSM	   images	   (375	   x	   375	   µm)	   of	   S.	   aureus	   5296	   biofilm,	   grown	   under	   static	   (A	   &	   C)	   and	  
dynamic	  conditions	  (B	  &	  D).	  	  
	  
Sectional	   (about	   1	   µm	   in	   thickness)	   analysis	   of	   each	   biofilm	   made	   it	  
possible	  to	  reconstruct	  the	  biofilms.	  Side	  views	  of	  CLSM	  images	  of	  S.	  aureus	  5296	  
biofilms	   illustrate	  that	   the	  biofilm	   is	   far	   thinner	   in	   the	  presence	  of	  Co-­‐Cr	  particles	  
compared	  to	  the	  control	  (Figure	  1).	  Biofilm	  architecture	  in	  the	  absence	  of	  particles,	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whether	   it	  was	   in	   the	  presence	  or	  absence	  of	  metal	   ions,	  was	   comparable	   for	  all	  
strains	  tested.	  	  
Figure	   2	   shows	   electron	   micrographs	   of	   Co-­‐Cr	   particles	   which	   were	  
incubated	   with	   bacteria	   under	   dynamic	   (Figure	   2A)	   and	   static	   growth	   conditions	  
(Figure	  2B).	  When	  grown	  under	  dynamic	  conditions,	  only	  a	  few	  bacteria	  adhered	  to	  
the	  particles,	  whereas	  under	  static	  growth	  conditions,	  the	  surface	  of	  the	  particles	  is	  

























Figure	   2.	   SEM	   images	  of	  Co-­‐Cr	  particles	  covered	  with	  a	  biofilm	  of	  S.	  aureus	  ATCC	  12600	  after	  growth	  




Co-­‐Cr	  particles	  and	  Co-­‐Cr	   ions	  alone	  appeared	  to	  have	  no	  significant	   influence	  on	  
biofilm	   formation	   under	   static	   growth	   conditions.	   Changing	   the	   experimental	  
conditions	   from	   static	   to	   dynamic	   decreased	   the	   ability	   of	   bacteria	   in	   general	   to	  
produce	  biofilm,	  with	   systematic	   differences	   found	  between	   individual	   strains.	   In	  
addition,	   the	   dynamic	   growth	   condition	   indicated	   bacteriostatic	   effects	   of	   Co-­‐Cr	  
particles	  for	  S.	  aureus	  7388.	  Thus,	  shear	  stress	  appears	  to	  have	  great	  influence	  on	  
biofilm	  formation,	  as	  also	  seen	  by	  other	  authors	  (9).	  	  
The	   dynamic	   growth	   conditions	   provide	   a	   model	   for	   biofilm	   formation,	  
simulating	  in	  vivo	  conditions	  in	  mobile	  patients	  with	  a	  constant	  synovial	  fluid	  flow.	  
However,	  the	  standard	  deviation	  over	  the	  data	   in	  Table	   III	   is	  rather	   large	  (22%	  on	  
average),	   which	   impedes	   drawing	   of	   statistically	   significant	   conclusions	   for	   each	  
strain.	   The	   average	   biovolume	   over	   all	   strains	   of	   control	   biofilms	   formed	   in	   the	  
absence	  of	  metal	  ions	  or	  particles	  was	  14.1	  ±	  7.2	  µm3/µm2	  (static	  growth	  condition)	  
and	  4.8	  ±	  3.0	  µm3/µm2	  (dynamic	  growth	  condition),	  which	  constitutes	  a	  statistically	  
significant	  difference	  (p	  <	  0.01)	  between	  static	  and	  dynamic	  growth	  conditions.	   In	  
the	  presence	  of	   the	  Co-­‐Cr	  particles	   and	   compared	   to	   the	   control,	   biovolume	  was	  
reduced	  to	  10.8	  ±	  8.7	  µm3/µm2	  under	  static	   (p	  >	  0.05)	  and	  to	  1.8	  ±	  2.5	  µm3/µm2,	  
under	   dynamic	   (p	   <	   0.01)	   growth	   conditions.	   Biovolumes	   as	   averaged	   over	   all	  
strains	   were	   not	   significantly	   (p	   >	   0.05)	   affected	   under	   dynamic	   growth	   in	   the	  
presence	  Co-­‐Cr	  ions	  derived	  from	  salt	  (4.3	  ±	  6.0	  µm3/µm2	  )	  or	  supernatant	  from	  Co-­‐
Cr	  particles	  (4.2	  ±	  4.7	  µm3/µm2)).	  Although	  we	  are	  concerned	  about	  the	  incidence	  
of	   large	   standard	  deviations	   throughout	  our	   study,	   this	  method	  has	  been	  able	   to	  
differentiate	  biofilm	  growth	  under	  static	  and	  dynamic	  conditions	  as	  averaged	  over	  
different	  strains.	  	  
It	  is	  interesting	  that	  under	  dynamic	  growth,	  biofilm	  formation	  is	  inhibited	  
in	   the	   presence	   of	   Co-­‐Cr	   particles	   compared	   to	   the	   control,	   while	   this	   inhibitory	  
effect	   is	   not	   seen	   under	   static	   growth	   conditions.	   This	   difference	   between	   the	  
dynamic	   and	   static	   conditions	   indicates	   that	   bacteria	   are	  much	  more	   vulnerable	  
under	  dynamic	   conditions	  due	   to	   their	   inability	   to	   form	  a	   thick	  biofilm	   (6).	  Metal	  
ion	   concentrations	   in	   direct	   vicinity	   of	   Co-­‐Cr	   particles	   may	   be	   high	   enough	   to	  
reduce	  biofilm	  formation	  by	  more	  or	  less	  single	  adhering	  bacteria	  (dynamic	  growth	  
condition),	  but	  below	  the	  inhibiting	  concentration	  for	  bacteria	  in	  a	  thick,	  full-­‐grown	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biofilm	  (static	  growth	  condition).	   In	  addition,	  the	  Co-­‐Cr	   ion	  mass	  transfer	   into	  the	  
biofilm	   may	   be	   larger	   under	   the	   dynamic	   condition	   with	   a	   larger	   Co-­‐Cr	   ion	  
concentration	  gradient	  through	  the	  bioﬁlm	  than	  under	  a	  static	  one.	  	  
The	   particles	   used	   in	   this	   study	   are	   not	   within	   the	   nanometer	   range	   as	  
found	   in	  vivo,	  possessing	  ranges	  between	  40-­‐120	  nm	  (7;19).	  Smaller	  particles	  may	  
release	   significantly	  more	   ions	   due	   to	   their	   larger	   area	   to	   volume	   ratio	   and	   thus	  
yield	  more	  pronounced	  effects	  than	  seen	  here.	  However,	  many	  clinically	  retrieved	  
Co-­‐Cr	   wear	   particles	   are	   in	   the	  micrometer	   size	   range	   (28;29),	   as	   in	   the	   current	  
study.	   Frequently	  micrometer	   sized	   particles	   are	   described	   as	   irregularly	   shaped,	  
fragmented	   or	   clustered,	   suggesting	   these	   particles	   to	   be	   aggregates	   of	   smaller	  
particles.	  Unfortunately,	  nanometer	  sized	  particles	  are	  scarce	  and	  not	  yet	  available	  
in	  large	  quantities	  needed	  for	  in	  vitro	  research.	  
Trace	  ions	  of	  alloying	  elements	  were	  not	  responsible	  for	  biofilm	  inhibition	  
as	  no	  significant	  effect	  was	  found	  towards	  averaged	  biofilm	  volumes	  when	  grown	  
during	  exposure	  to	  particle	  derived,	  supernatant	  metal	  ions.	  The	  exact	  role	  of	  Co-­‐Cr	  
ions	   in	   biofilm	   inhibition	   is	   still	   unclear.	   Staphylococcal	   strains	   possess	   Co-­‐Ni	  
permeases	  which	  facilitate	  influx	  of	  Co	  and	  Ni	  (13).	  Ni	  is	  known	  for	  its	  bactericidal	  
effect	  in	  staphylococcal	  strains	  (4).	  However	  only	  0.30	  %	  of	  the	  particle	  alloy	  used	  
consists	  of	  Ni	  (Table	  I).	  As	  for	  Co,	  this	  metal	  is	  suspected	  to	  display	  toxic	  effects	  due	  
to	   its	   involvement	   in	  competition	  with	   iron	  for	  uptake	   in	  the	  cell	   in	  Pseudomonas	  
aeruginosa	   (17).	   It	   has	   been	   suggested	   that	   the	   electromagnetic	   attraction	   of	  
negatively	   charged	   bacteria	   to	   the	   positively	   charged	   Co-­‐Cr	   oxide	   layer	  might	   be	  
responsible	   for	   oxidation	   of	   the	   bacteria	   (24).	   Metal	   ions	   are	   suggested	   to	  
inactivate	   proteins	   on	   the	   bacterial	   surface,	   decreasing	   membrane	   permeability,	  
and	   eventually	   causing	   cell	   death	   (31).	   This	   would	   explain	   the	   lack	   of	   inhibitory	  
effects	  in	  the	  metal	  ion	  groups.	  
Our	  XPS	  results	  showed	  a	  Mo-­‐enriched	  particle	  surface	  composition.	  The	  
surface	  oxide-­‐film	  of	  Co-­‐Cr	  alloy	  has	  been	  reported	  to	  consist	  of	  Co-­‐Cr	  oxides,	  with	  
Mo	  distributed	  in	  the	  inner	  layer.	  After	  dissolution	  in	  Hanks’	  solution,	  Co	  dissolves	  
and	   the	  oxide	   layer	   consists	   of	   a	   Cr2O3	  protective	   film	   layer	   (10)	   enriched	  by	  Mo	  
(11).	   Recent	   work	   by	   Hart	   et	   al.	   (12)	   revealed	   that	   the	  metallic	   debris	   retrieved	  
from	  tissues	  surrounding	  failed	  MOM	  hips	  contained	  Cr	  phosphate,	  metallic	  Co,	  but	  
also	  oxidized	  Mo.	  Albeit	   limited	  literature	  is	  available	  on	  the	  bacteriostatic	  effects	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of	  Mo,	  however,	  Yasasuki	  et	  al.	  recently	  presented	  data	  indicating	  that	  pure	  Mo	  is	  
less	  toxic	  than	  pure	  Co	  towards	  S.	  aureus	  (IFO	  No	  12732)	  using	  a	  novel	  film	  contact	  
method	  (30).	  It	  is	  therefore	  not	  plausible	  that	  Mo	  is	  responsible	  for	  biofilm	  growth	  
inhibition	  seen	  here.	  	  
In	   conclusion,	  Co-­‐Cr	  particles	  possess	  bacteriostatic	   characteristics	  under	  
dynamic	  growth	  conditions,	  unlike	  Co	  and	  Cr	  ions	  only.	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Treatment	  of	  biomaterial-­‐associated	  infection	  is	  complicated	  due	  to	  the	  resistance	  
of	   biofilms	   to	   antimicrobials	   with	   a	   potential	   impact	   of	   the	   type	   of	   biomaterial	  
involved.	   The	   aim	  of	   the	  present	   study	  was	   to	   compare	   the	  metabolic	   activity	   of	  
three	   Staphylococcus	   epidermidis	   and	   two	   Staphylococcus	   aureus	   strains	   in	  
biofilms	   grown	   on	   Ti,	   Co-­‐Cr	   and	   ultra-­‐high	   molecular	   weight	   polyethylene	  
(UHMWPE)	  discs	  and	  relate	  the	  efficacy	  of	  gentamicin	  against	  these	  biofilms	  with	  
metabolic	  activity.	  
Methods	  	  
Six	  hours	  old	  staphylococcal	  biofilms	  were	  grown	  in	  tryptone	  soya	  broth	  on	  Ti,	  Co-­‐
Cr	  and	  UHMWPE	  discs,	  after	  which	  growth	  was	  continued	  for	  another	  18	  h	   in	  the	  
absence	  or	  presence	  of	  gentamicin	  (6	  mg/mL).	  Biofilms	  were	  evaluated	  in	  terms	  of	  
the	  number	  of	  adhering	  bacteria,	  their	  live/dead	  ratio	  and	  metabolic	  activity	  on	  the	  
different	  biomaterials.	  	  
Results	  	  
The	   number	   of	   bacteria	   in	   the	   6	   h	   biofilms	   was	   similar	   on	   all	   biomaterials,	   with	  
minor	   strain	   dependent	   differences.	   Metabolic	   activity	   per	   bacterium	   in	   6	   h	   old	  
biofilms	  prior	  to	  growth	  was	  significantly	  lower	  in	  3	  out	  of	  the	  5	  strains	  in	  biofilms	  
on	   hydrophobic	   UHMWPE	   as	   compared	  with	  more	   hydrophilic	   Ti	   and	   Co-­‐Cr.	   The	  
reduction	   of	   viable	   organisms	   after	   18	   h	   subsequent	   growth	   in	   the	   presence	   of	  
gentamicin	   compared	   to	   biofilms	   grown	   in	   absence	   of	   gentamicin	  was	   lowest	   on	  
UHMWPE,	   but	   no	   statistically	   significant	   correlation	   was	   found	   between	   lower	  
metabolic	  active	  of	  6h	  biofilms.	  	  	  
Conclusion	  	  
Orthopaedic	   biomaterials	   influence	   metabolic	   activity	   of	   staphylococcal	   biofilms,	  
but	  metabolic	  activity	  did	  not	  correlate	  with	  staphylococcal	  killing	  by	  gentamicin	  in	  
24	  h	  old	  biofilms.	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Introduction	  
With	   the	   continuous	   increase	   in	   the	   use	   of	   biomaterials	   implants	   for	   the	  
restoration	   of	   human	   function,	   also	   biomaterial-­‐associated	   infections	   (BAI)	   occur	  
with	   increasing	   numbers	   over	   the	   past	   decades.	   Reducing	   the	   incidence	   of	   BAI	  
would	  provide	  a	  huge	  medical	  and	  financial	  benefit,	  as	  treatment	   is	   intensive	  and	  
exhausts	   healthcare	   resources	   (4;20).	   Staphylococcus	   epidermidis	   and	  
Staphylococcus	   aureus	   are	   the	   most	   frequently	   encountered	   strains	   in	   infected	  
bone	  and	  joint	  samples	  (8;16)	  and	  are	  responsible	  for	  both	  chronic	  and	  acute	  BAI	  
(7).	  When	  staphylococci	  adhere	  to	  a	  biomaterial	   implant,	  they	  form	  a	  biofilm.	  The	  
otherwise	   relatively	   susceptible	   organisms	   form	   a	   slimy	   layer,	   which	   makes	   the	  
bacteria	  more	  resistant	  to	  antibiotics	  and	  the	  host	  immune	  system	  (6;11).	  	  
In	   orthopaedics,	   the	   aminoglycoside	   gentamicin	   is	   the	   most	   frequently	  
applied	  local	  antibiotic.	   It	   is	  one	  of	  the	  few	  heat-­‐stable	  antibiotics	  suitable	  for	  use	  
in	   acrylic	   bone	   cements	   (PMMA)	   for	   the	   treatment	   and	   prevention	   of	   BAI	   (10).	  
Interestingly,	  the	  susceptibility	  of	  biofilms	  for	  gentamicin	  not	  only	  depends	  on	  the	  
bacterial	  strain	  involved	  and	  the	  gentamicin	  concentration	  applied,	  but	  also	  on	  the	  
material	  on	  which	  the	  biofilm	  is	  growing.	  On	  PMMA	  for	  instance,	  resistance	  of	  24	  h	  
biofilms	   from	   a	   variety	   of	   clinically-­‐derived	   and	   commercially-­‐available	  
staphylococci	  was	  larger	  than	  on	  stainless	  steel	  during	  1	  h	  exposure	  to	  gentamicin	  
in	   concentrations	   up	   to	   256	   µg/mL	   (12).	   Slime	   production,	   as	   directed	   by	   the	  
icaADBC	   operon,	   may	   be	   one	   of	   the	   mechanisms	   through	   which	   staphylococci	  
protect	   themselves	   against	   antibiotics	   (1).	   Indeed,	   similar	   as	   with	   respect	   to	   the	  
development	   of	   resistance	   against	   gentamicin	   of	   staphylococcal	   biofilms	   on	  
different	   materials,	   also	   ica-­‐expression	   and	   resulting	   slime-­‐production	   seems	   to	  
depend	  on	  the	  substratum	  involved.	  Slime	  production	  and	  gentamicin-­‐resistance	  in	  
three	   clinically-­‐derived	   and	   one	   commercially–available,	   24	   h	   old	   S.	   epidermidis	  
biofilms	   were	   higher	   on	   polyethylene	   than	   on	   stainless	   steel	   or	   PMMA	   when	  
exposed	  during	   24	   h	   to	   gentamicin	   concentrations	   up	   32	  µg/mL	   gentamicin	   (14).	  
Others	  have	   suggested	   that	   the	  biomaterial	   dictates	   antibiotic	   resistance	  without	  
an	   influence	   of	   slime	   production	   (18).	  More	   in	   general,	   antibiotic	   resistance	   has	  
been	   linked	   to	   the	  metabolic	   activity	   of	   surface	   adhering	   organisms	   (23)	   and	   for	  
Pseudomonas	   aeruginosa	   it	   has	   been	   shown	   that	   low	   metabolic	   activity	   is	  
correlated	  with	  a	  high	  tolerance	  to	  tobramycin	  and	  ciprofloxacin	  (9;22).	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Since	  no	  such	  studies	  have	  been	  performed	  for	  staphylococcal	  biofilms	  on	  
Co-­‐Cr	   alloy,	   the	   aim	  of	   this	   study	   is	   to	   determine	   a	   possible	   correlation	  between	  
antibiotic	  resistance	  and	  the	  metabolic	  activity	  of	  staphylococcal	  biofilms	  grown	  on	  
cobalt-­‐chromium	  alloy	   (Co-­‐Cr)	  as	  compared	  with	  titanium	  alloy	   (Ti)	  and	  ultra-­‐high	  
molecular	  weight	  polyethylene	  (UHMWPE).	  	  
	  
	  
Materials	  and	  Methods	  
Bacterial	  strains	  
Two	  clinical	  isolates,	  S.	  epidermidis	  64	  (Sardjito	  Hospital,	  Yogyakarta,	  Indonesia	  (15))	  
and	   S.	   aureus	   5298	   (University	  Medical	   Center	   Groningen,	   The	  Netherlands	   (13))	  
and	   two	  ATCC	   strains	   S.	   epidermidis	   ATCC	   12228	   and	   S.	   epidermidis	  ATCC	   35984	  
were	   used	   in	   this	   study.	   In	   addition,	   we	   included	   the	   bioluminescent	   S.	   aureus	  
Xen36	   (Xenogen,	   Alameda,	   CA).	   All	   strains	   were	   routinely	   cultured	   from	   frozen	  
stock	   on	   blood	   agar	   plates	   at	   37°C	   for	   24	   h	   in	   ambient	   air.	   A	   single	   colony	   was	  
inoculated	   in	   10	   mL	   tryptone	   soya	   broth	   (TSB;	   OXOID,	   Basingstoke,	   UK)	   and	  
incubated	  overnight	  at	  37°C.	  
Minimal	  inhibitory	  concentrations	  (MIC)	  of	  gentamicin	  for	  all	  strains	  were	  
determined	   using	   the	   E-­‐test	   (Biomerieux,	   MarcyI`Etoile,	   France).	   To	   this	   end,	   a	  
bacterial	   suspension	   with	   a	   density	   of	   1.3	   at	   600	   nm	   was	   streaked	   by	   a	   sterile	  
cotton	   swab	  on	  a	  Mueller	  Hinton	  agar	  plate,	   and	  after	  air	  drying	  a	  gentamicin	  E-­‐
strip	  was	  added	  to	  the	  plate.	  Agar	  plates	  were	  incubated	  at	  37°C	  for	  24	  h	  and	  the	  
MIC	  was	  determined	  by	  reading	  the	  E-­‐test.	  MIC	  values	  above	  4	  µg/mL	  gentamicin	  
were	  considered	  indicative	  of	  resistance	  (2).	  
	  
Substratum	  surfaces	  	  
Discs	   (0.2	  cm	  thickness,	  diameter	  1.0	  cm,	  area	  1.41	  cm2)	  of	   surgical-­‐grade	  Ti	   (ISO	  
5832-­‐3),	   Co-­‐Cr	   (ISO	   5832-­‐12)	   and	   UHMWPE	   (gamma	   irradiated,	   not	   Vitamin	   E	  
infused)	  were	  cut	  from	  a	  rod	  stock	  with	  a	  lathe	  and	  these	  were	  generously	  supplied	  
by	  Biomet	  (Warsaw,	  IN).	  All	  discs	  were	  polished	  with	  a	  6	  and	  3	  µm	  diamond	  water-­‐
based	  suspension	  (Metadi,	  Buehler,	  Lake	  Bluff,	  USA)	  on	  a	  polishing	  cloth	  (Buehler,	  
Lake	  Bluff,	  USA),	  cleaned	  by	  5	  min	  sonication	  in	  2%	  alkaline	  cleaning	  agent	  (RBS	  35,	  
Omniclean,	  Breda,	  The	  Netherlands)	  followed	  by	  thorough	  rinsing	  with	  tap	  water,	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sonication	   in	   ethanol	   and	   rinsing	   in	   ultrapure	   water.	   Ti	   and	   Co-­‐Cr	   discs	   were	  
passivated	  by	  sonicating	  the	  discs	   in	  34%	  HNO3	  followed	  by	  thorough	  rinsing	  with	  
ultrapure	   water.	   Subsequently,	   samples	   were	   glued	   to	   the	   bottom	   of	   a	   12-­‐wells	  
plate	   (Costar,	   Corning,	   NY)	   with	   a	   polyurethane-­‐rubber	   (Bison	   Kit	   Transparent,	  
Bison	  Int.,	  Goes,	  Belgium),	  previously	  evaluated	  not	  to	  affect	  bacterial	  viability	  and	  
left	  to	  dry	  for	  1	  h.	  	  
Surface	   roughness	   of	   each	   of	   the	   samples	   were	  measured	   using	   atomic	  
force	  microscopy	   (Veeco	   Instruments,	   Santa	  Barbara,	  CA)	  with	  a	   sharp	  SiN3	   tip	   in	  
the	   contact	   mode.	   Water	   contact	   angles	   were	   measured	   using	   the	   sessile	   drop	  
technique	   and	   a	   home-­‐made	   contour	   monitor	   in	   order	   to	   determine	   the	  
hydrophobicity	  of	  the	  different	  biomaterials	  surfaces.	  All	  physico-­‐chemical	  surface	  
characterization	  was	  done	  in	  triplicate	  with	  separate	  sample	  discs.	  	  
	  
Biofilm	  formation,	  metabolic	  activity	  and	  gentamicin	  susceptibility	  
12-­‐wells	  plates	  with	  the	  discs	  glued	  to	  the	  bottom	  of	  the	  wells	  were	  filled	  with	  3	  mL	  
TSB	  and	   inoculated	  with	  30	  µL	  of	   an	  overnight	   culture	  of	   a	   staphylococcal	   strain.	  
Discs	   were	   incubated	   for	   6	   h	   at	   37°C	   after	   which	   the	  metabolic	   activities	   of	   the	  
biofilms	   on	   the	   different	   biomaterials	   were	   determined	   by	   the	   MTT	   (3-­‐(4,5-­‐
dimethylthiazol-­‐2-­‐yl)-­‐2,5-­‐diphenyl	  tetrazolium	  bromide;	  Sigma-­‐Aldrich,	  Zwijndrecht,	  
Netherlands)	   assay.	   MTT,	   a	   yellow	   soluble	   tetrazolium	   salt	   is	   reduced	   by	  
metabolically	   active	   bacteria	   to	   a	   blue	   colored	   formazan	   (5).	   Briefly,	   2	   mL	   MTT	  
solution	  (0.5	  mg/mL)	  in	  PBS,	  containing	  0.1%	  glucose	  and	  10	  μL	  menadion	  (10	  μM),	  
was	  added	   to	  each	  well.	   Plates	  were	   incubated	  at	  37°C	   in	   the	  dark	   for	  2	  h.	  After	  
removal	  of	  the	  MTT	  solution,	  biofilms	  were	  washed	  twice	  with	  demineralized	  water	  
and	  resuspended	  in	  acid	   isopropanol	  (5%	  v/v	  1	  M	  HCl	   in	   isopropanol).	  Finally,	  the	  
absorbance	  was	  measured	   at	   560	   nm	   using	   a	   spectrophotometer	   (Spectronic	   20	  
Genesys™,	  Spectronic	  Instruments	  Inc.,	  Rochester,	  NY).	  	  
	   In	   a	   separate	   set	   of	   experiments,	   6	   h	   biofilms	   formed	   on	   the	   different	  
biomaterials	   in	   the	   12-­‐well	   plates	   were	   washed	   with	   phosphate	   buffered	   saline	  
(PBS,	   10	   mM	   potassium	   phosphate	   and	   150	   mM	   sodium	   chloride,	   pH	   7.0)	   and	  
stained	  with	  BacLight	   live/dead	  stain	  (Molecular	  Probes,	  Leiden,	  The	  Netherlands)	  
and	   calcofluor	   white	   polysaccharide-­‐binding	   stain	   (Optical	   Brightener,	   Sigma-­‐
Aldrich,	   Zwijndrecht,	   Netherlands).	   After	   15	   min	   in	   the	   dark,	   excess	   stain	   was	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removed	   and	   biofilms	  were	   immersed	   in	   3	  mL	   PBS.	   Subsequently,	   confocal	   laser	  
scanning	  microscopy	   (CLSM)	   images	  were	   collected	   using	   a	   Leica	   TCS	   SP2	  with	   a	  
40x	  water	  objective.	  To	  prevent	  reflection	  by	  the	  discs	  at	  an	  excitation	  wavelength	  
of	  488	  nm	  and	  emission	   filter	   settings	  of	  600	  nm	  and	  higher	   (red),	   sections	  were	  
collected	  just	  above	  the	  surface,	  excluding	  imaging	  of	  the	  bacteria	  attached	  to	  the	  
discs.	  	  
After	  imaging,	  discs	  were	  carefully	  removed	  with	  a	  pair	  of	  sterile	  forceps.	  
Biofilms	   were	   detached	   by	   sonication	   on	   ice	   with	   a	   Vibra	   Cell	   375	   (Sonics	   and	  
Materials,	   Danbury,	   CT).	   The	   resulting	   staphylococcal	   suspensions	   were	  
subsequently	   diluted	   and	   bacterial	   concentrations	   were	   determined	   in	   a	   Bürker-­‐
Türk	  counting	  chamber.	  Numbers	  of	  staphylococci	  are	  presented	  per	  unit	  area.	   In	  
order	   to	   assess	   bacterial	   viability,	   again	   live/dead	   stain	  was	   added	   to	   10	   µL	   of	   a	  
staphylococcal	   suspension	   on	   a	   glass	   slide	   and	   live/dead	   ratios	  were	   determined	  
with	  a	  fluorescence	  microscope.	  
Separately	  and	  in	  addition,	  wells	  with	  6	  h	  biofilms	  were	  refreshed	  with	  TSB	  
(control)	  or	  TSB	  supplemented	  with	  6	  mg/mL	  bio-­‐active	  gentamicin	  (Sigma-­‐Aldrich,	  
Zwijndrecht,	   Netherlands)	   and	   incubated	   for	   an	   additional	   18	   h.	   The	   gentamicin	  
concentration	  was	  expected	  to	  represent	  local	  concentrations	  around	  gentamicin-­‐
loaded	  spacers	  and	  beads	  during	  initial	  burst	  release	  (17).	  Considering	  for	  instance,	  
a	  volume	  of	  10-­‐15	  ml	   joint	  fluid	  and	  an	  antibiotic	  release	  of	  20	  %	  in	  the	  first	  24	  h	  
during	   local	   treatment	  of	  BAI	  with	  3	   strings	  of	  antibiotic-­‐loaded	  beads	  containing	  
30	  beads	  each	  with	  4.5	  mg	  active	  gentamicin	  per	  bead	   (17),	  a	  concentration	  of	  6	  
mg/mL	  can	  be	  expected.	  	  
After	  18	  h	  of	  biofilm	  growth	   in	   the	  absence	  and	  presence	  of	  gentamicin,	  
biofilms	  were	   characterized	   as	   described	   above	   and	   the	   percentage	   reduction	   of	  
viable	   bacteria	   in	   biofilms	   exposed	   to	   gentamicin	   as	   compared	   to	   the	   control	  
biofilm	  was	  calculated	  according	  to	  	  
	  
Viable	  count	  control	  	  –	  	  Viable	  countgentamicin	  	  
%	   reduction	   =	  	  	  	  	  	  	   *	  100	   	   	  
	  	  	  	  	  	  Viable	  count	  control	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Statistics	  
Differences	  in	  average	  counts,	  reductions	  and	  absorbance	  values	  were	  analyzed	  for	  
significance	  by	  ANOVA	  and	  followed	  by	  a	  Mann-­‐Whitney	  U-­‐test.	  A	  95%	  (p	  <	  0.05,	  
two-­‐tailed)	  confidence	  interval	  was	  applied	  for	  statistical	  significance.	  
	  
	  
Results	  and	  Discussion	  	  
Four	  of	  the	  five	  strains	  involved	  were	  found	  to	  be	  susceptible	  for	  gentamicin	  with	  a	  
MIC	  of	  less	  than	  1	  µg/mL	  (S.	  epidermidis	  ATCC	  12228,	  S.	  aureus	  5298,	  S.	  epidermidis	  
64	   and	  S.	   aureus	   Xen36).	  S.	   epidermidis	   ATCC	  35984	  had	  a	  MIC	  of	   32	  µg/mL	  and	  
was	   considered	   resistant	   to	   gentamicin.	   UHMWPE	   was	   found	   to	   be	   more	  
hydrophobic	  (water	  contact	  angle	  86	  degrees)	  than	  Ti	  and	  Co-­‐Cr	  surfaces	  (Table	  I),	  
while	   the	   surface	   of	   Ti	  was	   4	   to	   5	   times	   smoother	   than	  Co-­‐Cr	   and	  UHMWPE.	  All	  
surface	  roughnesses	  however,	  were	  well	  below	  1	  µm.	  Co-­‐Cr	  surfaces	  appeared	  to	  
possess	  scratches,	  presumably	  as	  a	  result	  of	  machining	  the	  discs.	  	  
The	   total	   number	   of	   bacteria	   in	   6	   h	   old	   biofilms	   showed	   no	   differences	  
between	   the	   biomaterials,	   while	   only	   small	   differences	   existed	   between	   strains	  
(Figure	  1A).	  The	  preference	  of	  S.	  aureus	   for	  adhesion	  to	  metal	  substrata,	   i.e.	  of	  S.	  
epidermidis	   to	   adhere	   to	   polymeric	   substrata	   (3)	   could	   not	   be	   confirmed	   by	   our	  
present	   results.	   Although	   surface	   roughness	   is	   also	   known	   to	   influence	   biofilm	  
formation	  under	   conditions	  of	   fluctuating	   flow,	  most	  notably	   the	  oral	   cavity	   (19),	  
this	  could	  not	  be	  confirmed	  under	  the	  static	  conditions	  of	  our	  experiments.	  
The	  viability	  of	   the	  6	  h	  biofilms	  was	  found	  higher	  than	  95%	  in	  all	  strains.	  
Metabolic	  activity	  expressed	  per	  bacterium	  in	  6	  h	  old	  biofilms,	   i.e.	  at	  the	  onset	  of	  
the	   growth	   phase,	   was	   found	   to	   be	   significantly	   (p	   <	   0.05)	   lower	   for	   all	   three	   S.	  
epidermidis	   strains	   grown	   on	  UHMWPE	   as	   compared	  with	   their	   growth	   on	   Co-­‐Cr	  
(Figure	   1B),	   while	   a	   similar	   tendency	   existed	   for	   S.	   aureus	   biofilms	   (p	   >	   0.05).	  
Moreover,	  a	   tendency	  of	   lower	  metabolic	  activity	  on	  UHMWPE	  compared	  with	  Ti	  
was	  revealed,	  but	  this	  was	  only	  significant	  (p	  <	  0.05)	  for	  S.	  epidermidis	  ATCC	  12228.	  
The	  24	  h	  old	  biofilms	  contained	  more	  bacteria	  than	  6	  h	  old	  ones,	  although	  the	  data	  
suffer	   from	  quite	   large	   standard	  deviations	   (Figure	  2).	   There	   is	   a	   tendency	   for	   all	  
strains	   toward	   less	   biofilm	   formation	   on	  UHMWPE	   than	   on	   the	  metal	   alloys,	   but	  
this	  was	  only	  significant	  (p	  <	  0.05)	  for	  biofilms	  of	  S.	  epidermidis	  ATCC	  35984	  on	  Co-­‐
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Cr.	  The	  viability	  of	  all	  24	  h	  old	  biofilms	  is	  high	  and	  varies	  on	  average	  from	  97%	  for	  
UHMWPE	  to	  89%	  for	  Co-­‐Cr.	  Biofilms	  exposed	  to	  gentamicin	  showed	  significantly	  (p	  
<	  0.05)	  lower	  total	  bacterial	  counts	  and	  lower	  viabilities	  than	  biofilms	  not	  exposed	  
to	  gentamicin	   (see	  also	  Figure	  2).	  Gentamicin	  was	  particularly	  effective	  against	  S.	  




Figure	   1.	   (A)	   The	   number	   of	   staphylococci	   per	   unit	   area	   in	   6	   h	   old	   biofilms	   formed	   on	   Ti,	   Co-­‐Cr	   and	  
UHMWPE	  discs.	  The	  viability	  6	  h	  biofilms	  was	  found	  to	  be	  higher	  than	  95%	  in	  all	  strains	  (not	  shown	  in	  
figure).	  (B)	  Metabolic	  activities	  by	  an	  MTT	  assay	  expressed	  as	  absorbance	  per	  bacterium	  in	  6	  h	  biofilms	  
on	   Ti,	   Co-­‐Cr	   and	  UHMWPE	  discs	   for	   the	  different	   staphylococcal	   strains	   employed	   in	   this	   study.	  Data	  
represent	   mean	   ±	   standard	   deviations	   over	   three	   experiments	   with	   separately	   cultured	   bacteria.	  
*indicates	  a	  significant	  difference	  in	  the	  metabolic	  activity	  of	  bacteria	  grown	  on	  Ti,	  Co-­‐Cr	  or	  UHMWPE	  
discs.	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Table	   I.	   Sample	   discs	   of	   the	   different	   orthopaedic	  materials	   used,	   together	   with	  
AFM	   images	   of	   their	   surfaces	   and	   their	   surface	   roughnesses	   and	   water	   contact	  
angles.	   Data	   represent	   averages	   with	   ±	   indicating	   the	   SD	   over	   3	   separate	  
experiments.	  
	   AFM	  image	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Figure	  2.	  The	  number	  of	  live	  (green)	  and	  dead	  (red)	  staphylococci	  per	  unit	  area	  as	  derived	  from	  24	  h	  old	  
biofilms	   formed	   on	   Ti,	   Co-­‐Cr	   and	   UHMWPE	   discs	   prior	   to	   (top)	   and	   after	   exposure	   to	   gentamicin	  
(bottom).	  Data	  represent	  mean	  ±	  standard	  deviations	  over	  three	  experiments	  with	  separately	  cultured	  
bacteria.	  *indicates	  a	  significant	  difference	  in	  the	  number	  of	  bacteria	  grown	  on	  Co-­‐Cr	  and	  UHMWPE.	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The	  numbers	  of	  viable	  Staphylococci	  as	  presented	   in	  Figure	  2	  have	  been	  
used	  to	  calculate	  a	  percentage	  reduction	  in	  the	  number	  of	  viable	  organisms	  on	  the	  
different	   biomaterials	   upon	   treatment	   by	   gentamicin.	   Figure	   3	   shows	   that	  
staphylococcal	   killing	   on	   UHMWPE	   is	   generally	   less	   than	   on	   the	   metal	   alloys,	  
although	  this	  was	  only	  significant	  for	  S.	  epidermidis	  ATCC	  35984	  (p	  <	  0.05).	  Possibly,	  
the	   use	   of	   a	   high	   concentration	   of	   gentamicin	   (6	  mg/mL)	   overrules	   all	   effects	   of	  
differences	   in	   substratum	   properties.	   In	   vivo,	   drainage	   fluid	   of	   patients	   with	  
concentrations	  as	  high	  as	  only	  440	  µg/mL	  gentamicin	  have	  been	   reported,	  which	  
does	   not	   rule	   out	   however,	   that	   much	   higher	   local	   concentrations	   may	   develop	  
around	  antibiotic-­‐loaded	  beads	  and	  spacers	   (21).	   Interestingly,	  despite	   the	  use	  of	  
relatively	  high	  gentamicin	  concentrations,	  killing	  efficacy	  never	  reached	  100%.	  	  
CLSM	   analysis	   of	   biofilms	   from	   all	   strains	   grown	   in	   the	   presence	   of	  
gentamicin	  showed	  an	  increased	  slime	  production	  on	  all	  substrata	  with	  respect	  to	  
biofilms	   grown	   in	   the	   absence	   of	   gentamicin	   (see	   Figure	   4).	   Nuryastuti	   et	   al.	  
observed	   more	   extensive	   slime-­‐production	   on	   UHMWPE	   as	   compared	   with	  
stainless	   steel	   and	   PMMA,	   but	   gentamicin	   concentration	   used	  were	  much	   lower	  
(16-­‐32	   µg/mL)	   than	   applied	   here,	   which	   might	   explain	   the	   massive	   slime-­‐
production	  observed	  regardless	  of	  the	  substratum	  properties	  (14).	  
In	   conclusion,	   orthopaedic	   biomaterials	   influence	   metabolic	   activity	   of	  
staphylococcal	  biofilms,	  but	  metabolic	  activity	  did	  not	  correlate	  with	  staphylococcal	  
killing	  by	  gentamicin	  in	  24	  h	  old	  biofilms.	  The	  reduction	  of	  viable	  organisms	  grown	  
in	   the	   presence	   of	   gentamicin	   compared	   to	   biofilms	   grown	   in	   absence	   of	  
gentamicin	  was	  lowest	  on	  UHMWPE,	  which	  was	  the	  most	  hydrophobic	  biomaterial	  
involved	   in	   this	   study.	   However,	   no	   statistically	   significant	   correlation	  was	   found	  
between	  lower	  metabolic	  activity	  at	  the	  onset	  of	  growth	  and	  lower	  staphylococcal	  




	  Figure	  3.	  Percentage	  reduction	  in	  the	  number	  of	  viable	  staphylococci	  in	  24	  h	  old	  biofilms	  formed	  Ti,	  Co-­‐
Cr	  and	  UHMWPE	  discs	  upon	  exposure	   to	  gentamicin	  as	   compared	   to	  untreated	  24	  h	  control	  biofilms.	  
Killing	  efficacy	  represents	  mean	  ±	  standard	  deviations	  over	  three	  experiments	  with	  separately	  cultured	  
bacteria.	  *indicates	  a	  significant	  difference	  in	  staphylococcal	  numbers	  reduction	  of	  bacteria	  exposed	  to	  




Figure	  4.	  CLSM	  images	  (375	  x	  375	  µm)	  of	  24	  h	  old	  S.	  epidermidis	  ATCC	  35984	  biofilm	  grown	  on	  Ti,	  Co-­‐Cr	  
and	  UHMWPE	  discs	  prior	  to	  (A,	  B	  and	  C)	  and	  after	  exposure	  to	  gentamicin	  (D,	  E	  and	  F).	  Baclight	  staining	  
visualizes	   live	   bacteria	   (green)	   and	   dead	   bacteria	   (red).	   Slime	   (blue)	   is	   visualized	   by	   calcofluor	  white.	  
Colors	  are	  based	  on	  the	  average	  voxel	  intensity	  throughout	  the	  depth	  of	  the	  biofilm.	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Wear	   of	   metal-­‐on-­‐metal	   (cobalt-­‐chromium,	   Co-­‐Cr	   particles)	   and	   metal-­‐on-­‐
polyethylene	   (ultra-­‐high-­‐molecular-­‐weight	   polyethylene,	   UHMWPE	   particles)	  
bearing	  surfaces	  in	  hip	  prostheses	  is	  a	  major	  problem	  in	  orthopedics,	  suggested	  to	  
cause	   inflammatory	   reactions	  and	  a-­‐septic	   loosening	  of	  prostheses.	  However,	   the	  
influence	  of	  wear	  particles	  on	  the	  risk	  of	  infection	  is	  still	  unclear.	  This	  study	  aimed	  
to	  compare	  the	  influence	  of	  Co-­‐Cr	  and	  UHMWPE	  particles	  on	  the	  risk	  of	  infection.	  
Methods	  	  
Bioluminescent	   Staphylococcus	   aureus	   Xen36	   were	   injected	   in	   air	   pouches	  
prepared	  in	  subcutaneous	  tissue	  of	  immuno-­‐competent	  BALB/c	  mice	  (control),	  as	  a	  
model	   for	   the	   joint	   space,	   in	   the	   absence	   or	   presence	   of	   Co-­‐Cr	   or	   UHMWPE	  
particles.	  Bioluminescence	  was	  monitored	   longitudinally	  up	   to	  21	  days,	   corrected	  
for	   absorption	   and	   reflection	   by	   the	   particles	   and	   expressed	   relative	   to	   the	  
bioluminescence	  found	  in	  the	  presence	  of	  staphylococci	  only.	  After	  termination,	  air	  
pouch	  fluid	  and	  air	  pouch	  membrane	  were	  cultured	  and	  histologically	  analyzed.	  
Results	  
Bioluminescence	   was	   initially	   lower	   in	   mice	   exposed	   to	   UHMWPE	   particles	   with	  
staphylococci	   than	   in	   mice	   injected	   with	   staphylococci	   only,	   possibly	   because	  
UHMWPE	  particles	  initially	  stimulated	  a	  higher	  macrophage	  presence	  in	  murine	  air	  
pouch	   membranes.	   For	   mice	   exposed	   to	   Co-­‐Cr	   particles	   with	   staphylococci,	  
bioluminescence	  was	  observed	  to	  be	  higher	  in	  two	  out	  of	  six	  animals	  compared	  to	  
the	  presence	  of	   staphylococci	   alone.	  Accordingly,	   a	  high	  number	  of	  macrophages	  
was	   found	   in	   the	   air	   pouch	   of	   the	  mouse	   showing	   the	  most	   prolonged,	   elevated	  
bioluminescence.	  	  
Conclusion	  
In	   the	   majority	   of	   mice,	   infection	   risk	   in	   the	   absence	   or	   presence	   of	   Co-­‐Cr	   and	  
UHMWPE	   particles	   appeared	   similar,	   assuming	   that	   the	   longevity	   of	   an	   elevated	  
bioluminescence	   is	   indicative	  of	  a	  higher	   infection	   risk.	  However,	   the	  presence	  of	  
Co-­‐Cr	   particles	   yielded	   a	   higher	   bioluminescence	   in	   two	   out	   of	   six	  mice,	   possibly	  
because	   the	  macrophage	  degradative	   function	  was	  hampered	  by	   the	  presence	  of	  
Co-­‐Cr	  particles.	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Introduction	  
Metal-­‐on-­‐metal	   (MOM)	   bearings	   have	   been	   favored	   compared	   to	   conventional	  
metal-­‐on-­‐polyethylene	   (MOP)	   bearings,	   because	   of	   their	   low	   wear	   in	   hip	  
arthroplasties	   for	   young	   and	   active	   patients	   (7;24).	   However,	   with	   up	   to	   three	  
million	  gait	  cycles	  (20),	  active	  MOM	  patients	  still	  accumulate	  nearly	  1	  mg	  of	  nano-­‐
sized	   cobalt-­‐chromium	   (Co-­‐Cr)	   wear	   particles	   per	   year	   (1).	   Patients	   with	   MOP	  
bearings	   gather	   approximately	   20-­‐	   to	   100-­‐fold	   more	   ultra-­‐high-­‐molecular-­‐weight	  
polyethylene	  (UHMWPE)	  particles	  after	  the	  same	  number	  of	  cycles	  (22).	  	  
Conflicting	   results	  have	  been	   reported	   concerning	   the	   influence	  of	  Co-­‐Cr	  
wear	   particles	   on	   bacterial	   growth	   and	   associated	   infection	   risks	   of	   total	   hip	  
arthroplasties	   with	   MOM-­‐bearings.	   Co-­‐Cr	   debris	   has	   been	   demonstrated	   to	  
promote	  bacterial	  growth	  in	  vitro	  (2),	  but	  on	  the	  other	  hand	  high	  concentrations	  of	  
Co	  and	  Cr	  ions	  appeared	  to	  possess	  bacteriostatic	  properties	  as	  well	  (14).	  Recently,	  
Co	   ions	  were	   reported	   to	   inhibit	  neutrophil	  proton	  pumps	   (6)	  and	  Co-­‐Cr	  particles	  
induced	   toxic	   effects	   when	   phagocytosed	   (15;26),	   frustrating	   the	   degradative	  
function	  of	  macrophages.	  These	  processes	  hamper	  the	  immune	  system	  and	  might	  
predispose	  MOM	  patients	  to	  infection	  at	  the	  implant	  site	  (27-­‐29).	  	  
In	  vitro	  it	  is	  impossible	  to	  determine	  the	  net	  effect	  of	  wear	  particles	  in	  the	  
presence	   of	   bacteria	   on	   infection	   risks.	   Clinically,	   investigating	   the	   influence	   of	  
wear	  particles	  on	  the	  development	  of	  an	  infection	  requires	  large	  patient	  groups	  as	  
infection	   only	   occurs	   in	   0.5	   -­‐	   3%	   of	   patients	   (5).	   Moreover,	   it	   is	   not	   feasible	   to	  
collect	  pseudosynovial	  fluid	  for	   infection	  analysis	  from	  such	  a	   large	  patient	  group,	  
as	  this	  invasive	  procedure	  bears	  the	  risk	  of	  introducing	  an	  infection.	  	  
An	  in	  vivo	  murine	  air	  pouch	  model	  has	  been	  developed	  in	  order	  to	  mimic	  
the	   joint	   lining	   around	   failed	   prostheses	   for	   comparing	   the	   biocompatibility	   of	  
particulate	   debris.	   Using	   this	   model,	   the	   presence	   of	   Co-­‐Cr,	   UHMWPE,	   Ti-­‐6Al-­‐4V	  
and	   polymetylmethacrylate	   (PMMA)	   particles	   in	   such	   pouches	   were	   found	   to	  
increase	   the	   air	   pouch	  membrane	   thickness,	   and	   the	   number	   of	  macrophages	   in	  
the	   pouches	   as	   well	   as	   the	   IL-­‐1	   response	   (25).	   Forty-­‐eight	   hours	   after	   the	  
introduction	   of	   particles	   into	   such	   pouches,	   Ti-­‐6Al-­‐4V	   showed	   the	   most	  
pronounced	   increase	   in	  membrane	   thickness	   and	   IL-­‐1	   response,	   while	   UHMWPE	  
particles	  were	  responsible	   for	   the	  highest	   increase	   in	  number	  of	  macrophages.	   In	  




severity	  of	   inflammatory	  response,	  with	  rough	  debris	  surface	  texture	  exerting	  the	  
most	   adverse	   tissue	   response	   (21).	   The	   effects	   of	   the	   combined	   presence	   of	  
bacteria	  and	  particulate	  debris	   in	  an	  air	  pouch	  model	  of	   the	   joint	   lining	  around	  a	  
prosthesis	  has	  never	  been	  performed.	  
In	  the	  current	  manuscript,	  we	  aim	  to	  compare	  the	  influence	  of	  Co-­‐Cr	  and	  
UHMPE	  particles	  on	  the	  risk	  of	  infection	  in	  an	  animal	  model.	  To	  this	  end,	  an	  in	  vivo	  
bio-­‐optical	   imaging	   system	   was	   used	   to	   longitudinally	   monitor	   the	   growth	   of	  
bioluminescent	  staphylococci	  in	  air	  pouches	  prepared	  in	  the	  subcutaneous	  tissue	  of	  
mice	   in	   the	   absence	   and	   presence	   of	   Co-­‐Cr	   or	   UHMWP	   particles.	   After	   sacrifice,	  




Wear	  particles	  	  
Commercially	   available	   pure	   UHMWPE	   particles	   (Ceridust	   3615,	   7	   μm	   mean	  
diameter)	  were	  generously	  provided	  by	   the	  manufacturer	   (Clariant,	  Coventry,	  RI).	  
Co-­‐Cr	   particles	   were	   derived	   from	   ISO	   5832-­‐4	   cast	   Co-­‐Cr	   alloy	  Micro-­‐Melt®	   dust	  
(Carpenter	  Powder	  Products,	  Wyomissing,	  PA),	  with	  courtesy	  of	  Biomet	   (Warsaw,	  
IN.).	   In	   order	   to	   obtain	   Co-­‐Cr	   particles	   with	   a	   size	   range	   similar	   to	   UHMWPE	  
particles,	  we	  used	  a	  pre-­‐separator	  attached	  to	  an	  inhaler	  2000	  adapter	  (Sympatec	  
GmbH,	  Clausthal-­‐Zellerfeld,	  Germany)	  to	  remove	  larger	  particles.	  Subsequently,	  the	  
smaller	  particles	  were	   trapped	   in	  an	  aerosol	  and	   liquid	   impinger	   in	  ethanol.	  Both	  
Co-­‐Cr	   and	   UHMWPE	   particles	   were	   washed	   in	   70%	   ethanol	   solution	   to	   remove	  
possible	   bound	   endotoxin	   from	   environmental	   bacteria	   and	   ethanol	   was	  
subsequently	  evaporated	  under	  vacuum.	  The	  absence	  of	  endotoxins	  was	  confirmed	  
using	  the	  Limulus	  assay	  (Endosafe,	  Charlestown,	  SC).	  Prior	  to	  inoculation,	  particles	  
were	  sonicated	  for	  30	  min	  to	  prevent	  aggregation.	  Final	  particle	  size	  distributions	  
were	   measured	   with	   a	   Sympatec	   HELOS	   compact	   KA	   laser	   diffraction	   apparatus	  
(Sympatec	   GmbH,	   Clausthal-­‐Zellerfeld,	   Germany),	   using	   a	   RODOS	   dry	   powder	  
disperser	  at	  3.0	  bar.	  A	  lens	  of	  200	  mm	  was	  used	  and	  calculations	  were	  based	  on	  the	  
Fraunhofer	   diffraction	   theory.	   Particle	   morphology	   was	   visualized	   with	   a	   JEOL	  
JSM6301	   scanning	  microscope	   (JEOL,	  USA	   Inc.,	   Peabody,	  MA,	  USA)	   at	   3	   kV,	   after	  
sputter-­‐coating	  the	  particles	  with	  a	  5	  nm	  thick,	  conductive	  film	  of	  Pd/Au.	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Bioluminescent	  Staphylococcus	  aureus	  Xen36	  
S.	   aureus	   Xen36	   (commercially	   obtained	   from	   Xenogen,	   Alameda,	   CA,	   USA)	   was	  
derived	  from	  S.	  aureus	  ATCC	  49525.	  The	  parental	  strain	  was	  a	  clinical	  isolate,	  made	  
bioluminescent	   by	   stably	   integrating	   a	   modified	   lux	   operon	   (Photorhabdus	  
luminescens	  luxABCDE)	  on	  a	  native	  plasmid.	  This	  modification	  enables	  the	  strain	  to	  
produce	   luciferase	  and	   its	   substrate,	   resulting	   in	  a	  photon-­‐emitting	  state	  when	   in	  
presence	   of	   ATP,	   the	   reduced	   biomolecule	   flavin	   mononucleotide,	   NADPH	   and	  
oxygen	  (12).	  	  
S.	   aureus	   Xen36	   was	   cultured	   from	   cryopreservative	   beads	   (Protect	  
Technical	  Surface	  Consultants	  Ltd,	  Lancashire,	  UK)	  onto	  tryptone	  soya	  broth	  (TSB;	  
Oxoid,	   Basingstoke,	  UK)	   agar	   plates	   supplemented	  with	   200	   µg/mL	   kanamycin	   at	  
37°C	   in	   ambient	   air.	  One	   colony	  was	  used	   to	   inoculate	   10	  mL	  TSB	   supplemented	  
with	   kanamycin	   for	   24	   h	   at	   37°C.	   Main	   cultures	   were	   grown	   overnight	   by	  
inoculating	   10	   mL	   TSB	   supplemented	   with	   kanamycin	   with	   0.5	   mL	   preculture.	  
Subsequently,	  main	   cultures	  were	   centrifuged	  and	   rinsed	   three	   times	  with	   sterile	  
phosphate-­‐buffered	  saline	  (PBS)	  and	  resuspended	  in	  PBS.	  The	  inoculum	  was	  diluted	  
to	  	  9	  x	  108	  cells/mL	  by	  counting	  in	  a	  Bürker-­‐Türk	  counting	  chamber.	  Aliquots	  of	  the	  
inoculum	  were	  incubated	  on	  agar	  plates	  for	  48	  h	  at	  37°C	  to	  yield	  the	  concentration	  
of	  CFUs	  in	  the	  inoculum,	  which	  was	  found	  to	  be	  5	  x	  108	  CFU/mL.	  	  
For	   animal	   experiments,	   a	   5%	   weight/volume	   (25)	   concentration	   was	  
chosen	   for	  Co-­‐Cr	  particles	   (25	  mg/mL)	  as	   suspended	   in	   syringes	  with	  1	  mL	  of	   the	  
staphylococcal	   suspension.	  The	  concentration	  of	  UHMWPE	  particles	  was	  adjusted	  
to	  match	  the	  number	  of	  Co-­‐Cr	  particles	  using	  the	  particle	  size	  distributions	  listed	  in	  
Table	   I,	   resulting	   in	   a	   concentration	   of	   5	   mg/mL.	   Although	   the	   bioluminescence	  
yield	   per	   bacterium	   should	   not	   a	   priori	   be	   influenced	   by	   its	   environment,	   the	  
presence	  of	   light	   reflecting	  or	  absorbing	  surfaces	   like	  Co-­‐Cr	  or	  UHMWPE	  particles	  
may	   influence	   the	   bioluminescence	   captured	   in	   bio-­‐optical	   imaging.	   Therefore,	  
syringes	   filled	   with	   only	   S.	   aureus	   Xen36	   and	   with	   Co-­‐Cr	   or	   UHMWPE	   particles	  
added	  were	   imaged	  with	  the	  bio-­‐optical	   imaging	  system,	  as	  described	  below.	  The	  
ratio	  between	  the	  bioluminescence	  yields	  in	  the	  absence	  and	  presence	  of	  Co-­‐Cr	  or	  
UHMWPE	   particles	   was	   used	   to	   correct	   the	   in	   vivo	   bioluminescence	   for	   possible	  




differences	   in	   geometry	   between	   the	   syringes	   and	   the	   air	   pouches	   can	   be	  
neglected.	  	  
	  
Table	   I.	   Cumulative	   volume	   distributions	   of	   Co-­‐Cr	   and	   UHMWPE	   particles,	  
measured	  with	  laser	  diffraction.	  	  
Cumulative	  distribution	  (%)	   Co-­‐Cr	   UHMWPE	  
	   Particle	  size	  beneath	  (µm)	  	  
10	   4.8	   3.7	  
25	   6.5	   5.8	  
50	   9.4	   8.3	  
75	   16.1	   11.2	  
90	   24.3	   14.1	  
99	   35.6	   18.8	  
	  
Murine	  air	  pouch	  infection	  model	  
Seven	   weeks	   old	   male	   BALB/c	   OlaHsd	   immune	   competent	   mice	   (Harlan	  
Netherlands	  BV,	  Horst,	  Netherlands)	  with	  specified	  pathogen	  free	  conditions	  were	  
quarantined	   in	  our	  animal	   facility	   for	  two	  weeks	  prior	  to	  experiments.	  All	  animals	  
were	  housed	  per	  groups	  of	  three	  in	  individual	  ventilated	  cages	  with	  Cellu-­‐dri	  Soft	  R	  
bedding	   (Shepherd	   Speciality	   papers,	   Kalamazoo,	   Michigan,	   US).	   The	   mice	   were	  
weighed	   daily	   and	   evaluated	   on	   the	   basis	   of	   activity,	   illness	   and	   alternative	  
behavior.	   All	  mice	  weighed	   20	   g	   or	   over	   at	   the	   start	   of	   the	   experiment	   (average	  
22.2	   ±	   1.0	   g)	   and	   had	   ad	   libitum	   access	   to	   food	   and	   water	   throughout	   the	  
experiment.	  	  
	   Air	  pouches	  were	  prepared	  through	  subcutaneous	  injections	  of	  sterile	  air	  
(10).	  Briefly,	  an	  area	  of	  2	  cm2	  dorsal	  skin	  was	  shaved	  and	  cleaned	  with	  alcohol	  to	  
provide	   the	  pouch	   site.	   Sterile	   air	   (1	  mL)	  was	   injected	   subcutaneously	   at	   a	   single	  
site	  with	   a	   25-­‐gauge	   needled	   syringe	   on	   alternate	   days	   for	   5	   days	   to	   establish	   a	  
definitive	   pouch,	   which	   filled	   spontaneously	   with	   serum.	   Buprenorphine	   (0.03	  
mg/kg)	  was	  administered	  subcutaneously	  30	  min	  prior	  to	  injections.	  During	  pouch	  
preparation,	   anesthesia	   was	   induced	   with	   a	   3.5%	   Isoflurane/O2	   (Zeneca,	  
Zoetermeer,	  Netherlands)	  gas	  mixture	  and	  maintained	  at	  1.5%.	  
6	   days	   after	   air	   pouch	   creation,	   pouches	   were	   injected	   with	   1	   mL	   of	   a	  
bioluminescent	   staphylococcal	   suspension	   (6	   mice)	   or	   a	   combination	   of	  
bioluminescent	  bacteria	  with	  Co-­‐Cr	  or	  UHMWPE	  particles	  (also	  6	  mice	  per	  group).	  
In	  addition,	  three	  smaller	  control	  groups	  (3	  mice	  per	  group)	  were	  injected	  with	  Co-­‐
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Cr	  or	  UHMWPE	  particles	  or	  only	  PBS	  in	  the	  absence	  of	  any	  bacteria.	  Subsequently,	  
bacterial	   presence	   was	   monitored	   for	   a	   period	   of	   21	   days	   by	   bioluminescence	  
imaging,	  as	  described	  below.	  At	  the	  end	  of	  the	  experimental	  period,	  animals	  were	  
euthanized	  under	  anesthesia	  by	  cervical	  dislocation.	  	  
Experiments	   were	   performed	   in	   accordance	   to	   federal	   legislation	  
regarding	  the	  protection	  of	  animals	  and	  were	  approved	  by	  the	  Animal	  Experiments	  
Committee	  at	  the	  University	  of	  Groningen.	  
	  
Bioluminescence	  imaging	  
Bioluminescence	  was	  imaged	  with	  a	  highly-­‐sensitive,	  cooled	  CCD	  camera	  (IVIS	  100	  
Imaging	   System,	   Caliper	   Life	   Sciences,	   Hopkinton,	   MA,	   USA).	   Bioluminescence	  
images	   were	   obtained	   with	   5	   min	   exposure	   time	   using	   a	   15-­‐cm	   field	   of	   view,	  
binning	   of	   4,	   1/f	   stop	   and	   open	   filters.	   Pseudo-­‐color	   images	   were	   obtained	   and	  
overlaid	  on	  a	  gray	  scale	  photograph	  of	  the	  mice.	  Mice	  were	  kept	  under	  anesthesia	  
during	   imaging.	   Bioluminescence	   was	   quantified	   as	   total	   bioluminescent	   flux	  
(photons/s)	   within	   a	   circular	   region	   of	   interest	   (2.5	   cm2)	   by	   using	   living	   image	  
software	   (Xenogen,	   Alameda,	   CA,	   USA).	   In	   case	   of	   imaging	   of	   the	   syringes	   filled	  
with	  bioluminescent	  bacteria	  in	  the	  absence	  and	  presence	  of	  particles,	  the	  area	  of	  
the	  syringe	  was	  taken	  as	  the	  region	  of	  interest.	  	  
In	   order	   to	   account	   for	   effects	   of	   the	   presence	   of	   particles	   on	  
staphylococcal	   bioluminescent	   fluxes	   measured,	   all	   measured	   fluxes	   were	  
corrected	   for	   absorption	   and	   reflection	   using	   the	   in	   vitro	   bioluminescence	   ratios	  
between	   syringes	   filled	   with	   bacteria	   in	   the	   absence	   and	   presence	   of	   particles.	  
Subsequently,	  data	  of	  the	  groups	  of	  mice	  with	  S.	  aureus	  Xen36	  in	  combination	  with	  
particles	   were	   normalized	   by	   dividing	   the	   corrected	   bioluminescence	   flux	   of	  
individual	   mice	   on	   each	   day	   by	   the	   average	   corrected	   bioluminescence	   flux	  
observed	  in	  the	  presence	  of	  S.	  aureus	  Xen36	  only.	  	  
	  
Analysis	  of	  tissue	  samples	  
Air	  pouch	  fluid	  was	  collected	  during	  anesthesia	  by	  flushing	  an	  air	  pouch	  with	  1	  mL	  
sterile	  PBS,	  immediately	  before	  euthanizing	  the	  mice.	  Directly	  after	  euthanasia,	  air	  
pouch	  membrane	   samples	   were	   collected	   from	   the	   dorsum	   of	   the	   air	   pouch	   for	  




	   For	  histological	  analysis,	  tissue	  samples	  were	  taken	  from	  all	  animals.	  Part	  
of	  a	  tissue	  sample	  was	  fixed	  in	  10%	  buffered	  formalin,	  dehydrated,	  and	  embedded	  
in	  paraffin	  blocks	  with	  particular	  care	  to	  preserve	  the	  original	  shape	  of	  the	  pouch	  
tissue,	   while	   the	   other	   part	   was	   used	   for	   culturing.	   Sections	   were	   cut	   along	   the	  
pouch	  middle	   line,	  mounted	  and	  stained	  with	  hematoxylin	  and	  eosin	  stain.	  Cover	  
slips	  were	  fitted	  to	  the	  slides	  using	  glass	  bonding	  adhesive.	  
	   After	  scanning	  with	  a	  NanoZoomer	  2.0-­‐HT	  system	  (Hamamatsu	  photonics,	  
Hamamatsu,	   Japan),	   three	   separate	   sections	   per	   specimen	   were	   evaluated	   with	  
NDP	  view	  software	  (Olympus,	  Center	  valley,	  PA,	  USA)	  in	  a	  blinded	  fashion	  by	  three	  
individuals.	   Tissue	   reaction	  was	   scored	   by	  measuring	   the	   thickness	   of	   the	   pouch	  
membrane	  and	  enumeration	  of	  the	  number	  of	  macrophages	  per	  mm2	  of	  analyzed	  
air	  pouch	  membrane.	  	  
	   For	  culturing,	   tissue	  samples	  were	  sonicated	  on	   ice	  with	  a	  Vibra	  Cell	  375	  
(Sonics	  and	  Materials,	  Danbury,	  CT)	  and	  subsequently	   rubbed	  with	  sterile	   forceps	  
on	  TSB	  agar	  plates.	  Both	  the	  sonication	  fluid	  from	  tissue	  samples	  and	  the	  air	  pouch	  
fluid	   were	   serially	   diluted	   and	   spread	   on	   TSB	   agar	   plates.	   All	   plates	   were	   left	   to	  
incubate	  for	  24,	  48	  and	  72	  h	  at	  37°C	  and	  CFUs	  were	  counted.	  	  
	  
Statistics	  	  
Normalized	  bioluminescence	  fluxes	  were	  compared	  at	  each	  observation	  day	  during	  
the	   21-­‐days	   follow-­‐up	   period	   by	   ANOVA	   followed	   by	   a	  Mann-­‐Whitney	   U-­‐test.	   In	  
addition,	  air	  pouch	  membrane	  thickness	  and	  macrophage	  counts	  were	  analyzed	  by	  





Laser	   diffraction	   revealed	   volume	   size-­‐distributions	   to	   be	   within	   the	  micrometer	  
size	  range	  (Table	  I).	  Differences	  between	  Co-­‐Cr	  and	  UHMWPE	  particles	  were	  minor	  
and	  confined	  to	  particle	  sizes	  above	  10	  μm.	  SEM	  images	  demonstrated	  that	  Co-­‐Cr	  
particles	   are	   more	   spherically	   shaped,	   with	   UHMWPE	   particles	   having	   a	   more	  
irregular	  flake-­‐shape	  (Figure	  1).	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The	   bioluminescence	   captured	   in	   the	   bio-­‐optical	   imaging	   system	   was	  
influenced	   by	   the	   presence	   of	   Co-­‐Cr	   and	   UHMWPE	   particles,	   as	   can	   be	   seen	   in	  
Figure	  2.	  Bioluminescence	  arising	   from	  1	  mL	  syringes	   filled	  with	  5	  x	  108	  S.	  aureus	  
Xen36	  in	  the	  presence	  of	  Co-­‐Cr	  particles	  was	  significantly	  weaker	  (0.8x)	  than	  in	  the	  
absence	  of	  Co-­‐Cr	  particles,	  due	  to	  absorption	  of	  light	  by	  the	  particles.	  On	  the	  other	  
hand,	   extensive	   reflection	   by	   UHMWPE	   particles	   significantly	   increased	   the	  
bioluminescence	   measured	   (1.6x).	   These	   ratios	   were	   employed	   to	   correct	   the	  
bioluminescence	  arising	  from	  mice	  infected	  with	  S.	  aureus	  Xen36	  in	  the	  presence	  of	  
particles.	  
Figure	  3	  shows	  examples	  of	  bioluminescence	   images	  of	  an	   individual	  mouse	  from	  
each	   of	   the	   three	   experimental	   groups,	   followed	   longitudinally.	   Weakest	  
bioluminescence	   is	   seen	   for	   the	  mouse	   injected	  with	   S.	   aureus	   Xen36	   and	   Co-­‐Cr	  
particles,	   while	   more	   prominent	   and	   lasting	   bioluminescence	   arises	   from	   the	  
mouse	   injected	   with	   S.	   aureus	   Xen36	   and	   UHMWPE	   particles.	   These	   images	  
however,	  may	  not	  be	  taken	  as	  indicative	  for	  the	  course	  of	  infection,	  as	  they	  do	  not	  
account	  for	  absorption	  and	  reflection	  of	  the	  bioluminescence	  signal.	  
Bioluminescence	   from	   all	   three	   groups	   of	   mice,	   as	   corrected	   for	  
absorption	  and	  reflection	  were	  subsequently	  normalized	  by	  dividing	  the	  corrected	  
bioluminescence	   fluxes	   by	   the	   average	   bioluminescence	   flux	   at	   each	   day	   in	   the	  
group	  of	  mice	  injected	  with	  bacteria	  only.	  Figure	  4	  reveals	  a	  clear	  difference	  in	  the	  
course	   of	   infection	   in	   animals	   having	   received	   Co-­‐Cr	   particles	   and	   UHMWPE	  
particles.	  In	  the	  Co-­‐Cr	  group,	  normalized	  bioluminescence	  was	  below	  unity	  in	  four	  
out	   of	   the	   six	   mice.	   In	   the	   two	   mice	   with	   bioluminescence	   above	   unity,	  
bioluminescence	   returned	   to	   unity	   within	   9	   to	   21	   days.	   In	   the	   UHMWPE	   group,	  
bioluminescence	   was	   initially	   less	   than	   unity,	   with	   only	   one	   animal	   on	   day	   3	  
emitting	  a	  slightly	  higher	  bioluminescence,	  but	  after	  9	  days	  there	  was	  no	  difference	  
anymore	  in	  bioluminescence	  arising	  from	  mice	  injected	  with	  S.	  aureus	  Xen36	  only	  
or	  with	  staphylococci	  and	  UHMWPE	  particles.	  	  
Background	  bioluminescence	  flux	  was	  found	  to	  be	  below	  1.2	  x	  105	  (p/s)	  in	  
control	   groups	   injected	   with	   PBS	   or	   particles	   only	   and	   coincided	   with	   the	  
bioluminescence	  observed	  in	  all	  groups	  of	  mice	  after	  21	  days.	  Histological	  analyses	  
revealed	  no	  signs	  of	  inflammation	  in	  26	  out	  of	  the	  27	  mice	  in	  the	  different	  groups	  







Figure	   1.	   Scanning	   electron	   micrographs	   of	   Co-­‐Cr	   (A)	   and	   UHMPWE	   (B)	   particles,	   showing	   clear	  
differences	  in	  morphology	  between	  both	  particles.	  
	  
	  
Figure	   2.	   Bioluminescence	   flux	   from	   1	  mL	   syringes	   filled	  with	   5	   x	   108	   CFUs	   S.	   aureus	   Xen36,	  with	   or	  
without	   5	   mg	   Co-­‐Cr	   or	   25	   mg	   UHMWPE	   particles	   added.	   *	   indicates	   a	   significant	   difference	   in	  
bioluminescence	  flux	  (p	  <	  0.05).	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Figure	  3.	  Bioluminescence	  images	  of	  mice	  injected	  with	  S.	  aureus	  Xen36	  alone	  (C)	  and	  with	  Co-­‐Cr	  (A)	  or	  
UHMWPE	   (B)	   particles	   added,	   taken	   immediately	   after	   injection	   (day	   0)	   and	   3,	   6	   and	   21	   days	   after	  
injection.	   The	   scalebar	   represents	   bioluminescence	   flux	   (x	   106	   p/s/cm2/sr).	   Note	   that	   images	   do	   not	  
account	  for	  absorption	  and	  reflection	  of	  the	  bioluminescence	  signal.	  
	  
Average	  air	  pouch	  membrane	  thickness	  after	  sacrifice	  was	  found	  to	  be	  1.3	  
±	   0.6	  mm	  with	   no	   significant	   differences	   across	   groups	   (Table	   II).	   Similarly,	  mice	  
injected	   with	   staphylococci	   in	   the	   absence	   or	   presence	   of	   particles,	   including	  
control	   mice,	   had	   no	   significant	   difference	   in	   macrophage	   counts	   after	   sacrifice,	  
with	  the	  exception	  of	  the	  animal	  in	  the	  Co-­‐Cr	  and	  S.	  aureus	  Xen36	  group	  for	  which	  
a	  high	  bioluminescent	  signal	  was	  measured	  until	  day	  18.	  This	  mouse	  showed	  a	  high	  
relative	   macrophage	   count	   of	   12.4.	   In	   addition,	   this	   mouse	   was	   observed	   to	  
possess	  a	  post-­‐inflammatory	  hematoma.	  Particulate	  debris	  was	  never	  detected	   in	  
any	  tissue,	  while	  extensive	  culturing	  did	  not	  reveal	  S.	  aureus	  Xen36	  bacteria	  in	  any	  




Table	   II.	   Relative	   air	   pouch	   membrane	   thickness	   and	   numbers	   of	   macrophages	  
contained	  in	  the	  presence	  of	  Co-­‐Cr	  or	  UHMWPE	  particles,	  expressed	  relative	  to	  the	  
membrane	   thickness	   and	   numbers	   of	  macrophages	   in	   the	   presence	   of	   S.	   aureus	  
Xen36	  only	  (1.6	  ±	  0.6	  mm	  and	  89	  ±	  32	  macrophages/mm2).	  






number	  of	  	  
macrophages	  	  
S.	  aureus	  Xen36	  only	   6	   1	   1	  
PBS	  only	   3	   0.8	   1.4	  
Co-­‐Cr	  particles	  only	  	   3	   0.7	   1.4	  
UHMWPE	  particles	  only	  	   3	   0.7	   1.8	  
UHMWPE	  particles	  with	  S.	  aureus	  Xen36	   6	   0.9	   1.5	  
Co-­‐Cr	  particles	  with	  S.	  aureus	  Xen36	   6	   0.7	   1.4*	  
All	  data	  were	  obtained	  after	  sacrifice	  at	  21	  days	  post-­‐particle	  injection.	  
*	  indicates	  data	  over	  five	  animals	  excluding,	  the	  animal	  showing	  consistent	  high	  bioluminescence	  fluxes	  




Figure	   4.	   Normalized	   bioluminescence	   flux	   as	   a	   function	   of	   time	   after	   correction	   for	   absorption	   and	  
reflection	   due	   to	   the	   presence	   of	   Co-­‐Cr	   or	   UHMWPE	   particles.	   The	   normalized	   bioluminescence	   flux	  
denotes	   the	   flux	   arising	   from	   air	   pouches	   filled	   with	   particles	   and	   bacteria	   relative	   to	   the	  
bioluminescence	   arising	   from	   pouches	   filled	   with	   S.	   aureus	   Xen36	   only.	   Each	   symbol	   represents	   one	  
mouse.	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Figure	   5.	   Air	   pouch	  membranes	   after	  hematoxylin	   and	  eosin	   staining	  of	   three	  mice	  exposed	   to	  Co-­‐Cr	  
particles	  and	  S.	  aureus	  Xen36	  (a),	  UHMWPE	  particles	  and	  S.	  aureus	  Xen36	  (b)	  and	  S.	  aureus	  Xen36	  only	  




Long-­‐term	   clinical	   data	   on	   infection	   rates	   for	   specific	   bearing	   types	   are	   not	   yet	  
available.	   Although	   there	   are	   in	   vivo	   studies	   available	   on	   the	   influence	   of	   bulk	  
material	   on	   the	   incidence	   of	   infection	   (19),	   this	   is	   the	   first	   in	   vivo	   study	   towards	  
assessing	  the	  influence	  of	  wear	  particles	  on	  bacterial	  infection	  risk.	  In	  this	  study,	  we	  
used	  a	  novel	  method	  of	  in	  vivo	  imaging	  to	  longitudinally	  monitor	  the	  persistence	  of	  
bioluminescent	   staphylococci	   in	   an	   artificial	   joint	   space.	   In	   the	  majority	   of	  mice,	  
infection	  risk	  in	  the	  absence	  or	  presence	  of	  Co-­‐Cr	  and	  UHMWPE	  particles	  appeared	  
similar,	  assuming	  that	  the	  longevity	  of	  an	  elevated	  bioluminescence	  is	  indicative	  of	  




mice	  exposed	  to	  UHMWPE	  particles	  with	  staphylococci	  than	  in	  mice	  injected	  with	  
staphylococci	  only,	  possibly	  because	  UHMWPE	  particles	  initially	  stimulated	  a	  higher	  
macrophage	  presence	   in	  murine	  air	  pouch	  membranes	   (21;25).	  For	  mice	  exposed	  
to	  Co-­‐Cr	  particles	  with	  staphylococci,	  bioluminescence	  was	  observed	  to	  be	  higher	  
in	   two	   out	   of	   six	   animals	   compared	   to	   the	   presence	   of	   staphylococci	   alone	   and	  
accordingly	   a	   high	   number	   of	   macrophages	   was	   found	   in	   the	   air	   pouch	   of	   the	  
mouse	  showing	  the	  most	  prolonged,	  elevated	  bioluminescence.	  Therefore	  it	  can	  be	  
concluded	  that	  whereas	  the	  presence	  of	  UHMWPE	  particles	  does	  not	  increase	  the	  
risk	   of	   infection,	   Co-­‐Cr	   particles	   may	   have	   variable	   effects	   on	   infection	   risk	   in	  
different	  individuals.	  This	  study	  can	  not	  provide	  a	  clue	  as	  to	  why	  two	  mice	  injected	  
with	  Co-­‐Cr	  particles	  and	  S.	  aureus	  showed	  elevated	  bioluminescence	  for	  prolonged	  
periods	   of	   time	   as	   compared	   to	   the	   four	   other	   mice	   in	   this	   group,	   showing	   a	  
response	  similar	  to	  the	  one	  of	  mice	  injected	  with	  UHMWPE	  particles	  and	  S.	  aureus.	  
Although	   an	   increased	   number	   of	  macrophages	  was	   reported	   48	   h	   after	  
injection	   of	   Co-­‐Cr	   or	   UHMWPE	   particles	   into	  murine	   air	   pouches	   (25),	   it	   is	   clear	  
from	  the	  present	  study	  that	  macrophage	  numbers	  reduce	  to	  control	   levels	  within	  
21	   days	   even	   during	   simultaneous	   exposure	   to	   S.	   aureus	   Xen36.	   If,	   for	   unknown	  
reasons,	   a	   relatively	   fulminant	   infection	   occurs,	   higher	   numbers	   of	  macrophages	  
persist	   for	   longer	   periods	  of	   time.	   This	   occurred	   in	   two	  mice	  of	   the	  Co-­‐Cr	   group,	  
which	  may	  not	  be	  a	  coincidence	  since	  it	  has	  been	  shown	  that	  macrophages	  in	  the	  
presence	  of	  Co-­‐Cr	  particles	  with	  staphylococci	  can	  be	  prone	  to	  toxic	  effects	  of	  Co	  
ions	   (6;15;26),	   frustrating	   their	   degradative	   function.	   This	   evidently	   does	   not	  
necessarily	  occur	   in	  all	  animals.	  Generally,	  histological	   studies	  of	   tissues	   retrieved	  
from	  revised	  prostheses	  have	  shown	  infiltration	  of	  surrounding	  tissues	  with	  Co-­‐Cr	  
or	   UHMWPE	   debris	   (8).	   In	   our	   study,	   particulate	   debris	   was	   not	   visible	   in	   any	  
histological	  sample,	  nor	  was	  there	  any	  sign	  of	  inflammation	  after	  21	  days	  observed	  
in	  five	  out	  of	  six	  animals	  injected	  with	  Co-­‐Cr	  particles	  and	  S.	  aureus	  Xen36.	  This	  may	  
imply	   transport	   of	   particles	   to	   other	   parts	   of	   the	   body,	   as	   described	   earlier	   in	  
patients	  where	  metal	  wear	  debris	  has	  been	  found	  in	  lymph	  nodes,	  liver	  and	  spleen	  
(23),	  despite	  the	  fact	  only	  10	  %	  of	  our	  particles	  were	  sized	  beneath	  4	  µm.	  Clinically	  
derived	   particles	   from	   periprosthetic	   tissues	   size	   between	   40-­‐120	   nm	   for	   Co-­‐Cr	  
(9;17)	  and	  are	  around	  660	  nm	  for	  UHMWPE	  (18).	  However,	  more	  than	  50	  %	  of	  the	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particles	  used	  were	   in	   the	  phagocytosable	  size	   range	  smaller	   than	  10	  micrometer	  
(13)	  and	  may	  be	  expected	  to	  provoke	  inflammatory	  reactions	  in	  vivo	  (30).	  	  	  
One	   of	   the	   benefits	   of	   using	   bioluminescence	   is	   the	   relative	   ease	   with	  
which	   bacterial	   presence	   can	   be	   monitored	   longitudinally	   in	   one	   and	   the	   same	  
animal	  (3).	  This	  is	  the	  first	  study	  to	  combine	  the	  use	  of	  an	  in	  vivo	  air	  pouch	  model	  
with	   bioluminescence	   measurements	   to	   evaluate	   bacterial	   persistence	   in	   the	  
absence	   and	   presence	   of	   wear	   debris.	   All	   current	   studies	   employing	  
bioluminescence	   measurements	   to	   assess	   the	   longevity	   and	   severity	   of	  
biomaterials-­‐associated	   infections	   have	   used	   subcutaneous	   implantation	   of	  
biomaterials.	  Kadurugamuwa	  et	  al.	  pre-­‐inoculated	  a	  Teflon	  catheter	  and	  measured	  
significant	  in	  vivo	  bioluminescence	  signals	  up	  to	  20	  days	  (16).	  Engelsman	  et	  al.	  pre-­‐
inoculated	   surgical	   meshes	   of	   different	   composition	   and	   found	   higher	   levels	   of	  
bioluminescence	  up	  to	  10	  days	  that	  coincided	  with	  ex	  vivo	  counts	  of	  the	  number	  of	  
colony	   forming	   units	   that	   could	   be	   retrieved	   from	   explanted	   meshes	   (11).	   The	  
detection	   limit	   of	   bioluminescence	  measurements	   to	   detect	   bacterial	   presence	   is	  
much	   lower	   than	   of,	   for	   instance,	   plate	   counting,	   and	   bacterial	   persistence	   in	  
tissues	   surrounding	   infected	   biomaterial	   has	   been	   demonstrated	   despite	   the	  
absence	   of	  measurable	   bioluminescence	   (12).	   In	   fact,	   it	   has	   been	   suggested	   that	  
bacteria	  on	  and	  around	  an	   implanted	  biomaterial	  not	  only	  find	  protection	  against	  
antibiotics	  and	  the	  host	   immune	  system	  in	  their	  biofilm	  mode	  of	  growth,	  but	  also	  
seek	  protection	  in	  surrounding	  tissue	  (4).	  It	  might	  well	  be	  a	  unique	  feature	  of	  this	  
air	   pouch	   model	   that	   it	   does	   not	   allow	   bacteria	   to	   migrate	   and	   find	   shelter	   in	  
surrounding	   tissue,	   possibly	   because	   the	   air	   pouch	   membrane	   is	   heavily	  
vascularized.	  	  
	   In	   conclusion,	   the	   presence	   of	   staphylococci	   in	   combination	   with	  
UHMWPE	   particles	   did	   not	   increase	   the	   risk	   of	   infection,	   possibly	   as	   a	   result	   of	  
initially	   higher	   macrophage	   levels.	   The	   combination	   of	   staphylococci	   with	   Co-­‐Cr	  
particles	   is	   known	   to	   frustrate	   the	   degradative	   function	   of	   macrophages	   and	  
accordingly	  bioluminescence	  was	  higher	  and	  more	  prolonged	  in	  two	  out	  of	  six	  mice,	  
suggesting	   that	   Co-­‐Cr	   particles	   may	   increase	   the	   risk	   of	   infection.	   However,	  
influences	   of	   the	   presence	   of	   particulate	   material	   in	   combination	   with	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There	   is	   an	   ongoing	   need	   to	   review	   large	   series	   of	   hip	   arthroplasties	   performed	  
with	   use	   of	   metal-­‐on-­‐metal	   (MOM)	   and	   metal-­‐on-­‐polyethylene	   (MOP)	   implants.	  
We	  now	  evaluate	  such	  a	  nationwide	  series	  for	  the	  influence	  of	  bearing	  type	  on	  the	  
revision	  risk.	  	  
Methods	  
Records	  of	  hip	  arthroplasties,	  performed	  between	  September	  1999	  and	  December	  
2008,	   were	   retrieved	   from	   the	   Australian	   National	   Joint	   Registry	   and	  
retrospectively	   reviewed	   at	   a	   mean	   of	   3.4	   years	   after	   the	   primary	   procedure.	  
Comparisons	  were	  made	  between	  age,	  gender,	  indications	  for	  the	  index	  procedure	  
and	   head	   size	   of	   the	   prosthesis	   between	   patients	  with	  MOM	   and	  MOP	   implants	  
using	   Pearson's	   chi-­‐square	   test.	   Cox	   proportional-­‐hazard	  models	  were	   performed	  
to	  determine	  predictors	  of	   revision	   for	   infection.	  Cumulative	  curves	  were	  used	   to	  
describe	  the	  infection-­‐	  and	  non-­‐infection	  revision	  risk.	  	  
Results	  
100,906	  hip	  arthroplasties,	  of	  which	  17,510	  MOM	  and	  83,396	  MOP	  implants,	  were	  
performed	  during	  our	  study	  period.	  2720	  prostheses	  were	  revised	  (2.7%	  of	  total).	  
The	  overall	  cumulative	  8-­‐year	  revision	  rate	  was	  5%;	  6%	  for	  MOM	  implants	  and	  5%	  
for	  MOP	  prostheses.	  The	  cumulative	  8-­‐year	  revision	  rate	  for	  infection	  was	  1.2%	  for	  
MOM	  implants	  and	  0.8%	  for	  MOP	  prostheses.	  MOM	  bearings	  with	  a	  head	  size	  >	  32	  
mm	  had	   a	   hazard	   ratio	   for	   revision	   of	   1.24	   compared	   to	  MOP	  prostheses	  with	   a	  
head	   size	   ≤	   32	  mm.	   In	   addition,	  MOM	  bearings	  with	   a	   head	   size	   >	   32	  mm	  were	  
found	  to	  be	  revised	  more	  often	  for	  infection	  (0.3	  revisions	  per	  100	  observed	  years)	  
compared	   to	  prostheses	  with	  a	   smaller	  head	  size	   (0.1	   revisions	  per	  100	  observed	  
years).	  	  
Conclusion	  
The	  Australian	  National	  Joint	  Registry	  revealed	  significantly	  higher	  revision	  rates	  of	  
MOM	  implants,	  specifically	  with	  a	  head	  size	  >	  32	  mm	  compared	  to	  MOP	  prostheses.	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Introduction	  
Worldwide	   there	   is	   an	   increasing	   number	   of	   total	   hip	   revisions	   (9).	   The	  
accompanying	   high	   costs	   and	   increased	   patient	  morbidity	   of	   revision	   surgery	   are	  
reasons	  for	  the	  scientific	  society	  to	  review	  these	  failures	  and	  their	  possible	  causes.	  
Since	  the	   introduction	  of	   joint	   registries	   (18;20;34),	   there	  has	  been	  the	  possibility	  
of	  comparing	  survival	  rates	  of	  nationwide	  numbers	  of	  prosthetic	  implants.	  However,	  
no	  comparison	  on	  bearing	  types	  has	  been	  performed	  yet.	  	  	  
Metal-­‐on-­‐metal	   (MOM)	   hip	   implants	   have	   been	   extensively	   implanted	  
throughout	  many	  institutions	  worldwide	  from	  the	  time	  they	  were	  re-­‐introduced,	  at	  
the	  end	  of	  the	  last	  century	  (8;10).	  	  Due	  to	  the	  hypothesis	  that	  wear	  products	  of	  the	  
established	   metal-­‐on-­‐polyethylene	   (MOP)	   were	   responsible	   for	   osteolysis	   (41),	  
development	   of	   new	   bearings	   was	   at	   that	   time	   endorsed	   by	   the	   orthopaedic	  
society.	  Remarkably	  low	  wear	  of	  MOM	  bearings	  in	  large	  diameter	  implants	  has	  led	  
to	  its	  resurgence	  in	  use	  in	  young	  and	  active	  patients	  (13;32;38-­‐40).	  However,	  MOM	  
implants	  are	  not	  immune	  to	  osteolysis	  (31).	  In	  addition,	  metal	  alloys	  used	  in	  MOM	  
bearings	  degrade	  by	  wear,	  corrosion,	  or	  a	  combination	  of	  the	  two	  (26;42)	  and	  the	  
clinical	   impact	   of	   these	   particles	   is	   for	   the	  most	   part	   unclear.	   Extensive	   research	  
efforts	   have	  been	  done	   to	   determine	   the	   consequences	  of	  wear	   particles	   and	   its	  
corrosion	  products	  on	  osteolysis	  or	  other	  reasons	  for	  revision	  (11;16;23).	  Although	  
recent	  results	  towards	  the	  use	  of	  MOM	  implants	  are	  encouraging	   in	  several	  small	  
and	  a	   few	   larger	   clinical	   series	   (3;4;30),	   there	   is	   the	  need	   for	  evaluation	  of	   larger	  
numbers,	  such	  as	  can	  be	  obtained	  from	  a	  Joint	  Registry.	  
Approximately	   9-­‐15%	  of	   all	   revisions	   are	   carried	   out	   for	   infection	   (1;35),	  
indicating	   the	   importance	  of	   this	   postoperative	   complication.	   Infection	   risk	  might	  
be	   influenced	  by	  wear	  particles	  as	  planktonic	  bacterial	  growth	   is	  stimulated	  more	  
by	   MOM	   particles	   than	   by	   MOP	   wear	   debris	   (6).	   On	   the	   other	   hand,	   high	  
concentrations	   of	   metal	   ions	   derived	   from	   salts	   have	   shown	   to	   possess	  
bacteriostatic	  effects	  (22).	  There	  is	  limited	  literature	  available	  on	  the	  clinical	  impact	  
of	   these	   findings,	   as	   long-­‐term	   results	   on	   revision	   rates	   and	   especially	   infection	  
rates	  are	  scarce	  in	  newly	  introduced	  hip	  arthroplasties.	  	  
The	  purposes	  of	  this	  study	  were,	  firstly,	  to	  report	  on	  the	  early	  results	  of	  a	  
nationwide	   series	   of	   hip	   arthroplasties	   performed	   with	   MOM	   and	   MOP	   implant	  
designs,	   and	   secondly,	   to	   evaluate	   the	   effect	   of	   diverse	   demographic	   and	   clinical	  
Chapter	  7	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variables	   on	   revision	   rate	   and	   infection	   rate	   in	   particular,	  with	   regard	   to	   gender,	  




Material	  and	  methods	  
Source	  of	  data	  
The	   Australian	   Orthopaedic	   Association	   National	   Joint	   Replacement	   Registry	  
(AOANJRR)	   was	   established	   in	   1999	   and	   data	   collection	   became	   fully	   national	  
during	  2002	  (18).	  It	  stores	  information	  on	  primary	  and	  revision	  joint	  arthroplasties	  
performed	  in	  Australia.	  	  
Between	   1	   September	   1999	   and	   31	   December	   2008,	   all	   recorded	  MOM	  
and	  MOP	  implants	  were	  included.	  Subsequently,	  the	  number	  of	  recorded	  revisions	  
was	  extracted,	   as	  defined	   in	   the	   Joint	  Registry	   as	   exchange	  or	   removal	   of	   one	  or	  
more	  components.	  We	  analyzed	  the	  effect	  of	  age,	  gender,	   the	   indications	   for	   the	  
index	   procedure	   (i.e.	   primary	   osteoarthritis,	   rheumatoid	   arthritis	   or	   other,	   not	  
further	  specified),	  bearing	  type	  (i.e.	  MOM	  versus	  MOP)	  and	  head	  size	  (>	  32	  mm	  or	  
≤	   32	   mm)	   on	   revision	   rate.	   Primary	   conventional	   hip	   arthroplasties	   using	   Artek	  
(Centerpulse,	   Winterthur,	   Switzerland)	   or	   Inter-­‐Op	   (Sulzermedica,	   acquired	   by	  
Zimmer,	  Warsaw,	   IN)	  acetabular	  components	  were	  excluded	  from	  the	  analysis,	  as	  
they	  had	  been	  withdrawn	   from	  the	  market	   soon	  after	   introduction	  due	   to	  a	  high	  
revision	  rate.	  	  
	  
Statistics	  
Comparisons	   between	   age,	   gender	   and	   indications	   for	   the	   index	   procedure	  were	  
made	   between	  MOM	   and	  MOP	   patients	   using	   Pearson's	   chi-­‐square	   test.	   Critical	  
proportion	  testing	  was	  used	  for	  the	  statistical	  differences	  in	  the	  reason	  and	  type	  of	  
revision	   in	   patients	   with	   MOM	   versus	   MOP	   prostheses	   (14).	   Cox	   proportional-­‐
hazards	  modeling	  were	  performed	   to	  determine	   the	  effect	   of	   bearing	   type,	   head	  
size	  and	  preoperative	  diagnosis	  on	  the	  hazard	  of	  revision	  and	  infection	  in	  particular.	  
Cumulative	   curves	   were	   used	   to	   describe	   the	   rate	   of	   revision	   in	   general	   and	  
infection	   individually.	   Data	   was	   consequently	   corrected	   for	   age	   and	   gender	   if	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applicable.	   For	   all	   statistical	   tests,	  p	   <	   0.05	  was	   considered	   to	   be	   significant.	   The	  




100,906	  hip	  arthroplasties,	  of	  which	  17,510	  MOM	  and	  83,396	  MOP	  implants,	  were	  
recorded	   to	   have	   been	   performed	   throughout	   Australia	   during	   the	   study	   period.	  
Review	   of	   the	   registry	   data	   took	   place	   at	   a	  mean	   of	   3.4	   years	   after	   the	   primary	  
procedure.	  Forty-­‐two	  different	  brands	  of	  femoral	  prostheses	  were	  recorded	  (Table	  
I)	  and	  eleven	  individual	  acetabular	  components	  were	  used.	  
	  
Table	  I.	  Combinations	  with	  both	  MOM	  and	  MOP	  attributes	  and	  at	  least	  10	  
procedures	  in	  each	  attribute	  group.	  
Femoral	  prosthesis	  type	   Acetabular	  component	  type	  
ABGII	  1,	  Accolade	  1,	  Adapter	  7,	  Alloclassic	  2,	  Anthology	  3,	  Apex	  4,	  C-­‐
Stem	  5,	  CBC	  Stem	  6,	  CBH	  Stem	  6,	  CLS	  2,	  CPCS	  3,	  CPT	  7,	  Cone	  Stem	  2,	  
Corail	  8,	  Edinburgh	  7,	  Elite	  Plus	  8,	  Emperion	  3,	  Epoch	  2,	  Exeter	  V40	  1,	  
Freeman	  5,	  Hayes	  Consensus	  12,	  Integral	  9,	  M/L	  Taper	  2,	  MS	  30	  2,	  
Mallory-­‐Head	  	  9,	  Margron	  13,	  Mayo	  2,	  Natural	  Hip	  7,	  Platform	  7,	  
Profemur	  Z	  1,	  Revitan	  2,	  S-­‐Rom	  8,	  SL-­‐Plus	  3,	  Spectron	  EF	  3,	  Stability	  
7,	  Summit	  8,	  Synergy	  3,	  Taper	  Fit	  10,	  Taperloc	  9,	  Trabecular	  Metal	  2,	  
VerSys	  2,	  Wagner	  2	  
Allofit	  2,	  Bionik	  14,	  CBF	  Cup	  6,	  
Delta	  7,	  Fitmore	  2,	  Lineage	  11,	  
Mallory-­‐Head	  9,	  Morscher	  2,	  
Pinnacle	  8,	  Reflection	  3,	  S-­‐Rom	  8	  
1	  Stryker,	  Kalamazoo,	  MI;	  2	  Zimmer,	  Warsaw,	  IN;	  3	  Smith	  &	  Nephew,	  London,	  UK;	  4	  Omnilife	  Science, East	  
Taunton,	  MA;	  5	  Finsbury	  Orthopaedics,	  Surrey,	  UK;	  6	  Synthes,	  West	  Chester,	  PA;	  7	  not	  known	  to	  authors;	  
8	  DePuy	  Orthopaedics,	  Warsaw,	  IN;	  	  9	  Biomet,	  Warsaw,	  IN;	  	  10	  Corin,	  Cirencester,	  UK;	  11	  Wright	  Medical,	  
Arlington,	  TN;	  12	  Consensus	  Orthopedics,	  El	  Dorado	  Hills,	  CA;	   	   13	  Portland	  Orthopaedics,	  St.	  Clair,	  MI;	   14	  
Orthodynamics,	  Lübeck,	  Germany.	  
	  
Fifty	   seven	  percent	  of	   the	  patients	  were	   female.	   Thirty-­‐seven	  percent	  of	  
the	  patients	  was	  aged	  above	  75.	  The	  diagnosis	  was	  primary	  osteoarthritis	  for	  88%;	  
rheumatoid	  arthritis	  for	  1%	  and	  other,	  not	  further	  specified,	  for	  11%.	  Patients	  with	  
a	   MOM	   implant	   were	   significantly	   younger	   and	   comprised	   of	   significantly	   more	  
males	   (odds	   ratio	   1.7)	   compared	   to	   MOP	   patients	   (Table	   II).	   The	   diagnosis	   of	  
osteoarthritis	  for	  the	  initial	  procedure	  was	  divided	  equally	  in	  both	  bearing	  groups.	  
In	   the	  MOM	  group	   the	  odds	   ratio	  of	   receiving	  an	   implant	  with	  a	  head	   size	   larger	  
than	  32	  mm	  was	  24.7	  compared	  to	  the	  MOP	  group.	  
2720	   revision	   procedures	   had	   been	   recorded	   (2.7%	   of	   total).	   Fifty-­‐four	  
percent	  of	   the	  patients	  who	  had	  a	   revision	  were	  male	   (not	  displayed	   in	  Table	   II).	  
Forty	  percent	  of	   these	  patients	  were	  older	   than	  75.	  Dislocation	  of	   the	  prosthesis	  
was	  cited	  as	  the	  predominant	  reason	  for	  revision	  (910	  hips).	  Loosening	  occurred	  in	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719	   hips,	   500	   patients	   had	   undergone	   revision	   surgery	   due	   to	   infection,	   380	  
because	  of	   fractures,	  and	  37	   implants	  were	  revised	  due	  to	  pain.	  Differences	  were	  
seen	   for	   revision	   diagnosis	   between	   MOM	   and	   MOP	   patients	   (Table	   III).	   As	   for	  
MOM	  patients,	   loosening	  was	   noted	   as	   the	  most	   frequent	   reason	   for	   revision	   in	  
contrast	   to	   dislocation	   of	   the	   prosthesis	   in	   MOP	   patients.	   Subsequent	   revision	  
procedures	  involved	  predominantly	  replacement	  of	  the	  femoral	  component	  only	  in	  
750	   patients	   (Table	   IV).	   The	   acetabular	   component	  was	   replaced	   in	   673	   patients	  
and	  the	  entire	  prosthesis	  in	  350	  patients.	  	  
	  
Table	  II.	  Odds	  ratios	  for	  demographic	  and	  clinical	  data	  of	  patients	  who	  had	  a	  MOM	  




Patients	  who	  had	  
a	  MOM	  implant	  
Odds	  
ratio	  
Patients	  who	  had	  
a	  MOP	  implant	  
Patients	  who	  






had	  a	  revision	  




Patients	  who	  did	  




100906	   17510	   	   	   83396	   	   500	   	   	   2220	   	   	   98186	   	  
	   	   n	   %	   	   n	   %	   n	   %	   	   n	   %	   	   n	   %	  
Age:	   	   	   	   	   	   	   	   	   	   	   	   	   	   	  
<55	   9212	   3821	   22	   8.2*	   5391	   6	   56	   11	   1.5**	   232	   10	   1.2**	   8924	   9	  
55-­‐64	   19131	   5564	   32	   4.8*	   13567	   16	   105	   21	   1.4**	   487	   22	   1.2**	   18539	   19	  
65-­‐74	   34977	   5165	   29	   2.0*	   29812	   36	   189	   38	   1.4**	   730	   33	   1.0	   34058	   35	  
≥75	  (ref)	   37586	   2960	   17	   1.0	   34626	   42	   150	   30	   1.0	   771	   35	   1.0	   36665	   37	  
Male	   43830	   9521	   54	   1.7*	   34309	   41	   261	   52	   1.4**	   974	   44	   1.0	   42595	   43	  
Female	  (ref)	   57076	   7989	   46	   1.0	   49087	   59	   239	   48	   1.0	   1246	   56	   1.0	   55591	   57	  
Indication:	   	   	   	   	   	   	   	   	   	   	   	   	   	   	  
Osteoarthritis	   88582	   15478	   88	   1.0	   73104	   88	   418	   84	   0.7**	   1834	   83	   0.7**	   86330	   88	  
Other	  (ref)	   10922	   1854	   11	   1.0	   9068	   11	   75	   15	   1.0	   339	   15	   1.0	   10508	   11	  
Rheumatoid	  
Arthritis	  
1402	   178	   1	   0.7*	   1224	   1	   7	   1	   0.7	   47	   2	   1.1	   1348	   1	  
Head	  size:	   	   	   	   	   	   	   	   	   	   	   	   	   	   	  
≤32mm	  (ref)	   79642	   4650	   27	   1.0	   74992	   90	   393	   79	   1.0	   1821	   82	   1.0	   77428	   79	  
>32mm	   21263	   12859	   73	   24.7*	   8404	   10	   107	   21	   1.0	   399	   18	   0.8**	   20757	   21	  
Ref	  indicates	  reference	  group	  of	  patients	  who	  had	  a	  MOM	  implant	  or	  a	  revision	  for	  infection	  or	  non-­‐
infection	  
*	  indicates	  a	  significant	  difference	  from	  patients	  that	  had	  a	  MOP	  implant	  (p	  <	  0.05)	  
**	  indicates	  a	  significant	  difference	  from	  patients	  that	  did	  not	  had	  a	  revision	  (p	  <	  0.05)	  
	  
Cumulative	   curves	   as	   a	   function	   of	   time	   since	   the	   primary	   hip	  
arthroplasties	  revealed	  that	  the	  overall	  8-­‐year	  revision	  rate	  was	  4.9%	  (95%	  CI:	  4.6-­‐
5.2%),	  5.7%	  (95%	  CI:	  4.9-­‐6.7%)	  for	  MOM	  implants	  and	  4.8%	  (95%	  CI:	  4.5-­‐5.1%)	  for	  
MOP	   implants	   (Figure	   1).	   MOP	   bearings	   reduced	   revision	   risk	   with	   0.7	   (95%	   CI:	  
0.72-­‐0.78)	   revisions	   per	   100	   observed	   years	   compared	   to	   1.1	   (95%	  CI:	   1.00-­‐1.19)	  
revisions	  in	  MOM	  bearings.	  Cox	  proportional	  hazards	  analysis	  corrected	  for	  age	  and	  
gender	  revealed	  a	  hazard	  ratio	  for	  revision	  of	  MOM	  implants	  of	  1.24	  (95%	  CI:	  1.12-­‐
1.37)	   compared	   to	  MOP	   implants	   (p	   <	   0.001).	  When	   corrected	   for	   diagnosis,	   the	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likelihood	  of	  revision	  for	  MOM	  prostheses	  compared	  to	  MOP	  in	  only	  osteoarthritis	  
patients	  was	  1.35	  (95%	  CI:	  1.21-­‐1.50).	  
	  
Table	  III.	  Data	  on	  the	  hips	  that	  had	  a	  revision	  hip	  arthroplasty	  grouped	  by	  bearing	  
type	  	  
Reason	  for	  revision	  (%)	   MOM	  implant	   MOP	  implant	  
Loosening/lysis	  	   34.9*	   28.4	  
Infection	  	   18.1	   18.4	  
Dislocation	  of	  prosthesis	  	   17.3*	   33.1	  
Fracture	  	   14.4	   13.9	  
Metal	  sensitivity	  	   5.1*	   0.1	  
Pain	  	   2.5	   1.1	  
Leg	  length	  discrepancy	  	   2.3	   1.0	  
Incorrect	  sizing	   1.6	   0.5	  
Other	  	   1.4	   1.0	  
Malposition	  	   1.0	   0.7	  
Implant	  breakage	  acetabular	  	   0.6	   0.5	  
Implant	  breakage	  stem	   0.4	   0.4	  
Wear	  acetabulum	  	   0.2	   0.1	  
Instability	  	  	   0.2	   0.4	  
Heterotropic	  bone	  	  	   0	   0.2	  
Tumor	  	  	   0	   0.1	  
Number	  of	  arthroplasties	   513	   2207	  
*	  indicates	  a	  significant	  difference	  from	  patients	  that	  had	  a	  MOP	  implant	  (p	  <	  0.05)	  
	  
	  
Table	  IV.	  Data	  on	  the	  procedures	  following	  revision	  hip	  arthroplasty	  grouped	  by	  
bearing	  type.	  
Type	  of	  Revision	  (%)	  	   MOM	  implant	   MOP	  implant	  
Femoral	  only	   30.4*	   26.9	  
Acetabular	  only	   30.2*	   23.5	  
THR	  (femoral/acetabular)	   14.6	   12.5	  
Head	  only	   9.6*	   5.3	  
Head/insert	   6.2*	   21.3	  
Cement	  spacer	   6.0	   5.0	  
Minor	  components	   1.9	   1.9	  
Removal	  of	  prostheses	   0.6	   1.0	  
Insert	  only	   0.2*	   2.4	  
Neck	  only	   0.2	   0.0	  
Reinsertion	  of	  
components	  
0.0	   0.2	  
Bipolar	  head	  and	  femoral	   0.0	   0.0	  
Number	  of	  arthroplasties	   513	   2207	  
*	  indicates	  a	  significant	  difference	  from	  patients	  that	  had	  a	  MOP	  implant	  (p	  <	  0.05)	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The	  most	  significant	  determining	  factor	  of	  survival	  rates	  was	  found	  to	  be	  
the	  head	  size	  in	  combination	  with	  the	  type	  of	  bearing:	  MOM	  implants	  with	  a	  head	  
size	  >	  32	  mm	  had	  a	  significantly	  higher	  number	  of	  revision	  per	  100	  observed	  years	  
(1.3;	  95%CI:	  1.17-­‐1.45)	  compared	  to	  MOM	  implants	  with	  a	  head	  size	  ≤	  32	  mm	  (0.8;	  
95%	  CI:	  0.68-­‐0.93)	  and	  MOP	   implants	  with	  head	  sizes	  >	  32	  mm	  (1.0;	  95%CI:	  0.85-­‐
1.18)	  and	  ≤	  32	  mm	  (0.7;	  95%CI:	  0.70-­‐0.77)	  (Figure	  2).	  	  
The	   cumulative	   curves	   revealed	   that	   type	   of	   bearing	   also	   influenced	  
infection	  rates	  (Figure	  3).	  The	  overall	  cumulative	  8-­‐year	  revision	  rate	  was	  1.2%	  for	  
MOM	  implants	  and	  0.8%	  for	  MOP	  prostheses.	  The	  hazard	  ratio	  for	  infection	  in	  the	  
first	  three	  months	  after	  the	  initial	  operation	  of	  MOM	  versus	  MOP,	  adjusted	  for	  age	  
and	  gender,	   is	  0.41	  (0.24,	  0.72)	   (p	  =0.001).	  After	  three	  months	  the	  hazard	  ratio	   is	  
1.50	   (1.16,	   1.95)	   (p	   =0.002).	   The	   highest	   infection	   rates	   were	   found	   in	   MOM	  
bearings	  with	  a	  head	  size	  >	  32	  mm	  (0.3	  revisions	  per	  100	  observed	  years)	  compared	  




Worldwide	   increasing	  numbers	  of	   total	  hip	  revisions	  developed	  a	  demand	  for	   the	  
comparison	  of	  bearing	  types	  and	  their	  influence	  on	  revision	  risk.	  To	  our	  knowledge,	  
this	   is	   the	   first	   study	   to	   compare	  MOM	   versus	  MOP	   implants	   based	   on	   national	  
registry	  data.	  The	  Australian	  National	  Joint	  Registry	  has	  the	  advantage	  of	  receiving	  
patient	   data	   from	   over	   290	   hospitals	   resulting	   in	   large	   numbers	   of	   patients	  
registered.	  Additionally	  MOM	  implants	  had	  already	  been	  introduced	  in	  Australia	  in	  
1999	  and	  had	  been	  extensively	  used	  since	  by	  many	  orthopaedic	  surgeons	  (17).	  	  
The	  overall	  revision	  rate	  of	  2720	  out	  of	  100,906	  hip	  arthroplasties	  (2.7%	  of	  
total)	   with	   a	   mean	   follow	   up	   of	   3.4	   years	   is	   difficult	   to	   compare	   with	   current	  
literature,	  because	  there	  are	  no	  comparable	  patient	  groups	  with	  regard	  to	  the	  use	  
of	  all	  the	  different	  MOM	  and	  MOP	  implants.	  In	  addition,	  despite	  the	  availability	  of	  
well-­‐established	  combinations	  with	  good	  results,	  Australian	  surgeons	  used	  128	  new	  
combinations	  of	  prostheses	  in	  the	  year	  2008	  not	  previously	  used	  in	  2007,	  resulting	  
in	  a	  dataset	  less	  favorable	  for	  comparisons.	  On	  the	  whole,	  a	  5-­‐year	  survival	  rate	  of	  
97%	  is	  comparable	  with	  data	  derived	  from	  the	  New	  Zealand	  National	  Joint	  Registry	  
(35).	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Figure	  1.	  Yearly	  cumulative	  percent	  revision	  curve	  adjusted	  for	  age	  and	  gender	  of	  primary	  conventional	  





Figure	  2.	  	  Yearly	  cumulative	  percent	  revision	  curve	  adjusted	  for	  age	  and	  gender	  of	  primary	  conventional	  




Figure	  3.	  Yearly	  cumulative	  percent	  revision	  curve	  for	  infection	  adjusted	  for	  age	  and	  gender	  of	  primary	  




Figure	  4.	  Yearly	  cumulative	  percent	  revision	  curve	  for	  infection	  adjusted	  for	  age	  and	  gender	  of	  primary	  
conventional	  THA	  by	  bearing	  type	  and	  head	  size.	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The	  most	   important	   result	  of	   this	  evaluation	  was	   that	  MOM	  bearings	  on	  
the	  whole	  increased	  revision	  risk	  with	  a	  ratio	  of	  1.6	  compared	  to	  MOP	  bearings	  per	  
100	   observed	   years.	   Due	   to	   the	   fact	   that	   loosening	   turned	   out	   to	   be	   the	   main	  
reason	  for	  revision	  in	  MOM	  prostheses,	  it	  can	  be	  hypothesized	  that	  this	  prosthesis	  
is	  more	  prone	  to	  osteolysis.	  When	  taking	  into	  account	  the	  worldwide	  use	  of	  MOM	  
bearings,	   e.g.	   35%	   of	   all	   prostheses	   in	   the	   United	   States	   in	   2006	   (8),	   this	   should	  
cause	   some	   concern,	   especially	   when	   considering	   that	   MOM	   arthroplasties	   are	  
generally	   implanted	   in	   younger	   patients	   with	   less	   co-­‐morbidity.	   However,	   it	   is	  
advised	   throughout	   the	   literature	   that	   caution	   should	   be	   applied	   in	   attributing	  
differences	   in	   outcomes	   directly	   to	   the	   arthroplasty	   technology	   (15).	   The	  
indications	   for	   hard-­‐on-­‐hard	   bearings	   are	   narrower	   than	   those	   for	   MOP	   and	  
relatively	   young	   males	   with	   osteoarthritis	   who	   are	   currently	   prone	   to	   receive	   a	  
MOM	   implant	  might	   have	   an	   increased	   risk	   for	   failure	   regardless	   of	   the	   implant	  
choice	  (27).	  	  
High	  failure	  rates	  of	  MOM	  resurfacing	  hip	  implants	  were	  already	  reported	  
with	  the	  use	  of	  data	  derived	  from	  the	  National	  Joint	  Registry	  for	  England	  and	  Wales	  
(36).	   The	   3-­‐year	   revision	   rate	   was	   found	   to	   be	   2.6%	   (95%	   CI:	   2.1%-­‐3.1%)	   for	  
resurfacing	   implants	   compared	   to	   0.9%	   (95%	   CI:	   0.8%-­‐1.1.%)	   in	   cemented	  
prostheses.	   Resurfacing	   now	   constitutes	   only	   0.5%	   or	   less	   of	   the	   procedures	   in	  
Norway,	   Denmark	   and	   Sweden	   (19).	   The	   reason	   for	   its	   popularity	   in	   the	   United	  
States	  might	  partially	  be	  due	   to	   initial	  optimistic	   scientific	  evidence,	   tradition	  and	  
marketing	  policies	  of	  the	  manufacturers.	  The	  use	  of	  MOM	  implants	  in	  Australia	  has	  
recently	   declined	   and	   a	   recent	   publication	   from	   the	   AOANJRR	   reviewing	   12,093	  
primary	  resurfacing	  hip	  replacements	  showed	  a	  cumulative	  percent	  8-­‐year	  revision	  
rate	   of	   5.3	   (4.6-­‐6.2)	   compared	   to	   4.0	   (3.8-­‐4.2)	   for	   conventional	   total	   hip	  
replacement	  (33).	  
Larger	  head	  implants	  have	  been	  advocated	  in	  the	  literature	  for	  many	  years	  
in	  order	  to	  decrease	  the	  incidence	  of	  dislocation	  (5;7;12)	  and	  recommendations	  for	  
its	   usage	   are	   made	   in	   patients	   undergoing	   revision	   surgery	   (25;37).	   However,	  
primary	   larger	   head	   sized	   MOM	   prostheses	   were	   found	   to	   have	   an	   increased	  
revision	   compared	   to	   the	   smaller	   sized	  MOM	   and	  MOP	   prostheses.	   Randomized	  
controlled	  trials	  may	  shed	  light	  if	  this	  revision	  rate	  is	  caused	  by	  confounders	  such	  as	  
surgeon	  experience,	  or	  the	  individual	  implant	  designs	  in	  both	  groups.	  	  	  
Chapter	  7	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Another	   intriguing	   finding	   from	   this	   study	   is	   the	   low	   hazard	   ratio	   for	  
infection	   for	   MOM	   implants	   in	   the	   first	   three	   months	   after	   the	   initial	   operation	  
(0.41)	   versus	  MOP	   implants.	   Recent	   research	   efforts	   towards	   the	   bacteriological	  
influences	   of	   the	   MOM	   degradation	   products	   suggested	   that	   particulate	   debris	  
reduce	   biofilm	   formation	   (Chapter	   4).	   Hip	   simulator	   and	   clinical	   retrieval	   studies	  
have	   shown	   that	   MOM	   hip	   implants	   commonly	   have	   an	   initial	   high	   wear	   or	  
running-­‐in	  phase,	  generally	  followed	  by	  a	  low	  wear	  or	  steady-­‐state	  phase	  (29).	  It	  is	  
conceivable	   that	   high	   running-­‐in	   bacteriostatic	   particle-­‐production	   is	   responsible	  
for	   the	   low	   infection	   rate.	   After	   three	   months,	   however,	   the	   hazard	   ratio	   for	  
infection	  has	  increased	  for	  MOM	  implants	  to	  1.50	  compared	  to	  MOP	  implants.	  The	  
highest	   infection	   rates	  were	   found	   in	  MOM	  bearings	  with	   a	   head	   size	   >	   32	  mm.	  
Several	   studies	   claimed	   that	   wear	   rates	   of	   MOM	   bearings	   turned	   out	   to	   be	  
impacted	  in	  a	  positive	  way	  by	  increasing	  the	  head	  size	  (2;28).	  Low	  wear	  or	  steady-­‐
state	   phase	   will	   only	   provide	   a	   bacteriostatic	   effect	   and	   might	   not	   eradicate	   an	  
infection	  focus,	  but	  may	  hamper	  the	  degradative	  function	  of	  macrophages	  (24).	  	  
Although	   we	   acknowledge	   the	   great	   value	   of	   national	   registries,	   it	   is	  
questionable	  if	  the	  data	  on	  infection	  rate	  is	  reliable	  enough.	  First	  of	  all,	  the	  registry	  
is	  notified	  of	  a	  procedure	  by	  the	  completion	  of	  a	  data	  form	  at	  the	  time	  of	  surgery.	  
As	   a	   consequence,	   it	   is	   likely	   that	   there	   is	   an	   under	   reporting	   of	   infection	   as	   a	  
revision	   diagnosis,	   as	   bacteriological	   growth	   from	  per-­‐operatively	   acquired	   tissue	  
samples	  can	  only	  be	  objectified	  after	  several	  days.	  Several	  studies	  also	  suggested	  a	  
possible	   role	   for	   bacteria	   and	   a	   bacterial	   biofilm	   in	   ‘aseptic’	   implant	   failure	   (21),	  
resulting	   in	  an	  even	  higher	  number	  of	   false	  negatives.	   Secondly,	   there	   is	  also	   the	  
potential	   for	   false	   positives,	   particularly	   with	   MOM	   prostheses	   in	   which	   ALVAL	  
(aseptic	   lymphocyte-­‐dominated	   vasculitis	   associated	   lesion)	   patients	   have	   the	  
potential	   to	  be	  cited	  as	  revision	  due	  to	  an	   infection	  at	   the	  time	  of	  surgery	  before	  
full	  microbiological	  and	  histological	  analysis	  is	  available.	  	  
	   In	  conclusion,	   the	  Australian	  National	   Joint	  Registry	   revealed	  significantly	  
higher	   revision	   rates	   of	   MOM	   implants,	   specifically	   with	   a	   head	   size	   >	   32	   mm	  
compared	   to	  MOP	   prostheses.	   In	   addition,	  MOM	  bearings	  with	   a	   head	   size	   >	   32	  
mm	  were	  more	  prone	  to	  be	  revised	  for	  an	  infection	  compared	  to	  smaller	  and	  MOP	  
implants.	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The	   number	   of	   total	   hip	   arthroplasty	   (THA)	   procedures	   is	   increasing	   worldwide,	  
resulting	   in	   a	   growing	   amount	   of	   patients	   with	   an	   infected	   arthroplasty	   (14).	  
Infection	   burden	   for	   primary	   and	   revision	   hip	   prostheses	   is	   expected	   to	   increase	  
between	  2005	  and	  2030	  from	  1.4%	  to	  6.5%	  and	  rate	  of	  revisions	  because	  of	  deep	  
infection	   from	   8.4%	   to	   47.5%	   (15).	   Infection	   is	   a	   devastating	   complication	   with	  
severe	   adverse	   consequences	   for	   the	   patient,	   i.e.	   re-­‐operation,	   removal	   of	   the	  
implant	  and	  increased	  morbidity,	  accompanied	  with	  high	  costs	  for	  society	  (>	  $500	  
million	  dollars	  in	  the	  U.S.	  (4)).	  Infection	  prevention	  will	  be	  of	  major	  importance	  for	  
orthopaedic	  practice.	  	  
Until	   now,	   the	   two	  most	   commonly	   implanted	   hip	   arthroplasty	   bearings	  
are	   metal-­‐on-­‐polyethylene	   (MOP)	   and	   metal-­‐on-­‐metal	   (MOM)	   articulations	   (3).	  
MOP	  is	  considered	  to	  be	  the	  gold	  standard.	  Due	  to	  adverse	  effects	  of	  MOP	  wear,	  
MOM	  prosthesis	  development	  was	  set	  up	  with	  the	  goal	  of	  manufacturing	  a	   lower	  
wear	   bearing.	   A	   recent	   meta-­‐analysis	   on	   MOM	   bearings	   supported	   their	   use	   in	  
young	   and	   active	   patients	   (19).	   In	   addition	   MOM	   resurfacing	   prostheses	   were	  
found	   comparable	   to	   MOP	   THA	   in	   cost-­‐effectiveness	   (5).	   Recently,	   however,	  
warnings	   have	   been	   issued	   by	   several	   orthopaedic	   associations	   advocating	  
prudency	  towards	  MOM	  bearing	  use	  due	  to	  adverse	  soft	  tissue	  complications.	  We	  
will	   discuss	   these	   general	   concerns	   briefly.	   The	   different	   studies	   are	   interpreted	  
with	  specific	  focus	  on	  the	  general	  aim	  of	  this	  thesis	  to	  investigate	  the	  influence	  of	  
MOM	  wear	  debris	  on	  deep	  infections	  after	  hip	  arthroplasty.	  	  
	  
General	  MOM	  concerns	   	  
For	  the	  majority	  of	  patients,	  hip	  implants,	  regardless	  of	  bearing	  type,	  will	  improve	  
their	   overall	   quality	   of	   life.	   This	   is	   also	   the	   case	   for	   MOM	   implants,	   having	  
successfully	   relieved	   pain	   and	   improved	   function	   in	   the	   majority	   of	   all	   patients.	  
Implants	  of	  all	  bearing	  types	  will	  produce	  wear	  and	  consequently	  pose	  risks	  related	  
to	   the	   debris.	   However,	   recently,	   great	   concern	   has	   arisen	   among	   orthopaedic	  
surgeons	   regarding	   the	   use	   of	   MOM	   bearings.	   Since	   2007	   higher	   revision	   rates	  
were	   reported	   for	   individual	   MOM	   implants	   in	   the	   Australian	   Orthopaedic	  
Association	   National	   Joint	   Replacement	   Registry	   (1).	   The	   ASR	   Total	   Hip	   System	  
(Depuy,	  Warsaw,	   IN,	   USA)	   and	   Durom	  Acetabular	   Component	   (Zimmer,	  Warsaw,	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IN,	   USA)	   were	   reported	   to	   demonstrate	   more	   than	   twice	   the	   risk	   of	   revision	  
compared	  to	  other	  resurfacing	  prostheses.	  Attribution	  of	  doubled	  revision	  rates	  to	  
surgeon’s	   learning	   curves	  was	   rebutted	   due	   to	   the	   absence	   of	   such	   a	   pattern	   in	  
other	  newly	   introduced	  prostheses.	  The	  ASR	  system	  and	  Durom	  cup	  are	  currently	  
subject	   of	   voluntary	   recalls.	   In	   addition,	  MOM	   THA	  with	   head	   sizes	   over	   28	  mm	  
turned	  out	  to	  have	  higher	  risk	  of	  revision	  compared	  to	  all	  other	  bearing	  surfaces.	  	  
In	   April	   2010	   the	   U.K.	   Medicines	   and	   Healthcare	   products	   Regulatory	  
Agency	   issued	   a	   medical	   device	   alert	   based	   on	   data	   of	   the	   U.K.	   National	   Joint	  
Registry,	  for	  specific	  follow-­‐up	  recommendations	  for	  patients	  implanted	  with	  MOM	  
implants.	   One	   year	   later,	   the	   U.S.	   Food	   and	   Drug	   Administration	   (FDA)	   issued	   a	  
public	   health	   communication	   about	   MOM	   THA.	   However,	   FDA	   is	   still	   gathering	  
additional	   information,	  which	   is	   complicated	   by	   the	   fact	   that	   the	   American	   Joint	  
replacement	   Registry	   is	   not	   yet	   functional.	   Polls	   held	   during	   the	   American	  
Academia	   of	   Orthopaedic	   Surgeons	   Meeting	   2011	   already	   revealed	   a	   rapid	  
reduction	  in	  the	  use	  of	  MOM	  implants.	  	  
This	  thesis	  comprises	   in	  vitro	  studies	  delineating	  biofilm	  inhibitory	  effects	  
of	  both	  metal	   ions	  as	  metal	  particles	   (Chapter	   3	  &	   4),	  while	   the	   two	   final	   in	   vivo	  
chapters	  report	  on	  an	  Co-­‐Cr	  particle	  induced	  higher	  infection	  risk	  (Chapter	  6	  &	  7).	  
Albeit	   the	   narrowness	   of	   in	   vitro	   work	   is	   exemplified	   when	   extrapolating	   the	  
conclusions	   of	   these	   chapters	   to	   the	   in	   vivo	   situation,	   all	   in	   vitro	   chapters	   do	  
provide	   valuable	   detail	   oriented	   insights	   in	   the	   several	   roles	   of	   wear,	   holding	  
particulate	  Co-­‐Cr	  and	  its	  corrosion	  products	  only	  responsible	  for	  biofilm	  inhibitory	  
effects	   in	   relatively	   high	   concentrations	   (Chapter	   3	   &	   4),	   which	   provides	   more	  
credit	   to	   the	   hypothesis	   of	   macrophage	   degradation	   by	   Co-­‐Cr	   particles	   will	   be	  
responsible	  for	   increased	  infection	  risk	  as	  proposed	  in	  Chapter	  6.	  The	  conclusions	  
from	   our	   work	   is	   difficult	   to	   extrapolate	   on	   its	   turn	   to	   the	   human	   condition	  
depending	  on	  the	  shortage	  of	  long-­‐term	  studies	  with	  large	  patient	  groups,	  yielding	  
infection	  rates	  in	  MOM	  implants	  unknown	  (16;24).	  Until	  now,	  a	  systematic	  review	  
of	   several	   smaller	   studies	   (13)	  and	  a	  bigger	   retrospective	   clinical	   cohort	   study	   (7)	  
have	   lacked	  the	  numbers	  needed	  for	  small	  differences	   in	   infection	  rates	  between	  
patient	   groups	   (Figure	   I).	   In	   Chapter	   7	   we	   presented	   a	   registry	   study	   towards	  
infection	   rates	   in	   MOM	   and	   MOP	   patients.	   We	   revealed	   the	   hazard	   ratio	   for	  
infection	  three	  months	  after	  the	  initial	  procedure,	  had	  increased	  for	  MOM	  implants	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to	  1.50	  compared	  to	  MOP	  implants,	  which	  was	  found	  to	  be	  in	  line	  with	  the	  results	  
derived	  from	  Chapter	  6,	  suggesting	  an	  in	  vivo	  hampering	  of	  the	  immune	  system	  in	  
individual	  cases.	  Therefore,	  registry	  data	  can	  provide	  a	  good	  perspective	  in	  the	  field	  




Figure	  1.	  Numbers	  of	  patients	  needed	  to	  obtain	  a	  study	  with	  power	  =	  0.8	  and	  p	  <	  0.05.	  A	  priori	  sample	  
sizes	  were	  calculated	  using	  statistical	  tests	  for	  differences	  between	  two	  independent	  proportions	  with	  
the	  statistical	  computer	  program	  G*Power	  Version	  3.1.2.	  (University	  of	  Kiel,	  Kiel,	  Germany).	  	  
	  
Methodological	  aspects	  of	  this	  thesis	  	  
We	  acknowledge	   two	   limitations	   towards	   the	   validity	   of	   the	   described	   studies	   in	  
this	  thesis.	  First	  of	  all,	  particles	  used	  for	  in	  vitro	  and	  animal	  studies	  throughout	  the	  
thesis	  were	  of	  larger	  size	  than	  clinically	  obtained	  nano-­‐sized	  wear	  debris.	  As	  noted	  
in	   Chapter	   6,	   larger	   sized	   particles	   are	   not	   expected	   to	   influence	   the	   provoked	  
inflammatory	   reactions	   (25),	   but	   do	   influence	   the	   phagocytosability,	   which	  	  
determines	   whether	   wear	   debris	   is	   exposed	   to	   an	   acid	   environment	   inside	  
lysosomes	  accelerating	  corrosion.	  However,	  more	  than	  50	  %	  of	  the	  particles	  used	  
were	  in	  the	  phagocytosable	  size	  range	  smaller	  than	  10	  μm	  (8).	  Moreover,	  Ceridust	  
particles	  have	  been	  reported	  to	  resemble	  UHMWPE	  wear	  debris	  derived	  from	  MOP	  
implants	  (8;12).	  We	  chose	  to	  work	  with	  micrometer	  sized	  particles,	  as	  in	  vitro	  work	  
requires	   large	   quantities	   of	   particles	   which	   are	   not	   readily	   available	   in	   case	   of	  
nanoparticles.	  Moreover,	  microparticle	  size	  distributions	  could	  be	  equalized	  for	  Co-­‐
Cr	   and	   UHMWPE	   particles.	   In	   future	   experiments	   one	   may	   consider	   the	   use	   of	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commercially	   available	   Cr-­‐phosphate	   or	   Cr-­‐oxide	   particles,	   recently	   found	   to	   be	  
present	   in	   the	   joint	   tissues	   of	   MOM	   patients	   (10).	   	   However,	   since	   the	   final	  
conclusion	  of	  this	  thesis,	  particularly	  based	  on	  our	  animal	  study,	  is	  in	  line	  with	  our	  
registry	  analysis,	  we	  do	  not	  consider	  these	  limitations	  as	  being	  severe.	  	  
 
Future	  research	  directions	  
There	   is	   growing	   concern	   that	   metal	   contamination	   co-­‐regulates	   resistance	   of	  
antibiotic-­‐resistant	   strains	   (2;23)	   (Chapter	   2).	  We	  explored	  effects	  of	  orthopaedic	  
biomaterials	   on	   gentamicin	   efficacy	   in	   Chapter	   5,	   but	   did	   not	   investigate	   metal	  
induced	   resistance	   towards	   antibiotics.	   The	   relationship	   between	   antibiotic	   and	  
metal	  susceptibility	  has	  been	  established	  in	  general	  (20)	  for	  staphylococcal	  species	  
against	  multiple	  metals	   and	   antibiotics	   (22)	   and	   in	   particular	   for	   Co-­‐Cr	   increasing	  
sensitivity	   to	   penicillin	   (17).	   	   Future	   research	   is	   needed	   to	   establish	   the	   clinical	  
significance	  of	  these	  findings.	  	  
Alongside	   the	   use	   of	   MOP	   and	   MOM	   implants,	   already	   14%	   of	   all	  
prostheses	   implanted	   in	   2006	   in	   the	   U.S.	   contained	   ceramic-­‐on-­‐ceramic	   bearings	  
(3).	  Wear	  rates	  of	  ceramic-­‐on-­‐ceramic	  bearings	  are	  low,	  and	  induce	  little	  biological	  
reactions	   (11;18).	   Therefore,	   this	   bearing	   type	   seems	   promising	   for	   future	   use	   in	  
young	  and	  active	  patients	  and	  necessitates	  investigations	  towards	  the	  influence	  of	  
its	  wear	  on	  infection	  risk.	  
In	  THAs	  the	  concept	  “race	  for	  the	  surface”	  applies.	  This	  concept	  describes	  
the	   competition	   between	   host	   tissue	   and	   bacteria	   for	   the	   colonization	   of	   the	  
surface	  of	  implanted	  materials	  (9;21).	  However,	  this	  concept	  could	  also	  be	  true	  for	  
the	   competition	   between	   individual	   bacterial	   strains.	   Do	   surfaces	   or	   wear	   of	  
prosthetic	   components	  attract	  different	  bacterial	   species?	   It	  would	  be	   interesting	  
to	  evaluate	  multi-­‐strain	  bacterial	  preference	  for	  biomaterials.	  First	  of	  all,	  this	  would	  
have	   a	   clinical	   significance	   in	   determining	   the	   infection	   pathway;	   with	   S.	  
epidermidis	  being	  responsible	  for	  a	  low-­‐grade	  chronic	  infection	  and	  S.	  aureus	  being	  
responsible	  for	  acute	  infections	  (6).	  Secondly,	  non-­‐pathogenic	  bacteria	  opposed	  to	  
difficult	  to	  treat	  pathogens	  might	  be	  attracted	  or	  deterred	  by	  a	  certain	  bearing	  or	  
wear	  type,	  influencing	  the	  chances	  of	  pathologic	  colonization	  of	  the	  implant.	  	  
In	  summary,	  this	  thesis	  contains	  an	  analysis	  of	  the	  infection	  risk	  associated	  
with	   wear	   debris	   from	   MOM	   hip	   arthroplasties.	   We	   conclude	   from	   our	   in	   vitro	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studies	   that	  Co-­‐Cr	   ions	   and	  particles	   impact	  biofilm	   formation	  and	   that	   substrata	  
influence	   the	   susceptibility	   to	   gentamicin.	   In	   vivo,	   animal	   studies	   in	   mice	  
demonstrate	   a	   higher	   infection	   risk	   in	   the	   presence	   of	   Co-­‐Cr	   particles	   compared	  
with	   UHMWPE	   particles,	   possibly	   because	   the	   macrophage	   degradative	   function	  
was	   hampered	   by	   the	   Co-­‐Cr	   particles.	   Whether	   or	   not	   this	   conclusion	   may	   be	  
extrapolated	   to	   the	   human	   situation	   remains	   to	   be	   seen,	   but	   this	   conclusion	  
concurs	  with	   our	   comparison	   of	   the	   cumulative	   8-­‐year	   revision	   rate	   for	   infection	  
MOM	   implants	   (1.2%)	   and	   for	  MOP	   prostheses	   (0.8%).	   It	   is	   an	   important	   finding	  
that	   wear	   influences	   infection	   risk,	   which	   stimulates	   future	   research	   toward	   the	  
influence	   of	   wear	   of	   newer	   bearing	   types	   on	   infection,	   possibly	   altering	   future	  
prosthesis	  development.	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The	   main	   aim	   of	   this	   thesis	   was	   to	   investigate	   the	   influence	   of	   metal-­‐on-­‐metal	  
(MOM)	   wear	   debris	   on	   deep	   infections	   after	   hip	   arthroplasty.	   The	   first	   chapter	  
addressed	  the	  rationale	  behind	  this	  aim	  (Chapter	  1).	  	  
A	  literature	  review	  (Chapter	  2)	  revealed	  that	  wear	  products	  influenced	  the	  
risk	   of	   infection	   by	   hampering	   the	   immune	   system,	   inhibiting	   or	   accelerating	  
bacterial	   growth	   and	   by	   a	   possible	   antibiotic	   resistance	   and	   heavy	   metal	   co-­‐
selection	  mechanism.	  Whether	  or	  not	  the	  combined	  effects	  of	  MOM	  wear	  products	  
make	  MOM	  bearings	   less	  or	  more	  prone	  to	   infection	  requires	  more	   investigation,	  
as	  aimed	  for	  in	  this	  thesis.	  
The	  consequences	  of	  corrosion	  products	  of	  cobalt-­‐chromium	  (Co-­‐Cr)	  alloys	  
are,	  for	  the	  most	  part,	  unclear,	  and	  the	  influence	  of	  Co-­‐Cr	  ions	  on	  biofilm	  formation	  
has	  never	  been	   studied.	  Therefore,	   the	  aim	  of	   the	   first	   in	   vitro	   study	   (Chapter	   3)	  
was	   to	  evaluate	  how	  Co-­‐Cr	   ions	  affected	  bacterial	  growth,	  biofilm	   formation,	  and	  
architecture.	  A	  collection	  of	  clinically	  isolated	  and	  commercially	  available	  bacterial	  
strains	   was	   exposed	   to	   Co-­‐Cr	   concentrations	   as	   found	   in	   serum	   and	   higher,	   as	  
found	   in	   adjacent	   tissue.	   Planktonic	   growth	   of	   bacteria	   was	   inhibited	   by	  
concentrations	   of	   200,000/93,000	   µg/L	   Co-­‐Cr.	   Co-­‐Cr	   concentrations	   up	   to	   20/9.3	  
µg/L	   as	   reported	   to	   occur	   in	   serum,	   revealed	   no	   consistent	   influence	   on	   biofilm	  
formation,	  but	  higher	  concentrations	  of	  200,000/93,000	  µg/L	  significantly	  reduced	  
Staphylococcus	  aureus	   	   and	  CNS	  biofilm	   formation.	  As	   indicated	  by	  confocal	   laser	  
scanning	  microscopy,	  no	  dead	  bacteria	  were	  encountered	  in	  the	  biofilms,	  and	  the	  
Co-­‐Cr	   ion	   concentrations	   used	   must	   be	   classified	   as	   growth-­‐inhibiting	   and	   not	  
bactericidal.	  The	  results	  suggested	  that	  Co-­‐Cr	  ions	  may	  yield	  MOM	  prostheses	  less	  
prone	  to	  biofilm	  formation	  and	  subsequent	  infection.	  
Next	   (Chapter	   4),	   the	   influence	   of	   Co-­‐Cr	   particles	   on	   biofilm	   formation	   was	  
examined.	   Viable	   volumes	   of	   staphylococcal	   biofilms	   were	   determined	   on	  
polystyrene	   in	   the	  absence	  and	  presence	  of	  Co-­‐Cr	  particles	  and	  Co-­‐Cr	   ions.	  Three	  
clinically	   derived	   and	   two	   commercially	   available	   staphylococcal	   strains	   were	  
grown	  in	  the	  presence	  of	  200,000	  µg/L	  Co-­‐Cr	  particles	  or	  1000/500	  µg/L	  Co-­‐Cr	  ions	  
derived	   from	   Co-­‐Cr	   salts	   or	   from	   particle	   supernatant,	   under	   static	   and	   dynamic	  
growth	   conditions.	   A	   dynamic	   model	   simulated	   the	   conditions	   that	   apply	   for	  
biofilm	  formation	  in	  the	  human	  body,	  as	  synovial	  fluid	  in	  mobile	  patients	  with	  hip	  
prostheses	  is	  in	  constant	  motion	  with	  accompanying	  shear	  rates.	  Images	  of	  24	  h	  old	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biofilms	  were	  made	  with	  confocal	  laser	  scanning	  microscopy	  and	  analyzed	  with	  the	  
mathematical	  computer	  program	  COMSTAT,	  yielding	  the	  biovolume	  of	  a	  biofilm.	  X-­‐
ray	   photoelectron	   spectroscopy	   was	   performed	   on	   the	   particles	   to	   study	   their	  
elemental	   surface	   composition.	   Characterization	   of	   the	   outer	   surface	   of	   the	  
particles	   revealed	   a	   Co-­‐Cr	   oxide	   layer	   enriched	   by	   Mo	   relative	   to	   the	   bulk	  
concentration.	  Most	   isolates	  showed	  a	  tendency	  of	  reduced	  biofilm	  growth	  in	  the	  
presence	  of	  Co-­‐Cr	  particles	  compared	  to	  growth	  during	  exposure	  to	  metal	  ions,	  but	  
this	   was	   only	   significant	   in	   one	   strain	   under	   the	   dynamic	   growth	   condition	   (S.	  
aureus	   7388).	   MOM	   wear	   particles	   were	   found	   to	   possess	   antibacterial	  
characteristics	  under	  dynamic	  growth	  conditions.	  	  
	   In	  Chapter	  5,	  metabolic	  activity	  of	  three	  S.	  epidermidis	  and	  two	  S.	  aureus	  
strains	   in	   biofilms	   grown	   in	   tryptone	   soya	  broth	  on	   titanium-­‐alloy	   (Ti),	   Co-­‐Cr	   and	  
ultra-­‐high	   molecular	   weight	   polyethylene	   (UHMWPE)	   discs	   was	   compared	   and	  
related	   to	   the	   efficacy	   of	   gentamicin	   against	   these	   biofilms.	   Six	   hours	   old	  
staphylococcal	  biofilms	  were	  grown	  on	  Ti,	   Co-­‐Cr	  and	  UHMWPE	  discs,	   after	  which	  
growth	  was	  continued	  for	  another	  18	  h	  in	  the	  absence	  or	  presence	  of	  gentamicin	  (6	  
mg/mL).	  Biofilms	  were	  evaluated	  in	  terms	  of	  the	  number	  of	  adhering	  bacteria,	  their	  
live/dead	  ratio	  and	  metabolic	  activity	  on	  the	  different	  biomaterials.	  The	  number	  of	  
bacteria	   in	   the	   6	   h	   biofilms	   was	   similar	   on	   all	   biomaterials,	   with	   minor	   strain	  
dependent	  differences.	  Metabolic	  activity	  per	  bacterium	  in	  6	  h	  old	  biofilms	  prior	  to	  
growth	  was	  significantly	  lower	  in	  3	  out	  of	  the	  5	  strains	  in	  biofilms	  on	  hydrophobic	  
UHMWPE	  as	  compared	  with	  more	  hydrophilic	  Ti	  and	  Co-­‐Cr.	  The	  reduction	  of	  viable	  
organisms	  after	  18	  h	  subsequent	  growth	  in	  the	  presence	  of	  gentamicin	  compared	  
to	   biofilms	   grown	   in	   absence	   of	   gentamicin	   was	   lowest	   on	   UHMWPE,	   but	   no	  
statistically	   significant	   correlation	  was	   found	  between	   lower	  metabolic	   activity	   at	  
the	   onset	   of	   growth.	   Orthopaedic	   biomaterials	   were	   revealed	   to	   influence	  
metabolic	   activity	   of	   staphylococcal	   biofilms,	   but	   metabolic	   activity	   did	   not	  
correlate	  with	  staphylococcal	  killing	  by	  gentamicin	  in	  24	  h	  old	  biofilms.	  	  
The	   in	   vivo	   influence	   of	   Co-­‐Cr	   and	   UHMWPE	   particles	   on	   the	   risk	   of	  
infection	   was	   compared	   by	   injecting	   particles	   with	   or	   without	   bioluminescent	   S.	  
aureus	   Xen36	   in	   air	   pouches,	   prepared	   in	   subcutaneous	   tissue	   of	   immuno-­‐
competent	   BALB/c	   mice	   (Chapter	   6).	   Bioluminescence	   was	   monitored	  




particles.	   After	   termination,	   air	   pouch	   fluid	   and	   air	   pouch	   membranes	   were	  
cultured	   and	   histologically	   analyzed.	   Bioluminescence	   was	   initially	   lower	   in	   mice	  
exposed	   to	   UHMWPE	   particles	   with	   staphylococci	   than	   in	   mice	   injected	   with	  
staphylococci	   only.	   For	   mice	   exposed	   to	   Co-­‐Cr	   particles	   with	   staphylococci,	  
bioluminescence	  was	  observed	  to	  be	  higher	  in	  two	  out	  of	  six	  animals	  compared	  to	  
the	  presence	  of	   staphylococci	   alone.	  Accordingly,	   a	  high	  number	  of	  macrophages	  
was	   found	   in	   the	   air	   pouch	   of	   the	  mouse	   showing	   the	  most	   prolonged,	   elevated	  
bioluminescence.	  In	  the	  majority	  of	  mice,	  infection	  risk	  in	  the	  absence	  or	  presence	  
of	  Co-­‐Cr	  and	  UHMWPE	  particles	  appeared	   similar,	   assuming	   that	   the	   longevity	  of	  
an	  elevated	  bioluminescence	   is	   indicative	  of	  a	  higher	   infection	   risk.	  However,	   the	  
presence	   of	   Co-­‐Cr	   particles	   yielded	   a	   higher	   infection	   in	   two	   out	   of	   six	   mice,	  
possibly	   because	   the	   macrophage	   degradative	   function	   was	   hampered	   by	   the	  
presence	  of	  Co-­‐Cr	  particles.	  	  
Lastly,	   2720	   revisions	   from	   the	   Australian	   national	   joint	   replacement	  
registry	   were	   reviewed	   at	   a	   mean	   of	   3.4	   years	   after	   the	   primary	   procedure,	  
comparing	   the	   infection	   data	   on	   metal-­‐on-­‐metal	   (MOM)	   versus	   metal-­‐on-­‐
polyethylene	  (MOP)	  prostheses	  (Chapter	  7).	  Comparisons	  were	  made	  between	  age,	  
gender,	   indications	   for	   the	   index	   procedure	   and	   head	   size	   of	   the	   prosthesis	  
between	   patients	  with	  MOM	   and	  MOP	   implants	   using	   Pearson's	   chi-­‐square	   test.	  
Cox	   proportional-­‐hazard	   models	   were	   performed	   to	   determine	   predictors	   of	  
revision	  for	   infection.	  Cumulative	  curves	  were	  used	  to	  describe	  the	   infection-­‐	  and	  
non-­‐infection	   revision	   risk.	   In	   total,	   100,906	   hip	   arthroplasties,	   of	   which	   17,510	  
MOM	   and	   83,396	   MOP	   implants,	   were	   performed	   during	   our	   study	   period.	   Of	  
these,	  2720	  prostheses	  were	  revised	  (2.7%	  of	  total).	  The	  overall	  cumulative	  8-­‐year	  
revision	   rate	   was	   5%,	   6%	   for	   MOM	   implants	   and	   5%	   for	   MOP	   prostheses.	   The	  
cumulative	  8-­‐year	  revision	  rate	  for	  infection	  was	  1.2%	  for	  MOM	  implants	  and	  0.8%	  
for	  MOP	  prostheses.	  MOM	  bearings	  with	  a	  head	  size	  >	  32	  mm	  had	  a	  hazard	  ratio	  
for	   revision	   of	   1.24	   compared	   to	  MOP	   prostheses	  with	   a	   head	   size	   ≤	   32	  mm.	   In	  
addition,	  MOM	  bearings	  with	  a	  head	  size	  >	  32	  mm	  were	  found	  to	  be	  revised	  more	  
often	  for	  infection	  (0.3	  revisions	  per	  100	  observed	  years)	  compared	  to	  prostheses	  
with	  a	  smaller	  head	  size	  (0.1	  revisions	  per	  100	  observed	  years).	   In	  conclusion,	  the	  
Australian	   National	   Joint	   Registry	   revealed	   significantly	   higher	   revision	   rates	   of	  
MOM-­‐implants,	  specifically	  with	  a	  head	  size	  >	  32	  mm	  compared	  to	  MOP	  prostheses.	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The	  results	  from	  the	  studies	  as	  delineated	  above	  were	  interpreted	  in	  view	  
of	   the	   general	   influence	   of	   MOM	   wear	   debris	   on	   deep	   infections	   (Chapter	   8).	  
Overall,	  Co-­‐Cr	  particles	  may	  hamper	  macrophage	  functioning	  yielding	  an	  increased	  
risk	   of	   prolonged	   bacterial	   presence	   post-­‐surgery	   as	   compared	   with	   UHMWPE	  
particles.	   Whether	   or	   not	   this	   conclusion	   may	   be	   extrapolated	   to	   the	   human	  












Het	   belangrijkste	   doel	   van	   dit	   proefschrift	   was	   om	   de	   invloed	   te	   bepalen	   van	  
slijtagepartikels	   van	   metaal-­‐op-­‐metaal-­‐heupprotheses	   (MOM-­‐heupprotheses)	   op	  
diepe	  infecties.	  Het	  eerste	  hoofdstuk	  bespreekt	  de	  klinische	  relevantie	  van	  dit	  doel	  
(Hoofdstuk	  1).	  	  
Uit	   	   literatuuronderzoek	   (Hoofdstuk	   2)	   blijkt	   dat	  MOM-­‐slijtageproducten	  
het	   immuunsysteem	   belemmeren,	   bacteriegroei	   remmen	   of	   juist	   stimuleren	   en	  
mogelijk	   verantwoordelijk	   zijn	   voor	   de	   resistentie	   tegen	   antibiotica	   en	   zware	  
metalen.	   Of	   de	   gecombineerde	   effecten	   van	   MOM-­‐slijtageproducten	   de	   MOM-­‐
heupprotheses	   meer	   of	   minder	   vatbaar	   maken	   voor	   infecties,	   vereist	   meer	  
onderzoek	  en	  behelst	  het	  doel	  van	  dit	  proefschrift.	  	  
Allereerst	  is	  het	  onbekend	  wat	  de	  gevolgen	  zijn	  van	  de	  corrosie	  die	  plaats	  
heeft	  bij	  cobalt-­‐chromium-­‐legeringen	  (Co-­‐Cr)	  op	  bacteriële	  groei.	  Daarom	  was	  het	  
doel	   van	   het	   eerste	   in	   vitro	   onderzoek	   (Hoofdstuk	   3)	   om	   de	   effecten	   van	   de	  
corrosieproducten	   te	   evalueren.	   Een	   verzameling	   van	   klinisch	   geïsoleerde	   en	  
commercieel	   beschikbare	   bacteriestammen	   werden	   blootgesteld	   aan	   Co-­‐Cr-­‐
ionenconcentraties,	   zoals	   aanwezig	   in	   het	   serum	   van	   patiënten	   met	   een	   MOM-­‐
prothese	   en	   hogere	   concentraties	   zoals	   verwacht	   in	   het	   aangrenzende	   weefsel.	  
Planktonische	   groei	   van	   bacteriën	   werd	   geremd	   door	   concentraties	   van	  
200.000/93.000	  µg/L	  Co-­‐Cr-­‐ionen.	  Co-­‐Cr-­‐ionen	  concentraties	  tot	  20/9,3	  µg/L,	  zoals	  
aanwezig	   in	   het	   serum,	   bleken	   geen	   consistente	   invloed	   te	   hebben	   op	   de	  
biofilmvorming,	   maar	   hogere	   concentraties	   van	   200.000/93.000	   µg/L	  
verminderden	   Staphylococcus	   aureus	   en	   Staphylococcus	   epidermidis	  
biofilmvorming	  aanzienlijk.	   Confocaal	   laser	   scanning	  microscopie	   liet	  weinig	  dode	  
bacteriën	   zien	   in	   de	   biofilms.	   De	   gebruikte	   concentraties	   Co-­‐Cr-­‐ionen	   moeten	  
daarom	   worden	   aangemerkt	   als	   groei-­‐remmend	   en	   niet	   bacterie-­‐dodend.	   De	  
resultaten	  suggereren	  dat	  Co-­‐Cr-­‐ionen	  de	  MOM-­‐prothesen	  minder	  gevoelig	  zouden	  
kunnen	  maken	  voor	  biofilmvorming	  en	  een	  daaropvolgende	  infectie.	  	  
Vervolgens	   (Hoofdstuk	   4)	   is	   de	   invloed	   van	   Co-­‐Cr-­‐partikels	   op	   biofilm	  
vorming	  onderzocht.	  Het	  biovolume	  van	  biofilms	  van	  staphylokokken	  werd	  bepaald	  
op	  polystyreen	  in	  de	  aan-­‐	  en	  afwezigheid	  van	  Co-­‐Cr-­‐partikels	  en	  Co-­‐Cr-­‐ionen.	  Drie	  
klinische	  en	  2	  commercieel	  verkrijgbare	  stammen	  werden	  gekweekt	  met	  2	  mg/mL	  
Co-­‐Cr-­‐partikels,	  of	  met	  concentraties	  van	  1000/500	  µg/L	  Co-­‐Cr-­‐ionen	  afkomstig	  van	  
Co-­‐Cr-­‐zouten	   of	   van	   het	   partikel-­‐supernatant,	   onder	   statische	   en	   dynamische	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groeicondities.	  Een	  dynamisch	  model	  simuleerde	  de	  condities	  die	  gelden	  voor	  een	  
biofilm	  in	  het	  menselijk	  lichaam,	  zoals	  gewrichtsvocht	  dat	  in	  mobiele	  patiënten	  met	  
heupprothesen	  constant	   in	  beweging	   is	  met	  bijbehorende	  flow-­‐krachten.	  Beelden	  
van	   24	   uur	   oude	   biofilms	   werden	   gemaakt	   met	   confocaal	   laser	   scanning	  
microscopie	  en	  geanalyseerd	  met	  het	  wiskundige	  computerprogramma	  COMSTAT.	  
Röntgen	   foto-­‐elektron	   spectroscopie	   (XPS)	   werd	   uitgevoerd	   om	   de	   elementaire	  
samenstelling	   van	   het	   partikeloppervlak	   te	   bestuderen.	   Karakterisering	   van	   de	  
partikels	   liet	   een	   met	   molybdeen	   verrijkte	   oxidelaag	   zien	   ten	   opzichte	   van	   de	  
bulkconcentratie.	   Bij	   de	   meeste	   bacteriestammen	   was	   er	   een	   tendens	   van	  
verminderde	   biofilmvorming	   in	   de	   aanwezigheid	   van	   Co-­‐Cr-­‐partikels	   ten	   opzichte	  
van	   de	   groei	   tijdens	   de	   blootstelling	   aan	   Co-­‐Cr-­‐ionen,	   maar	   dit	   was	   alleen	  
significant	   in	   één	   stam	   bij	   dynamische	   groeicondities	   (S.	   aureus	   7388).	  
Samenvattend,	   bleken	   Co-­‐Cr-­‐partikels	   alleen	   antibacteriële	   eigenschappen	   te	  
bezitten	  onder	  dynamische	  groeiomstandigheden.	  	  
In	  Hoofdstuk	  5	  is	  de	  metabole	  activiteit	  bepaald	  van	  3	  S.	  epidermidis	  en	  2	  
S.	  aureus	  stammen	  in	  biofilms	  gegroeid	  in	  tryptone-­‐soya-­‐groeimedium	  op	  titanium-­‐
legering-­‐	   (Ti-­‐),	   Co-­‐Cr-­‐	   en	   ultra-­‐hoog-­‐moleculair-­‐gewicht-­‐polyethyleen-­‐discs	  
(UHMWPE-­‐discs)	  en	  vergeleken	  met	  de	  effectiviteit	  van	  gentamicine	  op	  de	  biofilms.	  
Zes	   uur	   oude	   biofilms	   werden	   geïncubeerd	   op	   de	   discs	   van	   verschillend	  
orthopedisch	  materiaal,	  waarna	  18	  uur	  additionele	  groei	  in	  de	  aan-­‐	  en	  afwezigheid	  
van	   gentamicine	   (6	  mg/mL)	   volgde.	  De	   biofilms	  werden	  beoordeeld	   op	   basis	   van	  
het	   aantal	   bacteriën,	   hun	   live/dead	   ratio	   en	   hun	   metabole	   activiteit.	   Het	   aantal	  
bacteriën	   in	   de	   6	   uur	   oude	   biofilms	   was	   vergelijkbaar	   groot	   op	   alle	   discs,	   met	  
geringe	  stam-­‐afhankelijke	  verschillen.	  De	  metabole	  activiteit	  van	  bacteriën	  op	  meer	  
hydrofobe	   UHMWPE-­‐discs	   was	   lager	   in	   3	   van	   de	   5	   stammen	   dan	   in	   bacteriën	  
gehecht	   aan	   meer	   hydrofiele	   Ti-­‐	   en	   Co-­‐Cr-­‐discs. Het	   aantal	   levensvatbare	  
organismen	  na	  een	  additionele	  blootstelling	  aan	  gentamicine	   (18h)	   in	  vergelijking	  
met	   biofilms	   gekweekt	   in	   afwezigheid	   van	   gentamicine,	   was	   het	   hoogst	   op	  
UHMWPE-­‐discs	  vergeleken	  met	  het	  aantal	  op	  Ti-­‐	  en	  Co-­‐Cr-­‐discs.	  Het	  orthopedische	  
materiaal	   van	  de	  discs	  bleek	   van	   invloed	   te	   zijn	  op	  de	  metabole	   activiteit	   van	  de	  





In	  Hoofdstuk	   6	   zijn	  de	   in	   vivo	   effecten	  van	  Co-­‐Cr-­‐	   en	  UHMWPE-­‐partikels	  
op	  het	  risico	  van	  infectie	  vergeleken.	  Hiertoe	  werden	  de	  partikels	  geïnjecteerd	  met	  
of	  zonder	  bioluminescente	  S.	  aureus	  Xen36	  in	  luchtzakjes,	  die	  geprepareerd	  waren	  
in	   het	   subcutane	   weefsel	   van	   immuno-­‐competente	   BALB/c-­‐muizen.	  
Bioluminescentie	   werd	   gecontroleerd	   met	   een	   follow-­‐up	   van	   21	   dagen	   en	  
gecorrigeerd	  voor	  absorptie	  en	   reflectie	   van	  het	  bioluminescente	   signaal	  door	  de	  
partikels.	  Het	  vocht	  uit	  de	  luchtzakjes	  en	  het	  membraan	  van	  het	  luchtzakje	  werden	  
gekweekt	  en	  histologisch	  geanalyseerd.	  Bioluminescentie	  was	  aanvankelijk	  lager	  bij	  
muizen	   blootgesteld	   aan	   stafylokokken	   en	   UHMWPE-­‐partikels,	   dan	   in	   muizen	  
geïnjecteerd	   met	   stafylokokken	   alleen.	   Voor	   muizen	   blootgesteld	   aan	   Co-­‐Cr-­‐
partikels	  met	  stafylokokken	  werd	  een	  hogere	  bioluminescentie	  waargenomen	  in	  2	  
van	   de	   6	   dieren	   ten	   opzichte	   van	   de	   aanwezigheid	   van	   stafylokokken	   alleen.	   Er	  
werd	   een	   groot	   aantal	  macrofagen	   in	   het	   luchtzakje	   gezien	   van	   de	  muis	  met	   de	  
meest	  langdurige,	  verhoogde	  bioluminescentie.	  Bij	  de	  meerderheid	  van	  de	  muizen	  
blijkt	  hiermee	  het	  infectierisico	  bij	  de	  aan-­‐	  of	  afwezigheid	  van	  Co-­‐Cr-­‐	  en	  UHMWPE-­‐
partikels	  gelijk,	  uitgaande	  van	  de	  veronderstelling	  dat	  een	  hogere	  bioluminescentie	  
over	   een	   langere	   tijdsduur	   indicatief	   is	   voor	   een	   hoger	   infectierisico.	   Echter,	   de	  
aanwezigheid	  van	  Co-­‐Cr-­‐partikels	  zorgde	  voor	  een	  hoger	  infectierisico	  in	  2	  van	  de	  6	  
muizen,	   vermoedelijk	   vanwege	   de	   aantasting	   van	   macrofagen	   door	   de	  
aanwezigheid	  van	  Co-­‐Cr-­‐partikels.	  	  
Ten	   slotte	   (Hoofdstuk	   7)	   werden	   2720	   revisies	   van	   het	   Australische	  
nationale	  gewrichtsprothese	  register	  onderzocht,	  met	  name	  gericht	  op	  de	  infectie	  
gegevens	   van	   MOM-­‐	   versus	   MOP-­‐prothesen.	   Vergelijkingen	   tussen	   leeftijd,	  
geslacht,	  indicaties	  voor	  de	  primaire	  procedure	  en	  de	  kopgrootte	  van	  de	  prothese	  
werden	  gemaakt	  tussen	  patiënten	  met	  MOM-­‐	  en	  MOP-­‐protheses	  met	  behulp	  van	  
de	   Pearson	   chi-­‐kwadraat	   test.	   Cox	   proportionele	   hazard-­‐modellen	   werden	  
uitgevoerd	   om	   hun	   invloed	   op	   het	   infectie-­‐risico	   te	   bepalen.	   Cumulatieve	   curves	  
werden	  gebruikt	  om	  het	  risico	  op	  een	  septische	  en	  aseptische	  revisie	  te	  beschrijven.	  
100.906	   heuparthroplastieken,	  waarvan	   17.510	  MOM-­‐	   en	   83.396	  MOP-­‐protheses	  
werden	  verricht	  tijdens	  onze	  studie	  periode.	  Er	  hadden	  2720	  revisies	  plaats	  (2,7%	  
van	   het	   totaal).	   Het	   totale	   cumulatieve	   8-­‐jaars	   risico	   op	   revisie	   bedroeg	   5%,	   6%	  
voor	  MOM-­‐protheses	  en	  5%	  voor	  MOP-­‐prothesen.	  Het	  cumulatieve	  8-­‐jaars	  revisie	  
risico	  voor	   infectie	  was	  1,2%	  voor	  MOM-­‐protheses	  en	  0,8%	  voor	  MOP-­‐prothesen.	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MOM-­‐prothesen	  met	   een	   kopgrootte	   van	   >	   32	  mm	   bleken	   een	   hazard	   ratio	   van	  
1,24	  voor	  revisie	  te	  hebben	  ten	  opzichte	  van	  MOP-­‐prothesen	  met	  een	  kopgrootte	  ≤	  
32	   mm.	   Bovendien,	   MOM-­‐protheses	   met	   een	   kopgrootte	   >	   32	   mm	   bleken	   ook	  
vaker	  te	  worden	  gereviseerd	  voor	  een	  infectie	  (0,3	  revisies	  per	  100	  waargenomen	  
jaren)	   ten	   opzichte	   van	   prothesen	  met	   een	   kleinere	   kopgrootte	   (0,1	   revisies	   per	  
100	   waargenomen	   jaar).	   Concluderend,	   liet	   het	   Australische	   Nationaal	   Register	  
significant	  hogere	  revisie	  risico’s	  	  zien	  bij	  MOM-­‐protheses,	  in	  het	  bijzonder	  met	  een	  
kopgrootte	  >	  32	  mm,	  	  ten	  opzichte	  van	  MOP-­‐prothesen.	  	  
In	   Hoofdstuk	   8	   werden	   de	   resultaten	   van	   de	   studies	   zoals	   hierboven	  
afgebakend,	   geïnterpreteerd	   in	   het	   licht	   van	   de	   algemene	   invloed	   van	   MOM-­‐
slijtagedeeltjes	   op	   diepe	   infecties	   Wij	   concluderen	   dat	   Co-­‐Cr-­‐partikels	   het	  
functioneren	   van	   macrofagen	   kunnen	   belemmeren	   en	   dat	   dit	   leidt	   tot	   een	  
verhoogd	  risico	  op	  een	  langer	  durende	  aanwezigheid	  van	  bacteriën	  na	  een	  operatie	  
in	   vergelijking	   met	   UHMWPE-­‐partikels.	   Of	   deze	   conclusie	   kan	   worden	  







List	  of	  publications	  and	  
presentations	  
	  
List	  of	  publications	  and	  presentations	  
 
	  146	  
Comparison	   of	   techniques	   for	   correction	   of	  magnification	   of	   pelvic	   x-­‐rays	   for	   hip	  
surgery	   planning.	   	   B.	   The,	   J.W.J.	   Kootstra,	   A.H.	   Hosman,	   N.	   Verdonschot,	   C.L.E.	  
Gerritsma,	  R.L.	  Diercks.	  J	  Digit	  Imaging.	  2007	  Dec.	  	  
	  
A	   New	   Zealand	   national	   joint	   registry	   review	   of	   202	   total	   ankle	   replacements	  
followed	  for	  up	  to	  6	  years.	  A.H.	  Hosman,	  R.B.	  Mason,	  T.	  Hobbs,	  A.G.	  Rothwell.	  Acta	  
Orthop.	  2007	  Oct.	  	  
	  
Association	  between	  radiographic	  biomechanical	  determinants	  and	  RSA-­‐measured	  
wear	  rates	  in	  total	  hip	  arthroplasties.	  B.	  The,	  A.H.	  Hosman,	  J.W.J.	  Kootstra,	  V.	  Kralj-­‐
Iglic,	  G.	  Flivik,	  N.	  Verdonschot,	  R.L.	  Diercks.	  J	  Biomech.	  2008	  Oct.	  
	  
Metal-­‐on-­‐metal	  bearings:	   in	   vitro	   study	  on	   the	   influence	  of	   cobalt	   and	   chromium	  
ions	   on	   biofilm	   formation.	   A.H.	   Hosman,	   H.C.	   van	   der	   Mei,	   S.K.	   Bulstra,	   H.J.	  
Busscher,	  D.	  Neut.	  J	  Biomed	  Mater	  Res	  A.	  2008	  Mar.	  
	  
Effects	   of	  metal-­‐on-­‐metal	  wear	   on	   the	   host	   immune	   system	   and	   infection	   in	   hip	  
arthroplasty.	  A.H.	  Hosman,	  H.C.	   van	  der	  Mei,	   S.K.	  Bulstra,	  H.J.	  Busscher,	  D.	  Neut.	  
Acta	  Orthop.	  2010	  Oct.	  	  	  
	  
The	  influence	  of	  Co-­‐Cr	  and	  UHMWPE	  particles	  on	  infection	  risk	  -­‐	  an	  in	  vivo	  study	  in	  
mice.	   A.H.	   Hosman,	   S.K.	   Bulstra,	   J.	   Sjollema,	   H.C.	   van	   der	  Mei,	   H.J.	   Busscher,	   D.	  
Neut.	  Journal	  of	  Orthopaedic	  research	  2011.	  
	  
Influence	   of	   Co-­‐Cr	   particles	   and	   Co-­‐Cr	   ions	   on	   the	   growth	   of	   staphylococcal	  
biofilms.	   A.H.	   Hosman,	  H.C.	   van	   der	  Mei,	   R.	   Kuijer,	   S.K.	   Bulstra,	   H.J.	   Busscher,	   D.	  
Neut.	  Submitted	  
	  
Killing	   of	   staphylococcal	   biofilms	   on	   orthopaedic	   materials	   by	   gentamicin.	   A.H.	  
Hosman,	  S.K.	  Bulstra,	  H.C.	  van	  der	  Mei,	  H.J.	  Busscher,	  D.	  Neut.	  Submitted	  
	  
Total	  Ankle	  Replacement:	  The	  New	  Zealand	  Experience.	  Oral	  presentation,	  Foot	  &	  
Ankle	  Society	  Meeting	  2006,	  Wanaka,	  New	  Zealand	  
	  
Comparison	   of	   techniques	   for	   correction	   of	  magnification	   of	   pelvic	   x-­‐rays	   for	   hip	  
surgery	   planning.	   Oral	   presentation,	   Muscoloskeletal	   MRI	   and	   Interventional	  
Neuroradiology	  2007,	  Willemstad,	  Netherlands	  Antilles	  
	  
A	   New	   Zealand	   national	   joint	   registry	   review	   of	   202	   total	   ankle	   replacements	  
followed	  for	  up	  to	  6	  years.	  Oral	  presentation,	  Nordic	  Orthopaedic	  Federation	  2008,	  
Amsterdam,	  The	  Netherlands	  
	  
Metal-­‐on-­‐metal	  bearings	  in	  hip	  arthroplasties:	  Influences	  of	  cobalt	  chromium	  wear	  
debris	   on	   bacterial	   growth.	   Oral	   presentation,	   European	   Bone	   &	   Joint	   Infection	  
Society	  Meeting	  2009,	  Vienna,	  Austria	  
	  
Metal-­‐on-­‐metal	   wear	   and	   infection	   in	   total	   hip	   arthroplasty.	   Oral	   presentation,	  
Nordic	  Orthopaedic	  Federation	  2010,	  Århus,	  Denmark	  
	  	  
 
	   147	  
	  
	  












Graag	  zou	  ik	  iedereen	  willen	  bedanken	  voor	  alle	  hulp	  en	  adviezen	  in	  de	  afgelopen	  
jaren,	  in	  het	  bijzonder	  de	  navolgende	  mensen.	  
	  
Prof.	  dr.	   ir.	  H.J.	  Busscher,	  beste	  Henk,	   jij	   leerde	  mij	  met	  open	  vizier	  onderzoek	   te	  
doen	  en	  trok	  de	  rode	  draad	  door	  de	  onderzoeken	  heen.	  Naast	  het	  aansturen	  van	  
mij	  en	  tientallen	  andere	  promovendi,	  publiceer	  je	  als	  een	  wetenschappelijk	  kanon	  
en	  haal	  jij	  regelmatig	  grote	  fondsen	  binnen	  om	  dit	  allemaal	  te	  bekostigen.	  Jij	  hebt	  
de	   afdeling	   laten	   uitgroeien	   tot	   een	   gevestigde	   en	   gewaardeerde	  
wetenschapstoren	  waar	  het	  heel	  fijn	  werken	  was.	  Heel	  erg	  bedankt	  dat	  jij,	  ondanks	  
jouw	  drukke	  schema,	  altijd	   tijd	  vrij	   kon	  maken	  en	  het	  geduld	  opbracht	  om	  mij	   te	  
helpen.	  	  
	  
Prof.	  dr.	  H.C.	  van	  der	  Mei,	  beste	  Henny,	  het	  was	  een	  groot	  plezier	  om	  met	   jou	  te	  
mogen	   werken.	   Al	   vroeg	   vertelde	   je	   me	   dat	   ik	   altijd	   welkom	   was	   voor	   welk	  
ingewikkeld	  vraagstuk	  dan	  ook.	  Dat	  bleek	  niet	  alleen	  geruststellend,	  want	  bij	  crisis	  
in	   onderzoeksland	   was	   jouw	   opbouwende	   steun	   onmisbaar.	   Bedankt	   voor	   deze	  
hulp	  en	  alle	  bewonderenswaardige	  correcties	  in	  de	  manuscripten.	  
	  	  
Prof.	  dr.	  S.K.	  Bulstra,	  beste	  Sjoerd,	  	  jij	  bedacht	  het	  idee	  voor	  deze	  dissertatie.	  Vanaf	  
het	  moment	  dat	   jij	  mij	  de	  kans	  gaf	  om	  het	  promotietraject	  te	  starten,	  bleek	   jouw	  
klinische	  blik,	  steun	  en	  frisse	  humor	  onmisbaar.	  Bovenal	  wil	   ik	   je	  bedanken	  dat	   jij	  
mij	  de	  kans	  hebt	  gegeven	  om	  de	  opleiding	  tot	  orthopedisch	  chirurg	  te	  volgen:	  een	  
fijn	  toekomstperspectief.	  	  
Dr.	   ir.	  D.	  Neut,	  beste	  Daniëlle,	  bedankt	  voor	   jouw	  vele	  goede	   ideeën.	  Het	  was	  als	  
promovendus	  plezierig	  om	  een	  co-­‐promotor	  te	  hebben	  die	  volledig	  up-­‐to-­‐date	  was	  
met	   betrekking	   tot	   de	   literatuur	   en	   de	   allernieuwste	   technieken.	   Ik	   heb	   veel	  
waardering	   voor	   de	   helderheid	   en	   overzichtelijkheid	   waarmee	   je	   nieuwe	  
onderzoeksprojecten	  bedenkt.	  	  
Dr.	  B.	  The,	  beste	  Bertram,	  in	  de	  zomer	  van	  2003	  gaf	  jij	  mijn	  onderzoekscarrière	  een	  
vliegende	   start.	   Ik	  mocht	   samen	  met	   Johan	   Kootstra	   aan	   de	   slag	   in	   het	  Martini-­‐
meet-­‐team.	   Naast	   het	   feit	   dat	   jij	   mij	   co-­‐auteursschap	   van	   twee	   artikelen	   hebt	  
gegund,	   maakte	   je	   in	   vijf	   minuten	   mijn	   plannen	   voor	   een	   wetenschapsstage	   in	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Nieuw	  Zeeland	  compleet,	  wat	   leidde	  tot	  een	  frequent	  geciteerd	  artikel.	  Ook	  in	  de	  
kliniek	   had	   ik	   geen	   betere	   mentor	   kunnen	   hebben.	   Ontzettend	   bedankt	   voor	   al	  
jouw	  onmisbare	  hulp	  en	  enthousiasme.	  Je	  bent	  een	  lichtend	  voorbeeld.	  
	  
Prof.	  dr.	  J.E.	  Degener,	  Prof.	  dr.	  W.J.A.	  Dhert	  en	  Prof.	  dr.	  J.A.N.	  Verhaar,	  bedankt	  dat	  
u	  in	  de	  leescommissie	  van	  mijn	  proefschrift	  wilde	  plaatsnemen.	  	  
	  
Prof.	   dr.	   T.H.	   The,	  wat	  begon	  met	   een	   gesprek	  over	   Saabs	   aan	  de	   koffietafel	   van	  
een	  garage	  in	  Haren,	  leidde	  uiteindelijk	  tot	  een	  MD/PhD-­‐traject.	  Ik	  ben	  er	  natuurlijk	  
nog	  lang	  niet,	  maar	  ben	  vereerd	  dat	  u,	  als	  geestelijk	  vader	  van	  de	  Junior	  Scientific	  
Masterclass,	  mij	  zo	  geholpen	  heeft.	  	  
	  
Prof.	  dr.	  J.R.	  van	  Horn,	  ondanks	  het	  feit	  dat	  onze	  ontmoeting	  eenmalig	  is	  geweest,	  
wil	  ik	  u	  bedanken	  voor	  het	  vertrouwen	  dat	  u	  mij	  gaf	  om	  onderzoek	  te	  mogen	  doen	  
op	  uw	  afdeling.	  	  
	  
Dr.	  R.	  Kuijer,	  beste	  Roel,	  bedankt	   voor	   jouw	  steun	  en	  goede	  adviezen	  gedurende	  
het	  gehele	  promotietraject.	  	  
	  
Drs.	   A.L.	   Boerboom,	   beste	   Lex,	   ik	   weet	   dat	   je	   een	   hekel	   hebt	   aan	  
acknowledgements,	   maar	   ik	   wil	   je	   toch	   bedanken	   voor	   jouw	   steun	   sinds	   het	  
gouden	  Acta-­‐advies	  dat	   je	  gaf	   in	  2006.	  Ook	  daarna	  kon	   ik	  onder	   jouw	  hoede	  nog	  
contact	  met	  de	  kliniek	  houden.	  Voor	  het	  einde	  van	  de	  opleiding	  is	  ons	  artikel	  af!	  	  
	  
Dr.	   P.C.	   Baas,	   bedankt	   voor	   het	   vertrouwen	   om	   aan	   de	   slag	   te	   mogen	   op	   uw	  
afdeling	  in	  het	  Martini.	  Het	   is	  een	  grote	  stap	  van	  fulltime	  onderzoek	  naar	  de	  SEH,	  
maar	  dankzij	  alle	  goede	  begeleiding	  ervaar	  ik	  het	  tot	  nu	  toe	  al	  als	  een	  prachtige	  en	  
leerzame	  tijd.	  	  
	  
Dr.	   J.J.A.M.	   van	   Raaij,	   op	   uw	   afdeling	   mocht	   ik	   mijn	   eerste	   onderzoekservaring	  
opdoen.	  Volgens	  het	  opleidingsschema	  hoop	  ik	  straks,	  precies	  10	  jaar	  later,	  samen	  





Beste	   Ina,	   Willy,	   Ellen,	   Els	   en	   Yvonne,	   bedankt	   voor	   de	   heerlijk	   goede	   sfeer.	  
Daarnaast	   zorgen	   jullie	   er	   natuurlijk	   ook	   voor	   dat	   alles	   altijd	   goed	   komt	   en	   dat	  
stralen	  jullie	  dan	  ook	  uit.	  Heel	  erg	  bedankt	  voor	  jullie	  hulp.	  	  
	  
Iedereen	  van	  de	  afdeling	  orthopedie	   in	  het	  UMCG,	  het	  was	  een	  eer	  om	  met	   jullie	  
gewerkt	  te	  mogen	  hebben	  en	  een	  geweldige	  stimulans	  om	  weer	  snel	  terug	  te	  keren	  
naar	  de	  kliniek.	  Joris	  bedankt	  voor	  de	  zelfgemaakte	  wijn,	  heerlijk!	  
	  
Iedereen	  van	  de	  Centrale	  Dienst	  Proefdieren,	  bedankt	  voor	  jullie	  adequate	  hulp	  en	  
assistentie	  bij	  het	  belangrijkste	  hoofdstuk	  van	  dit	  boekje.	  
	  
Dr.	  J.	  Kuipers,	  beste	  Jeroen,	  bedankt	  voor	  de	  technische	  ondersteuning	  bij	  de	  SEM	  
in	  onze	  speurtocht	  naar	  micro-­‐	  en	  nanopartikels.	  	  	  
	  
Prof.	   dr.	   H.W.	   Frijlink	   en	   Floris	   Grasmeijer,	   bedankt	   voor	   jullie	   hulp	   in	   de	  
partikelredistributie.	  	  
	  
Dr.	   R.E.	   Stewart,	   beste	   Roy,	   bedankt	   voor	   de	   dagen	   samen	   ploeteren	   met	   de	  
registerdata.	  
	  
I	  am	  heartily	  thankful	  to	  the	  following	  persons	  for	  their	  share	  in	  discussing	  methods	  
or	  providing	  products	  we	  used	   in	  our	  experimental	  set	  ups:	   	  Dr.	   Imran	  Khan	  from	  
Biomet,	   Philippe	   van	   den	   Broeck	   from	   Clariant,	   Dr.	   Peter	   Ellison	   from	   the	   Corin	  
Group,	   Prof.	   dr.	   Alfons	   Fisscher	   and	   Dr.	   Robin	   Pourzal	   from	   the	   University	   of	  
Duisburg-­‐Essen,	  Dr.	  Joanne	  Tipper,	  Prof.	  dr.	  ir.	  Zhongmin	  Jin	  and	  Dr.	  Ian	  Leslie	  from	  
the	  University	  of	  Leeds.	  	  	  
	  
Prof.	   dr.	   Stephen	   Graves,	   I	   would	   like	   to	   thank	   you	   for	   your	   kind	   assistance	   in	  
providing	  us	  with	  the	  data	  from	  the	  AOANJRR	  and	  your	  help	  with	  the	  interpretation.	  	  
	  
I	   also	   would	   like	   to	   express	   my	   deepest	   gratitude	   to	   the	   Department	   of	  
Orthopaedic	   Surgery	  and	  Musculoskeletal	  Medicine	   in	  Christchurch.	  You	  gave	  me	  
the	   possibility	   to	   work	   on	   Registry	   data,	   which	   has	   proven	   to	   be	   a	   very	   useful	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experience.	  Thank	  you	  Alistair	  Rothwell,	  Rhett	  Mason,	  Tony	  Hobbs,	  Chris	  Frampton,	  
Lynley,	  Anne	  and	  Veronica.	  	  
	  
I	  would	  like	  to	  thank	  all	  colleagues	  at	  the	  Kolff	  Institute	  for	  the	  good	  years	  we	  had.	  
Especially	   I	  would	   like	  to	  thank	  Jesse,	  Ådam,	  Greg,	  Deepak,	  Agnieszka	  and	  Shariar	  
for	  providing	  me	  with	  sound	  advice	  and	  inspiration.	  
	  
Vrienden	  en	  familie,	  bedankt	  voor	  het	  maken	  van	  het	  leven.	  Jullie	  weten	  dat	  jullie	  
onmisbaar	  zijn.	  Laten	  we	  snel	  wat	  moois	  gaan	  doen!	  	  
	  
Beste	  paranimfen,	  als	  ware	  secundanten	  staan	  wij	  elkaar	  in	  het	  leven	  bij.	  En	  Berrie,	  
thanks	  voor	  het	  zijn	  van	  de	  perfecte	  grote	  broer.	  Jij	  bent	  uitstekend	  en	  Mette	  is	  dat	  
ook.	  
	  
Lieve	  paps	  &	  mams,	  in	  eerste	  instantie	  wilde	  ik	  jullie	  gewoon	  bedanken	  voor	  alles,	  
maar	  daarmee	  zou	  ik	  mij	  er	  te	  gemakkelijk	  van	  afmaken	  gezien	  hetgeen	  jullie	  voor	  
mij	  en	  deze	  promotie	  betekenen.	  In	  plaats	  daarvan	  zal	  ik	  de	  traditie	  voortzetten	  en	  
zo	  snel	  mogelijk	  ook	  zo’n	  blaagje	  (de	  wereld	  in)	  helpen	  en	  net	  als	  jullie	  zo	  steunen	  
tot	  een	  vergelijkbaar	  mooi	  moment	  als	  vandaag.	  	  
	  
Josephine,	  meisje	  van	  de	  zon,	  qui	  m'éclaire,	  mon	  univers,	  bedankt	  voor	  elke	  dag.	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